
<html lang="en"     class="pb-page"  data-request-id="e39b89ee-5eac-418e-b110-1aef106de31b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm7011276;issue:issue:10.1021/jmcmar.2008.51.issue-6;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of Prodrug 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Benzoate (TG100801): A Topically Administered Therapeutic Candidate in Clinical Trials for the Treatment of Age-Related Macular Degeneration" /></meta><meta name="dc.Creator" content="Moorthy S. S.  Palanki" /></meta><meta name="dc.Creator" content="Hideo  Akiyama" /></meta><meta name="dc.Creator" content="Peter  Campochiaro" /></meta><meta name="dc.Creator" content="Jianguo  Cao" /></meta><meta name="dc.Creator" content="Chun P.  Chow" /></meta><meta name="dc.Creator" content="Luis  Dellamary" /></meta><meta name="dc.Creator" content="John  Doukas" /></meta><meta name="dc.Creator" content="Richard  Fine" /></meta><meta name="dc.Creator" content="Colleen  Gritzen" /></meta><meta name="dc.Creator" content="John D.  Hood" /></meta><meta name="dc.Creator" content="Steven  Hu" /></meta><meta name="dc.Creator" content="Shu  Kachi" /></meta><meta name="dc.Creator" content="Xinshan  Kang" /></meta><meta name="dc.Creator" content="Boris  Klebansky" /></meta><meta name="dc.Creator" content="Ahmed  Kousba" /></meta><meta name="dc.Creator" content="Dan  Lohse" /></meta><meta name="dc.Creator" content="Chi Ching  Mak" /></meta><meta name="dc.Creator" content="Michael  Martin" /></meta><meta name="dc.Creator" content="Andrew  McPherson" /></meta><meta name="dc.Creator" content="Ved P.  Pathak" /></meta><meta name="dc.Creator" content="Joel  Renick" /></meta><meta name="dc.Creator" content="Richard  Soll" /></meta><meta name="dc.Creator" content="Naoyasu  Umeda" /></meta><meta name="dc.Creator" content="Shiyin  Yee" /></meta><meta name="dc.Creator" content="Katsutoshi  Yokoi" /></meta><meta name="dc.Creator" content="Binqi  Zeng" /></meta><meta name="dc.Creator" content="Hong  Zhu" /></meta><meta name="dc.Creator" content="Glenn  Noronha" /></meta><meta name="dc.Description" content="Age-related macular degeneration (AMD) is one of the leading causes of loss of vision in the industrialized world. Attenuating the VEGF signal in the eye to treat AMD has been validated clinically...." /></meta><meta name="Description" content="Age-related macular degeneration (AMD) is one of the leading causes of loss of vision in the industrialized world. Attenuating the VEGF signal in the eye to treat AMD has been validated clinically...." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 27, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm7011276" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm7011276" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm7011276" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm7011276" /></link>
        
    
    

<title>Development of Prodrug 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Benzoate (TG100801): A Topically Administered Therapeutic Candidate in Clinical Trials for the Treatment of Age-Related Macular Degeneration | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm7011276" /></meta><meta property="og:title" content="Development of Prodrug 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Benzoate (TG100801): A Topically Administered Therapeutic Candidate in Clinical Trials for the Treatment of Age-Related Macular Degeneration" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0007.jpeg" /></meta><meta property="og:description" content=" Age-related macular degeneration (AMD) is one of the leading causes of loss of vision in the industrialized world. Attenuating the VEGF signal in the eye to treat AMD has been validated clinically. A large body of evidence suggests that inhibitors targeting the VEGFr pathway may be effective for the treatment of AMD. Recent studies using Src/YES knockout mice suggest that along with VEGF, Src and YES play a crucial role in vascular leak and might be useful in treating edema associated with AMD. Therefore, we have developed several potent benzotriazine inhibitors designed to target VEGFr2, Src, and YES. One of the most potent compounds is 4-chloro-3-{5-methyl-3-[4-(2-pyrrolidin-1-yl-ethoxy)phenylamino]benzo[1,2,4]triazin-7-yl}phenol (5), a dual inhibitor of both VEGFr2 and the Src family (Src and YES) kinases. Several ester analogues of 5 were prepared as prodrugs to improve the concentration of 5 at the back of the eye after topical administration. The thermal stability of these esters was studied, and it was found that benzoyl and substituted benzoyl esters of 5 showed good thermal stability. The hydrolysis rates of these prodrugs were studied to analyze their ability to undergo conversion to 5 in vivo so that appropriate concentrations of 5 are available in the back-of-the-eye tissues. From these studies, we identified 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (12), a topically administered prodrug delivered as an eye drop that is readily converted to the active compound 5 in the eye. This topically delivered compound exhibited excellent ocular pharmacokinetics and poor systemic circulation and showed good efficacy in the laser induced choroidal neovascularization model. On the basis of its superior profile, compound 12 was advanced. It is currently in a clinical trial as a first in class, VEGFr2 targeting, topically applied compound for the treatment of AMD." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm7011276"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm7011276">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm7011276&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm7011276&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm7011276&amp;href=/doi/10.1021/jm7011276" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 1546-1559</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm0706618" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm070566z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Prodrug 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Benzoate (TG100801): A Topically Administered Therapeutic Candidate in Clinical Trials for the Treatment of Age-Related Macular Degeneration</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Moorthy+S.+S.++Palanki">Moorthy S. S. Palanki</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hideo++Akiyama">Hideo Akiyama</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Campochiaro">Peter Campochiaro</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianguo++Cao">Jianguo Cao</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chun+P.++Chow">Chun P. Chow</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luis++Dellamary">Luis Dellamary</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Doukas">John Doukas</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Fine">Richard Fine</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Colleen++Gritzen">Colleen Gritzen</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++Hood">John D. Hood</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Hu">Steven Hu</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shu++Kachi">Shu Kachi</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xinshan++Kang">Xinshan Kang</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Boris++Klebansky">Boris Klebansky</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ahmed++Kousba">Ahmed Kousba</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Lohse">Dan Lohse</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chi+Ching++Mak">Chi Ching Mak</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Martin">Michael Martin</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++McPherson">Andrew McPherson</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ved+P.++Pathak">Ved P. Pathak</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel++Renick">Joel Renick</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Soll">Richard Soll</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Naoyasu++Umeda">Naoyasu Umeda</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shiyin++Yee">Shiyin Yee</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katsutoshi++Yokoi">Katsutoshi Yokoi</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Binqi++Zeng">Binqi Zeng</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Zhu">Hong Zhu</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Glenn++Noronha">Glenn Noronha</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: +1-858-964-2136 . Fax: +1-858-678-0762. E-mail: <a href="/cdn-cgi/l/email-protection#24744548454a4f4d64504556434143414a0a474b49"><span class="__cf_email__" data-cfemail="98c8f9f4f9f6f3f1d8ecf9eafffdfffdf6b6fbf7f5">[email protected]</span></a></div><div class="corresp-fn" id="aff1">†TargeGen, Inc.</div><div class="corresp-fn" id="aff2">‡Johns Hopkins Hospital School of Medicine.</div><div class="corresp-fn" id="aff3">§BioPredict, Inc.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm7011276&amp;href=/doi/10.1021%2Fjm7011276" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 1546–1559</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 27, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 September 2007</li><li><span class="item_label"><b>Published</b> online</span>27 February 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 March 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm7011276" title="DOI URL">https://doi.org/10.1021/jm7011276</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1546%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMoorthy%2BS.%2BS.%2BPalanki%252C%2BHideo%2BAkiyama%252C%2BPeter%2BCampochiaro%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D6%26contentID%3Djm7011276%26title%3DDevelopment%2Bof%2BProdrug%2B4-Chloro-3-%25285-methyl-3-%257B%255B4-%25282-pyrrolidin-1-ylethoxy%2529phenyl%255Damino%257D-1%252C2%252C4-benzotriazin-7-yl%2529phenyl%2BBenzoate%2B%2528TG100801%2529%253A%2BA%2BTopically%2BAdministered%2BTherapeutic%2BCandidate%2Bin%2BClinical%2BTrials%2Bfor%2Bthe%2BTreatment%2Bof%2BAge-Related%2BMacular%2BDegeneration%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1559%26publicationDate%3DMarch%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm7011276"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2157</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">29</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm7011276" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Prodrug 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Benzoate (TG100801): A Topically Administered Therapeutic Candidate in Clinical Trials for the Treatment of Age-Related Macular Degeneration&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Moorthy&quot;,&quot;last_name&quot;:&quot;S. S. Palanki&quot;},{&quot;first_name&quot;:&quot;Hideo&quot;,&quot;last_name&quot;:&quot;Akiyama&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Campochiaro&quot;},{&quot;first_name&quot;:&quot;Jianguo&quot;,&quot;last_name&quot;:&quot;Cao&quot;},{&quot;first_name&quot;:&quot;Chun&quot;,&quot;last_name&quot;:&quot;P. Chow&quot;},{&quot;first_name&quot;:&quot;Luis&quot;,&quot;last_name&quot;:&quot;Dellamary&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Doukas&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Fine&quot;},{&quot;first_name&quot;:&quot;Colleen&quot;,&quot;last_name&quot;:&quot;Gritzen&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. Hood&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Shu&quot;,&quot;last_name&quot;:&quot;Kachi&quot;},{&quot;first_name&quot;:&quot;Xinshan&quot;,&quot;last_name&quot;:&quot;Kang&quot;},{&quot;first_name&quot;:&quot;Boris&quot;,&quot;last_name&quot;:&quot;Klebansky&quot;},{&quot;first_name&quot;:&quot;Ahmed&quot;,&quot;last_name&quot;:&quot;Kousba&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Lohse&quot;},{&quot;first_name&quot;:&quot;Chi&quot;,&quot;last_name&quot;:&quot;Ching Mak&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Martin&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;McPherson&quot;},{&quot;first_name&quot;:&quot;Ved&quot;,&quot;last_name&quot;:&quot;P. Pathak&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;Renick&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Soll&quot;},{&quot;first_name&quot;:&quot;Naoyasu&quot;,&quot;last_name&quot;:&quot;Umeda&quot;},{&quot;first_name&quot;:&quot;Shiyin&quot;,&quot;last_name&quot;:&quot;Yee&quot;},{&quot;first_name&quot;:&quot;Katsutoshi&quot;,&quot;last_name&quot;:&quot;Yokoi&quot;},{&quot;first_name&quot;:&quot;Binqi&quot;,&quot;last_name&quot;:&quot;Zeng&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Glenn&quot;,&quot;last_name&quot;:&quot;Noronha&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;1546-1559&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm7011276&quot;},&quot;abstract&quot;:&quot;Age-related macular degeneration (AMD) is one of the leading causes of loss of vision in the industrialized world. Attenuating the VEGF signal in the eye to treat AMD has been validated clinically. A large body of evidence suggests that inhibitors targeting the VEGFr pathway may be effective for the treatment of AMD. Recent studies using Src/YES knockout mice suggest that along with VEGF, Src and YES play a crucial role in vascular leak and might be useful in treating edema associated with AMD. Therefore, we have developed several potent benzotriazine inhibitors designed to target VEGFr2, Src, and YES. One of the most potent compounds is 4-chloro-3-{5-methyl-3-[4-(2-pyrrolidin-1-yl-ethoxy)phenylamino]benzo[1,2,4]triazin-7-yl}phenol (5), a dual inhibitor of both VEGFr2 and the Src family (Src and YES) kinases. Several ester analogues of 5 were prepared as prodrugs to improve the concentration of 5 at the back of the eye after topical administration. The thermal stability of these esters was studied, and it was&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7011276&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7011276" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7011276&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7011276" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7011276&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7011276" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm7011276&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7011276&amp;href=/doi/10.1021/jm7011276" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm7011276" /></input><a href="/doi/pdf/10.1021/jm7011276" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (669 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm7011276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm7011276%26sid%3Dliteratum%253Aachs%26pmid%3D18311895%26genre%3Darticle%26aulast%3DPalanki%26date%3D2008%26atitle%3DDevelopment%2Bof%2BProdrug%2B4-Chloro-3-%25285-methyl-3-%257B%255B4-%25282-pyrrolidin-1-ylethoxy%2529phenyl%255Damino%257D-1%252C2%252C4-benzotriazin-7-yl%2529phenyl%2BBenzoate%2B%2528TG100801%2529%253A%2BA%2BTopically%2BAdministered%2BTherapeutic%2BCandidate%2Bin%2BClinical%2BTrials%2Bfor%2Bthe%2BTreatment%2Bof%2BAge-Related%2BMacular%2BDegeneration%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D6%26spage%3D1546%26epage%3D1559%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291208" title="Hydrolysis">Hydrolysis</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/medium/jm-2007-011276_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011276&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Age-related macular degeneration (AMD) is one of the leading causes of loss of vision in the industrialized world. Attenuating the VEGF signal in the eye to treat AMD has been validated clinically. A large body of evidence suggests that inhibitors targeting the VEGFr pathway may be effective for the treatment of AMD. Recent studies using Src/YES knockout mice suggest that along with VEGF, Src and YES play a crucial role in vascular leak and might be useful in treating edema associated with AMD. Therefore, we have developed several potent benzotriazine inhibitors designed to target VEGFr2, Src, and YES. One of the most potent compounds is 4-chloro-3-{5-methyl-3-[4-(2-pyrrolidin-1-yl-ethoxy)phenylamino]benzo[1,2,4]triazin-7-yl}phenol (<b>5</b>), a dual inhibitor of both VEGFr2 and the Src family (Src and YES) kinases. Several ester analogues of <b>5</b> were prepared as prodrugs to improve the concentration of <b>5</b> at the back of the eye after topical administration. The thermal stability of these esters was studied, and it was found that benzoyl and substituted benzoyl esters of <b>5</b> showed good thermal stability. The hydrolysis rates of these prodrugs were studied to analyze their ability to undergo conversion to <b>5</b> in vivo so that appropriate concentrations of <b>5</b> are available in the back-of-the-eye tissues. From these studies, we identified 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (<b>12</b>), a topically administered prodrug delivered as an eye drop that is readily converted to the active compound <b>5</b> in the eye. This topically delivered compound exhibited excellent ocular pharmacokinetics and poor systemic circulation and showed good efficacy in the laser induced choroidal neovascularization model. On the basis of its superior profile, compound <b>12</b> was advanced. It is currently in a clinical trial as a first in class, VEGFr2 targeting, topically applied compound for the treatment of AMD.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88755" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88755" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the industrialized world, the leading causes of vision loss are diabetic retinopathy and age-related macular degeneration (AMD).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In both conditions, up-regulation of vascular endothelial growth factor (VEGF) leads to vascular dysfunction.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> In patients with diabetes, chronic hyperglycemia causes damage to vascular cells in the retina, resulting in capillary drop out and retinal ischemia. Retinal ischemia causes increased production of VEGF,<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> which promotes growth of new vessels along the surface of the retina (retinal neovascularization) and also causes pre-existent retinal vessels to become leaky. The development of retinal neovascularization heralds the onset of proliferative diabetic retinopathy, which often leads to blindness if untreated. The excessive leakage of plasma from pre-existent retinal vessels causes collection of fluid in the interstitial space of the macula, which is referred to as diabetic macular edema (DME). Collection of fluid in the macula causes loss of vision that is initially reversible if the leakage can be stopped, but if the edema is prolonged, structural damage occurs to retinal cells resulting in permanent loss of vision.</div><div class="NLM_p">In patients with AMD, a combination of oxidative damage and complement-mediated damage causes degeneration of photoreceptors and retinal pigmented (RPE) cells and gradual loss of vision. This gradual degeneration is generally referred to as “dry AMD” and by mechanisms that are not completely understood leads to up-regulation of VEGF in RPE cells, which in 20% of patients is sufficient to cause growth of neovascularization from the choroid into the sub-RPE and subretinal spaces (choroidal neovascularization) commonly referred to as “wet AMD”. Choroidal neovascularization tends to occur in the macula and is made up of fenestrated vessels that leak plasma causing subretinal and intraretinal fluid resulting in sudden loss of vision. As is the case with DME, the loss of vision from collection of excess fluid beneath and/or within the macula is initially reversible, but unless it is eliminated in a timely fashion, permanent visual loss occurs.</div><div class="NLM_p">Thus, VEGF-induced vascular leakage plays a central role in the vision loss associated with diabetic retinopathy and AMD.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7-10)</a> Ranibizumab (Lucentis TM, Genentech, South San Francisco, CA) is a humanized antigen binding fragment (Fab) that binds all isoforms of VEGF-A.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Monthly intraocular injections of ranibizumab caused significant visual improvement in patients with choroidal neovascularization due to AMD<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> and DME.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Bevacizumab, a humanized full-length monoclonal antibody that binds all isoforms of VEGF-A, has been approved for the treatment of colon cancer<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> but has also been given off-label by intraocular injection in patients with ocular diseases.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Intraocular injections are tolerated fairly well, but they carry some risks of infection and retinal detachment, and the more injections a patient receives, the greater is the risk. Also, returning for retinal examinations and possible injections every month is a hardship on many patients. Therefore, development of VEGF antagonists that can be delivered by less invasive means is a major priority for the treatment of AMD.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22 ref23">(17-23)</a></div><div class="NLM_p">Among angiogenic growth factors, the unique role of VEGF in disrupting endothelial barrier function has been established. Injection of exogenous VEGF into the eye of mice lacking Src or YES (Src<sup>−/−</sup> or YES<sup>−/−</sup>) did not compromise the endothelial barrier function clearly establishing a link between VEGF and Src in vascular leak.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Studies using chick embryos demonstrated that Src activity induced the coupling of focal adhesion kinase (FAK) to integrin α<sub>v</sub>β<sub>5</sub>, an important process in the VEGF-mediated signaling event in chick embryo blood vessels.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> When healthy mice were injected with VEGF intravitreally, the leakage of blood and serum into the retina and the vitreous was observed. However, intravitreal injection of VEGF to Src knockout mice did not result in the leakage of blood and serum establishing the role of Src in these disease conditions.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Apart from its role in AMD, Src is also known to be involved in oncology, osteopetrosis, and the matrix signaling pathway necessary for the maturation of osteoclasts.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> These results demonstrate that while VEGF plays a critical role in macular degeneration, Src and YES also play an important role in maintaining vascularity and the endothelial barrier.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Hence, we believe that small molecules targeting VEGFr, Src, and YES might offer a better therapeutic advantage over agents targeting VEGFr alone. Since both VEGF and Src are involved in several biological processes, topical application of drug to a local site might negate the side effects due to systemic circulation of an inhibitor.</div><div class="NLM_p">We focused on developing compounds that can be administered topically as eye drops and reach the back of the eye in sufficient concentrations for the treatment of back-of-the eye diseases, as in the case of AMD. In the case of AMD, therapeutically effective concentrations of a drug should be achieved in the sclera, choroid, and potentially the retina. It is also equally important that if the drug enters the systemic circulation, it should be cleared rapidly to lower the risk of accumulation and allay potential systemic effects. No compound in the market at present achieves these goals, and topical eye-drop delivery for back-of-the-eye disease is viewed with some skepticism because of the unique nature of the eye and the paucity of a systematic body of work, where back-of-the-eye tissues have been targeted and adequate drug level or therapeutic effect by topical delivery has been demonstrated.</div><div class="NLM_p last">We have recently disclosed a series of substituted benzotriazines as potent inhibitors of Src kinase,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and we have shown the potential utility of these compounds by demonstrating their activity in preclinical animal disease models of cancer.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> We designed these benzotriazines to potently inhibit Src, YES kinases, and VEGFr. Here, we present our efforts in optimizing the benzotriazine series starting with analogue <b>1</b> for its biochemical potency against VEGFr, Src, and YES. We also describe the further optimization of a subset of these benzotriazines to enhance ocular pharmacokinetics and to minimize systemic exposure, both of which we view as critical for a chronic therapy where localized effects in the eye are the target. We demonstrate that compound <b>12</b> is active in preclinical models when administered topically as an eye drop.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53732" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53732" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The compounds collated in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> were prepared as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. 4-Bromo-6-methyl-2-nitroaniline (<b>21</b>) was reacted with cyanamide and pyridine hydrochloride to give an intermediate guanidine. The guanidine was cyclized with 30% aqueous sodium hydroxide to give the 1-oxobenzotriazine <b>22</b>.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> The oxobenzotriazine <b>22</b> was reduced using Raney nickel and hydrogen in ethanol to give 3-amino-7-bromobenzotriazine <b>23</b> in good yield. Various aryl 7-substituted benzotriazines (<b>24a</b>−<b>e</b>) were prepared by treating 3-amino-7-bromo-5-methylbenzotriazine (<b>23</b>) with arylboronic acids such as 2-chloro-5-methoxyphenylboronic acid, phenylboronic acid, 2-chlorophenylboronic acid, 2,6-dimethylphenylboronic acid, and 2,6-dichlorophenylboronic acid to give <b>24a</b>−<b>e</b>, respectively, in good yield (50−70%) under Suzuki coupling conditions.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The advanced intermediates (<b>24b</b>−<b>e</b>) were treated with 4-(2-pyrrolidin-1-ylethoxy)bromobenzene (<b>25a</b>) under Buchwald−Hartwig cross-coupling reaction conditions using palladium and Xantphos to afford compounds <b>1</b>–<b>4</b>, respectively.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Similarly, the treatment of <b>24a</b> with various aryl bromides (<b>25a</b>−<b>e</b>) under Buchwald−Hartwig cross-coupling reaction conditions using palladium and Xantphos resulted in the intermediates (<b>26a</b>−<b>e</b>), respectively. The methoxy group in <b>26a</b>−<b>e</b> was cleaved using boron tribromide to give phenol analogues <b>5</b>–<b>9</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures of Benzotriazine Analogues and in Vitro Activities in Src and VEGFr2</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/medium/jm-2007-011276_0005.gif" alt="" id="_i5" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char=".">IC<sub>50</sub>, nM</th></tr><tr valign="top"><th align="left" valign="middle">compd</th><th align="char" valign="middle">R<sup>1</sup></th><th align="char" valign="middle">R<sup>2</sup></th><th align="center" valign="middle" char=".">Src</th><th align="center" valign="middle" char=".">VEGFr2</th><th align="center" valign="middle" char=".">YES</th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="left">Ph</td><td align="left">4-(2-pyrrolidin-1-ylethoxy)</td><td align="char" char=".">340</td><td align="char" char=".">530</td><td align="char" char=".">110</td></tr><tr valign="top"><td align="left"><b>2</b></td><td align="left">2-chlorophenyl</td><td align="left">4-(2-pyrrolidin-1-ylethoxy)</td><td align="char" char=".">35</td><td align="char" char=".">1900</td><td align="char" char=".">22</td></tr><tr valign="top"><td align="left"><b>3</b></td><td align="left">2,6-dimethylphenyl</td><td align="left">4-(2-pyrrolidin-1-ylethoxy)</td><td align="char" char=".">7</td><td align="char" char=".">560</td><td align="char" char=".">1.2</td></tr><tr valign="top"><td align="left"><b>4</b></td><td align="left">2,6-dichlorophenyl</td><td align="left">4-(2-pyrrolidin-1-ylethoxy)</td><td align="char" char=".">14</td><td align="char" char=".">130</td><td align="char" char=".">10</td></tr><tr valign="top"><td align="left"><b>5</b></td><td align="left">2-chloro-5-hydroxyphenyl</td><td align="left">4-(2-pyrrolidin-1-ylethoxy)</td><td align="char" char=".">1.8</td><td align="char" char=".">2.2</td><td align="char" char=".">0.3</td></tr><tr valign="top"><td align="left"><b>6</b></td><td align="left">2-chloro-5-hydroxyphenyl</td><td align="left">4-(2-pyrrolidin-1-ylethylaminosulfonyl)</td><td align="char" char=".">3.6</td><td align="char" char=".">4.7</td><td align="char" char=".">1.3</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="left">2-chloro-5-hydroxyphenyl</td><td align="left">4-(piperazin-1-ylcarbonyl)</td><td align="char" char=".">3.6</td><td align="char" char=".">1.8</td><td align="char" char=".">5.2</td></tr><tr valign="top"><td align="left"><b>8</b></td><td align="left">2-chloro-5-hydroxyphenyl</td><td align="left">4-(piperidin-4-ylsulfonyl)</td><td align="char" char=".">5.2</td><td align="char" char=".">1.7</td><td align="char" char=".">4.1</td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="left">2-chloro-5-hydroxyphenyl</td><td align="left">4-(3-pyrrolidin-1-ylpropyl)</td><td align="char" char=".">1.5</td><td align="char" char=".">2.7</td><td align="char" char=".">4.8</td></tr></tbody></table></div></div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/medium/jm-2007-011276_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0001.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011276&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) NH<sub>2</sub>CN, pyridine HCl, 100 °C, 12 h; (ii) 30% aqueous NaOH, 100 °C, 2 h; (b) 10% Raney nickel, H<sub>2</sub>, EtOH, room temp, 12 h; (c) R<sup>1</sup>B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME/EtOH/H<sub>2</sub>O, reflux, 12 h; (d) Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, reflux, 12 h; (e) BBr<sub>3</sub>, DCM, 0 °C to room temp; (f) Pd(OAc)<sub>2</sub>, Xantphos, K<sup>+</sup><i>t</i>-BuO<sup>−</sup>, dioxane, reflux, 12 h.</p></p></figure><div class="NLM_p">The synthesis of the compounds collected in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> is shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The treatment of <b>5</b> with acetyl chloride, isopropionyl chloride, benzoyl chloride, 4′-methylbenzoyl chloride, 2,2-dimethylpropionyl chloride, nicotinoyl chloride, 2,6-dimethylbenzoyl chloride, and 2,6-dichlorobenzoyl chloride resulted in compounds <b>10</b>, <b>11</b>, <b>12</b>, <b>13</b>, <b>14</b>, <b>17</b>, <b>18</b>, and <b>19</b>, respectively. Disodium phosphate analogue <b>15</b> was prepared from <b>5</b> by treating it with phosphorus oxychloride in the presence of triethylamine in dichloromethane, followed by sodium bicarbonate at room temperature. Glycinate analogue <b>16</b> was prepared by carbodiimide coupling of <b>5</b> with <i>tert</i>-butoxycarbonylaminoacetic acid, followed by the deprotection of butyloxycarbonyl using 5% trifluoroacetic acid in dichloromethane at room temperature. Compound <b>20</b> was also prepared by carbodiimide coupling of <b>5</b> with 4-(morpholin-4-ylmethyl)benzoic acid at room temperature.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Stability of Prodrugs of <b>5</b><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/medium/jm-2007-011276_0006.gif" alt="" id="_i7" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="bottom">R</th><th align="center" valign="middle">chem stability under autoclave conditions, %</th><th align="center" valign="middle">hydrolysis rate in rabbit eye homogenate, (ng/mL)/h</th></tr></thead><tbody><tr valign="top"><td align="left"><b>5</b></td><td align="left">H</td><td align="left">stable</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>10</b></td><td align="left">CH<sub>3</sub>CO</td><td align="left"><20</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="left">(CH<sub>3</sub>)<sub>2</sub>CO</td><td align="left">∼50</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="left">PhCO</td><td align="left">>90</td><td align="left">288</td></tr><tr valign="top"><td align="left"><b>13</b></td><td align="left"><i>p</i>-MePhCO</td><td align="left">>90</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>14</b></td><td align="left"><i>t</i>-BuCO</td><td align="left">>90</td><td align="left">172</td></tr><tr valign="top"><td align="left"><b>15</b></td><td align="left">Na<sub>2</sub>PO<sub>3</sub></td><td align="left"><20</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>16</b></td><td align="left">NH<sub>2</sub>CH<sub>2</sub>CO</td><td align="left"><20</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>17</b></td><td align="left">Nicotinoyl</td><td align="left">∼50</td><td align="left">ND</td></tr><tr valign="top"><td align="left"><b>18</b></td><td align="left">2,6-Dimethylbenzoyl</td><td align="left">>90</td><td align="left">1.1</td></tr><tr valign="top"><td align="left"><b>19</b></td><td align="left">2,6-Dichlorobenzoyl</td><td align="left">>90</td><td align="left">1.7</td></tr><tr valign="top"><td align="left"><b>20</b></td><td align="left">4-(morpholin-4-ylmethyl)benzoyl</td><td align="left">>90</td><td align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">The thermal stability of these prodrugs were measured at 120 °C for 1 h. The compounds that were stable to high temperature were selected and studied in rabbit eye homogenate for their ability to undergo hydrolysis to release <b>5</b>. ND = not determined.</p></div></div></div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/medium/jm-2007-011276_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0002.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011276&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) RCl, Et<sub>3</sub>N, DCM, room temp; (b) (i) POCl<sub>3</sub>, Et<sub>3</sub>N, DCM, room temp; (ii) NaHCO<sub>3</sub>, room temp; (c) (i) <i>tert</i>-butoxycarbonylaminoacetic acid, EDCI, DMAP, DMF, room temp; (ii) 5% TFA/DCM, room temp; (d) 4-(morpholin-4-ylmethyl)benzoic acid, EDCI, DMAP, DMF, room temp.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60228" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60228" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For clarity of discussion, only a selected group of compounds are shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> to describe the results of the structure−activity relationship studies. The 7-phenyl substituted analogue <b>1</b> showed modest inhibitory activity against both Src (IC<sub>50</sub> = 340 nM) and VEGFr2 (IC<sub>50</sub> = 530 nM). The introduction of a single chloro group at the 2-position of the 7-phenyl ring resulted in approximately a 10-fold increase in the activity against Src but resulted in a 4-fold drop in potency against VEGFr2 as seen with compound <b>2</b>. The introduction of two methyl groups at the 2 and 6 positions of the 7-phenyl group resulted in <b>3</b>, which increased its potency against Src (IC<sub>50</sub> = 7 nM) compared to <b>2</b>. Similarly compound <b>3</b> showed approximately 4-fold improvement in potency against VEGFr2 (IC<sub>50</sub> = 560 nM). The potency was improved approximately 4-fold against both Src and VEGFr2 when the dimethyl groups on the 7-phenyl ring were replaced with dichloro groups as shown in <b>4</b>. While compound <b>4</b> has acceptable biochemical potency against Src, it is 9 times weaker against VEGFr2. Consistent with earlier studies, the introduction of small hydrophobic ortho substituents on the phenyl ring orients this group perpendicular to the benzotriazine, resulting in improved binding with Src and VEGFr2.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Chloro substituents at the ortho position improve potency against VEGFr2.</div><div class="NLM_p">Further lead optimizations were carried out with the aid of molecular modeling studies. At the time the work was started, there was no crystal structure available for fully activated Src. As such, a homology model of activated Src was constructed on the basis of the activated crystal structure of Lck.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Crystal structures for fully activated VEGFr2 were available from the outset of work.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A depicts the binding of <b>2</b> at the ATP binding pocket of Src. The 2-chlorophenyl group was bound deep inside a hydrophobic pocket near the αC-helix. Glu310 located on the αC-helix and available only upon activation was in proximity to the phenyl group. The benzotriazine ring interacts with the ATP binding hinge region. We noticed that compound <b>2</b> in VEGFr2 was binding in a similar fashion to <b>2</b> in Src. The 2-chlorophenyl group is in proximity to Glu885 from the αC-helix in VEGFr2 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B). We therefore designed molecules with a donor moiety to interact with Glu310 in Src and Glu885 in VEGFr2 to enhance potency. On the basis of earlier lead optimization efforts, we decided to focus our initial efforts on the hydrophobic pocket where the 7-(2-chlorophenyl) group binds. We observed that Glu310 located on the αC helix deep within the hydrophobic pocket orients the carboxylic acid group of Glu310 toward the inside of the hydrophobic pocket in proximity to the 7-phenyl group. We envisioned that one could take advantage of this carboxylic group by incorporating a donor group at the 5-position of the 7-(2-chlorophenyl) group of <b>2</b>. This donor would potentially interact with the carboxylic acid and enhance its potency further (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C). Compound <b>5</b> was designed on the basis of these design ideas suggested by the homology model. Similar homology modeling studies using a VEGFr model also revealed that Glu883 on the αC-helix near the hydrophobic pocket orients the carboxylic group toward the meta position of the 7-phenyl ring. Homology modeling also showed that compound <b>5</b> binds to the ATP pocket of VEGFr2 in a similar fashion to the binding mode seen in Src and the hydroxy group of <b>5</b> interacts with Glu883 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>D). Modeling studies suggested that the hydroxyl group on the meta position of the 7-phenyl ring increases the potency of <b>5</b> toward both Src and VEGFr2 via these Glu hydrogen-bonding interactions. Interactions with this Glu deep within this hydrophobic pocket enhance dipole-charged interactions because of the low dielectric environment. This added interaction further stabilizes the activated form of Src. The concept of taking advantage of a carboxylic group buried deep within this hydrophobic pocket has been explored recently.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> It is noted that the homology models have limitations in the sense that it is well-known that active sites of kinases have sufficient flexibility to accommodate inhibitors through induced fit. We have disclosed the complete details of this design strategy targeting Src and utilized the above concept in developing different structural classes of compounds, selectively targeting and optimizing against different kinases.<a onclick="showRef(event, 'ref30 ref38'); return false;" href="javascript:void(0);" class="ref ref30 ref38">(30, 38)</a></div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/medium/jm-2007-011276_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Compound <b>2</b> at the ATP pocket of Src. The Glu310 from αC-helix is in proximity to the 7-phenyl ring. (B) Compound <b>2</b> at the ATP pocket of VEGFr2. The Glu885 from the αC-helix is in proximity to the 7-phenyl ring. (C) Compound <b>5</b> at the ATP pocket of Src. (D) Compound <b>5</b> at the ATP pocket of VEGFr2. The molecular surface is colored according to the hydrophobicity of the surrounding residues; blue is hydrophilic, and red is hydrophobic. The hydroxyl group of <b>5</b> acts as hydrogen bond donor and interacts with Glu310 in Src (C). The binding orientation of <b>5</b> in the VEGFr pocket is very similar to that of <b>5</b> in Src (D). There are two hydrogen bond interactions between the benzotriazine ring and Cys919 that serves as the hinge. The hydroxyl group on <b>5</b> acts as hydrogen bond donor and interacts with Glu885.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011276&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C depicts a minimized binding mode of a benzotriazine inhibitor <b>5</b> in the ATP pocket of the activated Src model, and the binding interactions are summarized as follows. The 7-substituted phenyl ring binds in the hydrophobic back pocket, positioning this phenyl ring perpendicular to the benzotriazine core. Our earlier studies<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> showed that a limited set of small hydrophobic groups may be substituted on this phenyl ring at very specific positions because the 7-phenyl binding pocket possesses a limited tolerance for larger groups. The 3-aminobenzotriazine moiety forms both donor and acceptor hydrogen bonds to Met341 in the hinge region, thus sharing a common site with the hinge binding purine ring of ATP. The 3-amino group from the benzotriazine core is attached to an aryl linker in a region of the ATP, which falls in the hydrophobic channel leading out toward a solvent accessible area. The spacer with a solublizing group binds in an area accessible to solvent. Benzotriazine inhibitors containing basic nitrogen in this region provide enhanced potency through protonation and interaction with Asp348.</div><div class="NLM_p">As anticipated, compound <b>5</b> showed improved potency toward both Src and VEGFr2. Compound <b>5</b> was 8 times more potent against Src and 60 times more potent against VEGFr2 compared to <b>2</b>. By keeping the 2-chloro-5-hydroxyphenyl group constant at the 7-position of the benzotriazine ring, we introduced several different groups at the R<sup>2</sup> position to further optimize this series. Compounds <b>6</b>–<b>9</b> showed equivalent potency to <b>5</b> with the designed donor interaction being the dominant driver of the potency. On the basis of the structure–activity relationship, compound <b>5</b> was selected for further studies.</div><div class="NLM_p">It is known that upon stimulation with VEGF, the intracellular signals leading up to various mitogen activated map kinases and focal adhesion kinases are activated via Src family kinases, resulting in retinal microvascular endothelial cells (RMECs) dysregulation, proliferation, and differentiation in retinopathies. The ability of compound <b>5</b> to block VEGF-stimulated proliferation was evaluated in retinal microvascular endothelial cells (hRMVECs) in vitro. Compound <b>5</b> showed very good biochemical potency in Src, VEGFr2, and YES<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> biochemical assays. In this study, <b>5</b> was shown to inhibit hRMVEC cell proliferation, with an IC<sub>50</sub> = 610 ± 72 nM. This suggests that <b>5</b> has the therapeutic potential to inhibit VEGF function in ocular endothelial cells, a contributing factor to pathological angiogenesis in diseases such as AMD and PDR.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">Next, we examined the tissue levels of compound <b>5</b> in various parts of the eye to evaluate the compound’s ability to penetrate to the back of the eye (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). A dose of 70 µg (137 nmol) of <b>5</b> in 10 µL (0.7% w/v solution of <b>5</b> in 27% w/v PL90G formulation in water) was administered topically to an eye. The concentrations of <b>5</b> were measured at two different locations. A concentration of 23.4 µM (<i>C</i><sub>max</sub>) was reached in 30 min (<i>T</i><sub>max</sub> = 0.5 h) in the choroid and the sclera. However, the levels of compound <b>5</b> in the retina were relatively low (AUC<sub>0–24h</sub> = 3.2 h·µg/mL). It is important for the compound to reach sufficient concentrations in the choroid and sclera in patients with AMD. However, in the case of patients with other blinding eye diseases (DME, for example), it is equally important for the drug to reach sufficient concentrations in the choroid and sclera as well as in the retina. The half-life of <b>5</b> in ocular tissues was very short; hence, the compound was administered topically minimum t.i.d. to maintain appropriate drug levels in the eye.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The maximum concentration one can achieve in formulations using compound <b>5</b> was 0.7% w/v. Further increase in concentration resulted in the precipitation of the material out of the solution. Since the compound solubility in the formulation was low, it was difficult to achieve the required concentration through a 10 µL drop. It is not advisable to administer a larger volume, since larger amount of the solution readily runs from the eyes, creating inconsistent results. Because of low levels of compound <b>5</b> in the retina, it was necessary to increase the frequency of administration to maintain sufficient levels in the eye. We also noticed that the increased frequency of administration of <b>5</b> caused irritation in the eyes of the animals. The eye irritation and low levels in retina coupled with short half-life (<i>T</i><sub>1/2</sub> = 0.5 h) made this compound less suitable for further development. One of the desirable properties of <b>5</b> is the lack of detectable levels in systemic circulation.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Exposure Levels of <b>5</b> in Ocular Tissues Following Single Bilateral Topical Instillation of <b>5</b> or <b>12</b> in Mice<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd administered</th><th align="center" valign="middle">compd measured</th><th align="center" valign="bottom">tissue</th><th align="center" valign="bottom"><i>T</i><sub>max</sub> (h)</th><th align="center" valign="bottom"><i>C</i><sub>max</sub> (µM)</th><th align="center" valign="middle">AUC (h·µg/mL)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>5</b></td><td align="left"><b>5</b></td><td align="left">retina</td><td align="left">0.5</td><td align="left">3.6</td><td align="left">3.2</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left">choroid/sclera</td><td align="left">0.5</td><td align="left">23</td><td align="left">240</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left">cornea</td><td align="left">0.5</td><td align="left">64</td><td align="left">560</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left">plasma</td><td align="left">6</td><td align="left">0.0020</td><td align="left">NS</td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="left"><b>12</b></td><td align="left">retina</td><td align="left">24</td><td align="left">5.3</td><td align="left">63</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left">choroid/sclera</td><td align="left">24</td><td align="left">27</td><td align="left">430</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left">cornea</td><td align="left">24</td><td align="left">3.7</td><td align="left">55</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left">plasma</td><td align="left">NS</td><td align="left">NS</td><td align="left">NS</td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="left"><b>5</b></td><td align="left">retina</td><td align="left">24</td><td align="left">2.4</td><td align="left">35</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left">choroid/sclera</td><td align="left">24</td><td align="left">29</td><td align="left">540</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left">cornea</td><td align="left">7</td><td align="left">33</td><td align="left">670</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left">plasma</td><td align="left">24</td><td align="left">0.0050</td><td align="left">NS</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">A 10 µL drop of <b>5</b> (70 µg, 137 nM) was instilled per eye to 20 male mice (C57BL/6). Similarly, a 10 µL drop of <b>12</b> (100 µg, 172 nM) was instilled per eye to 20 male mice (C57BL/6). Composite sampling was employed to generate tissue concentration−time profiles for <b>5</b> and <b>12</b> over the following time course (<i>N</i> = 4/time point): 0.5, 1, 3, 7, and 24 h postinstillation. Both eyes were removed from each mouse and dissected to obtain the cornea, retina, and eye cup (sclera and choroid). The maximum tissue concentrations of <b>5</b> were 3.6 and 23.4 µM for retinal and choroidal/sclera tissues, respectively, observed at 30 min postadministration for both tissues. Minimal system exposure (plasma concentrations, ≤2 nM) was observed for <b>5</b> following topical administration. Topical administration of <b>12</b> provided substantial posterior ocular tissue exposure to <b>5</b> and <b>12</b>. Conversion of <b>12</b> to the active <b>5</b> was observed in all ocular tissues. On the basis of total <b>5</b> tissue exposure (AUC<sub>0–24h</sub>), the topical instillation of the prodrug formulation resulted in an 11-fold increase in retinal tissue exposure versus topical delivery of <b>5</b>. NS: insufficient data for calculation of pharmacokinetic parameters.</p></div></div></div><div class="NLM_p">In order to attain adequate exposure of <b>5</b> in the relevant ocular tissues, followed by poor systemic levels, we decided to improve the back-of-the-eye tissue exposure levels of <b>5</b> through the preparation of prodrugs that masked the hydroxyl group. We reasoned that these ester prodrugs would be readily cleaved under physiological conditions to release the active drug in the eye.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> It was anticipated that the prodrugs would have better and more sustained ocular exposure levels in the relevant back-of-the-eye tissues and would undergo hydrolysis to release the drug. It was also anticipated that if the prodrug or drug enters systemic circulation, it would be cleared very quickly, since <b>5</b> has rapid clearance when given systemically.</div><div class="NLM_p">Several prodrugs were prepared and evaluated on the basis of two important criteria. First, in order to develop these compounds further, they have to be stable under thermal sterilization conditions. The prodrugs <b>10</b>−<b>20</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) were evaluated for their thermal stability at 120 °C for 1 h as a harsh accelerated test for thermal stability. The parent compound <b>5</b> was stable under these conditions. However, prodrugs such as the acetyl ester <b>10</b>, isopropyl ester <b>11</b>, sodium phosphate ester <b>15</b>, and glycine ester <b>16</b> all underwent rapid hydrolysis under thermal conditions to give <b>5</b>. Aliphatic esters were rapidly hydrolyzed compared to aromatic esters under thermal conditions. Since these esters were not stable under such harsh conditions, they are very likely not suitable for further development as drug candidates. Benzoyl ester <b>12</b>, 4-methylbenzoyl ester <b>13</b>, pivaloyl ester <b>14</b>, 2,6-dimethylbenzoyl ester <b>18</b>, and 2,6-dichlorobenzoyl ester <b>19</b> were stable under these conditions, and only less than 10% of the compound was hydrolyzed to form <b>5</b>. The second criterion for a prodrug is its ability to undergo hydrolysis to release the active drug in the eye. Thus, we selected four compounds (<b>12</b>, <b>14</b>, <b>18</b>, and <b>19</b>) that were stable under thermal conditions to study their hydrolysis rates in rabbit eye homogenates. Both 2,6-dimethylbenzoyl ester (<b>18</b>) and 2,6-dichlorobenzoyl ester (<b>19</b>) were very resistant to hydrolysis, as indicated by very low hydrolysis rates of 1.1 and 1.7 (ng/mL)/h, respectively. Both benzoyl ester <b>12</b> and pivaloyl ester <b>14</b> underwent hydrolysis at a moderate rate, 288 and 172 (ng/mL)/h, respectively, to generate compound <b>5</b>. As anticipated, the aromatic esters with substituents at the ortho positions were resistant to hydrolysis by esterase. The ortho substituents were introduced to modulate the ester hydrolysis by esterases. On the basis of these favorable properties, compound <b>12</b> was selected for further studies.</div><div class="NLM_p">Since compound <b>12</b> was chosen for clinical development on the basis of a combined set of drug substance and drug product properties, we will focus the rest of this article on <b>12</b>. Ocular pharmacokinetics using compound <b>12</b> were studied in mice, and the data are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. A single drop of 10 µL containing 100 µg (172 nM) of solution of compound <b>12</b> was instilled per eye. Both compounds <b>5</b> and <b>12</b> were detected in the eyes where drops were instilled, suggesting that the prodrug was hydrolyzed to <b>5</b>. While the amount of compound <b>5</b> seen in the choroid/sclera upon administration of compound <b>12</b> reached concentrations similar to that achieved by direct administration of compound <b>5</b>, this was not the case in the retina.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Much higher levels of <b>5</b> were seen in the retina upon topical eye drop administration of <b>12</b>. Both compounds <b>5</b> and <b>12</b> were seen in the choroid and sclera as well as in the retina for more sustained periods of time. The concentrations of <b>5</b> and <b>12</b> in retina upon instillation of <b>12</b> was >30-fold in retina when compared to that of <b>5</b> upon direct instillation of <b>5</b>. Upon instillation of <b>12</b>, the levels of both <b>5</b> and <b>12</b> reached a maximum in 24 h in the sclera/choroid<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and in the retina. The conversion of <b>12</b> to <b>5</b> was observed in both the retina and the sclera/choroids tissue samples. The sustained levels of <b>5</b> and <b>12</b> in the eye enable us to use a q.d. or q.o.d. dosing schedule. This dosing schedule also showed no eye irritation in the animal models. The plasma concentrations of both <b>5</b> and <b>12</b> were below the limit of detection (<1 ng/mL) at all time points after topical administration of <b>12</b>, suggesting that the compounds are not entering into systemic circulation.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The lack of compounds <b>5</b> and <b>12</b> in systemic circulation is very beneficial, as VEGFr2 inhibitors in systemic circulation are not desirable because of the role VEGFr plays in various biological functions. Therefore, it appears that the administration of compound <b>12</b> would enable either once a day or every other day dosing without any systemic buildup of either <b>5</b> or <b>12</b>.</div><div class="NLM_p">Possessing a compound with good ocular pharmacokinetics and desirable systemic pharmacokinetics, we turned our efforts to test <b>12</b> in a suitable animal model. Choroidal neovascularization (CNV) models in primates,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> rats,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> minipigs,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and rabbits<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> have been studied extensively. Laser-induced choroidal neovascularization in murine model offers several advantages and has been studied extensively.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">After laser-induced rupture of Bruch’s membrane at three locations in each eye, mice were treated by topical application t.i.d. with one drop containing 0.61% w/v of <b>12</b>, 1.83% w/v of <b>12</b>, or vehicle in one eye and no treatment in the fellow eye. A fourth group of mice had rupture of Bruch’s membrane and no treatment. After 14 days, eyes that had received drops containing 0.61% w/v (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A) or 1.83% w/v (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B) of <b>12</b> had CNV lesions that appeared smaller than those in eyes that had received formulation vehicle (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C) or no treatment (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D). Measurement of the area of CNV lesions by image analysis showed that compared to the untreated fellow eye, there were statistically significant reductions of 46 ± 7% or 35 ± 9% in the amount of CNV at Bruch’s membrane rupture sites in the eyes of mice that were treated with 0.61% w/v or 1.83% w/v of <b>12</b>, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>E). This difference between the treated and fellow eyes indicates that the suppression of CNV occurred by local delivery of <b>12</b> and without absorption into the blood stream that could have resulted in systemically mediated drug effects. Relative to vehicle control, there was a reduction of 39 ± 8% or 26 ± 10% in the amount of CNV at Bruch’s membrane rupture sites in the eyes of mice that were treated with 0.61% or 1.83% <b>12</b>, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>E). There is no statistical difference in biological responses from 0.61% and 1.83% dosing of <b>12</b> in the pharmacology model. There was no significant difference between the area of CNV at rupture sites in eyes treated with vehicle and fellow untreated eyes. This demonstrates that the inhibitory effect occurs locally following topical application with no hematogenous delivery to the fellow eye via systemic absorption. These data suggest that topically administered <b>12</b> has potential as a noninvasive suppressive therapy for treatment of diseases in which choroidal neovascularization is a significant component of the pathology. Compound <b>12</b> was inactive in Src (IC<sub>50</sub> ≥ 10 µM), VEGFr2 (IC<sub>50</sub> ≥ 10 µM), and YES (IC<sub>50</sub> ≥ 2.5 µM) biochemical assays. This would suggest that compound <b>12</b> is likely undergoing hydrolysis to release <b>5</b> in vivo which is responsible for its biological actions.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/medium/jm-2007-011276_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Topical administration of <b>12</b> inhibits laser-induced choroidal neovascularization: (A) Representative image of rupture site treated with 0.61% w/v of <b>12</b>;<b></b> (B) representative image of rupture site treated with 1.83% w/v of <b>12</b>; (C) representative image of rupture site treated with vehicle; (D) representative image of rupture site untreated; (E) choroidal neovascularization area vs treatment with different concentrations of <b>12</b> and controls. Topical administration of <b>12</b> reduced laser-induced choroidal neovascularization: 23 eyes/group; (∗) <i>p</i> = 0.0001, 0.61% <b>12</b> vs no treatment; (†) <i>p</i> = 0.0427, 0.61% <b>12</b> vs vehicle; (∗∗) <i>p</i> = 0.0063, 1.83% <b>12</b> vs no treatment. The data were analyzed by linear mixed model with the Dunnett method used to adjust for multiple comparisons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011276&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The capacity of topically applied <b>5</b> or <b>12</b> to suppress a VEGF-induced vascular leak in the retina has been demonstrated using a rodent model.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In order to establish the molecular target of <b>5</b> and its pharmacodynamic effects, the impact of <b>5</b> on the phosphorylation of focal adhesion kinase (FAK), a downstream substrate of VEGFr and Src, was studied in eye tissue<a onclick="showRef(event, 'ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54">(52-54)</a> The phosphorylation was monitored in the choroid/sclera of mice undergoing developmental angiogenesis.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> Compound <b>5</b> reduced FAK-Y861 phosphorylation in a dose-dependent manner with >90% inhibition observed at the 5 mg/kg dose.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The details of the experimental procedure is in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>. We have further evaluated the efficacy of compounds <b>5</b> and <b>12</b> in VEGF induced retinal leak model. As mentioned before, VEGF-induced vascular leakage is a significant pathology contributing to vision loss in AMD, PDR, and DME. On the basis of these attributes, the capacity of topically applied <b>5</b> or <b>12</b> to suppress a VEGF-induced vascular leak in the retina was assessed in a rodent model. Briefly, VEGF was injected and vitreous plasma leak was monitored at the back of the eye. Compounds <b>5</b> (0.7% w/v) and <b>12</b> (1.22% w/v) were instilled topically in a suitable media. Compound <b>5</b> decreased VEGF-induced leak by 60% after single topical instillation, q.d., to a mice model of VEGF induced retinal leak. When the compound <b>5</b> was administered t.i.d., there was a 80% decrease in VEGF induced leak response. However, a topical administration of <b>12</b>, q.d., completely abolished VEGF-induced leak in the above animal model. The prodrug <b>12</b> not only showed increased efficacy but also reduced frequency of administration. The details of VEGF induced leak model and the effects of compounds <b>5</b> and <b>12</b> on the model are in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34781" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34781" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have developed a series of benzotriazine-based compounds that inhibit Src and VEGFr2, both of which play critical roles in age-related macular degeneration. We optimized the inhibitory activity of a series of benzotriazine compounds toward both Src and VEGFr2. On the basis of in vitro activity in enzymatic and cellular assays, compound <b>5</b> was selected and studied further in ocular PK studies. However, compound <b>5</b> showed lower than expected ocular pharmacokinetic properties because of its inability to attain sustained concentrations in certain back-of-the-eye tissue. Subsequently, several prodrugs of <b>5</b> were prepared and evaluated for their thermal stability at higher temperature to identify appropriate prodrugs that are suitable for further development. Prodrugs that were stable under thermal conditions were selected and their hydrolysis rates in ocular tissue were evaluated as a surrogate for their propensity to generate the active compound <b>5</b> in the in vivo setting. Prodrug <b>12</b> showed much better pharmacokinetic properties compared to <b>5</b> and released sufficient amounts of <b>5</b> over sustained periods of time in the choroid, sclera, and retina. The analysis of blood samples withdrawn over time, after topical delivery of <b>12</b> as an eye drop, revealed that the amount of <b>12</b> or <b>5</b> in the systemic circulation was below quantifiable limits.</div><div class="NLM_p">In order to evaluate the capacity of <b>5</b> to inhibit choroidal angiogenesis, prodrug <b>12</b> was tested in a model of choroidal angiogenesis in which angiogenesis is caused using laser-induced rupture of Bruch’s membrane in the eyes of C57BL/6 mice. After laser-induced rupture of Bruch’s membrane, mice were treated by topical application with <b>12</b>. Relative to vehicle control, there is a reduction of 39 ± 8% and 26 ± 10% in the amount of CNV at Bruch’s membrane rupture sites in the eyes of mice treated with 0.61% w/v and 1.83% w/v of <b>12</b>, respectively.</div><div class="NLM_p last">Because of its in vitro activity in enzymatic and cellular assays, <b>5</b> was selected for the prodrug approach to improve its pharmacokinetic properties. On the basis of its favorable ocular pharmacokinetics and activity in a preclinical model, compound <b>12</b> was selected for further development for age-related macular degeneration. Compound <b>12</b> is currently undergoing evaluation in clinical trials for age-related macular degeneration.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All experiments were performed under anhydrous conditions in an atmosphere of argon, except where stated, using oven-dried apparatus and employing standard techniques in handling air-sensitive materials. All the solvents and chemicals from commercial sources were used as received without further purification. Aqueous solutions of sodium bicarbonate and sodium chloride (brine) were saturated. Analytical thin layer chromatography (TLC) was carried out using Merck Kieselgel 60 F<sub>254</sub> plates with visualization by ultraviolet and/or anisaldehyde, potassium permanganate, or phosphomolybdic acid dips. Flash chromatography was carried out using RediSep 45–60 μm silica gel columns using the Isco CombiFlash companion system. Preparative reverse-phase HPLC chromatography was carried out on Gilson preparative HPLC equipped with a 215 liquid handler and Waters SymmetryShield TM RP18 7µm (40 mm × 100 mm) Prep-Pak cartridge. The mobile phase consisted of HPLC grade acetonitrile and water, both containing 0.1% trifluoroacetic acid. Purification was carried out at a flow rate of 40 mL/min and a gradient such that the peak of interest was eluted between 12 and 15 min in a 30 min run. <sup>1</sup>H NMR spectra were recorded at NuMega Laboratories (San Diego, CA) on a Bruker AMX-II spectrometer operating at 500 MHz. Spectra were obtained on all the intermediates and the final products in deuterated dimethyl sulfoxide (DMSO-<i>d</i><sub>6</sub>) unless otherwise noted and were consistent with the proposed structures. Chemical shifts are calibrated to tetramethylsilane internal standard or residual solvent peak and expressed in δ (ppm) units. Peak multiplicities are represented as follows: s = singlet, d = doublet, t = triplet, q = quartet, qn = quintet, dd = doublet of doublets, m = multiplet, br s = broad singlet). Coupling constants (<i>J</i>/Hz) and integration are also listed. Coupling constants were taken directly from the spectra and are uncorrected. Mass spectrometry was carried out on a Waters analytical LC−MS system equipped with a C-18 reverse phase column. The analytical gradient consisted of 10% acetonitrile in water ramping up to 100% acetonitrile, both containing 0.05% trifluoroacetic acid, over 5 min unless otherwise stated. Low-resolution mass spectra was obtained on a micromass spectrometer using the electrospray (ES+) ionization method. The protonated parent ion (M + 1) or fragment of highest mass was quoted. The mass spectral data were consistent with the proposed structure. Purities of compounds were measured on a Shimadzu HPLC equipped with a Agilent C-18 Zorbax 250 mm × 4.6 mm column with 5 μm particle size and dual wavelength and evaporating light scattering detectors (ELSD). The analytical gradient consisted of 10% acetonitrile in water ramping up to 100% acetonitrile, both containing 0.05% trifluoroacetic acid, over 20 min unless otherwise stated. The column temperature was maintained at 40 °C for all the purity analyses. Elemental analyses were performed at NuMega Laboratories (San Diego, CA) on Perkin-Elmer series II-2400 CHNS analyzer, and the results are within 0.4% of the calculated values unless otherwise stated.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> 7-Phenyl-5-methyl-<i>N</i>-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine (<b>1</b>)</h3><div class="NLM_p last">The title compound was prepared using the procedure that is described for compound <b>26c</b> and converted to the hydrochloride salt using dioxane−hydrogen chloride solution (35%). <sup>1</sup>H NMR: δ 1.80–2.10 (m, 4H), 2.68 (s, 3H), 3.05–3.15 (m, 2H), 3.55–3.65 (m, 4H), 4.37 (t, <i>J</i> = 5.1 Hz, 2H), 7.09 (d, <i>J</i> = 9.1 Hz, 2H), 7.44 (t, <i>J</i> = 7.6 Hz, 1H), 7.54 (t, <i>J</i> = 7.6 Hz, 2H), 7.88 (d, <i>J</i> = 7.6 Hz, 2H), 7.98 (d, <i>J</i> = 9.0 Hz, 2H), 8.17 (s, 1H), 8.40 (d, <i>J</i> = 1.7 Hz, 1H), 10.83 (s, 2H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 426 [M + 1]. Anal. (C<sub>26</sub>H<sub>27</sub>N<sub>5</sub>O·HCl·0.5H<sub>2</sub>O) C, H, N. HPLC purity, 97% at 220 nm.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 7-(2-Chlorophenyl)-5-methyl-<i>N</i>-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine (<b>2</b>)</h3><div class="NLM_p last">The title compound was prepared using the procedure that is described for compound <b>26c</b> and converted to the hydrochloride salt using dioxane−hydrogen chloride solution (38%). <sup>1</sup>H NMR: δ 1.85–2.05 (m, 4H), 2.65 (s, 3H), 3.05–3.15 (m, 2H), 3.55–3.65 (m, 4H), 4.36 (t, <i>J</i> = 5.0 Hz, 2H), 7.09 (d, <i>J</i> = 9.2 Hz, 2H), 7.40–7.55 (m, 2H), 7.55–7.65 (m, 2H), 7.86 (dd, <i>J</i> = 0.95, 1.8 Hz, 1H), 7.98 (d, <i>J</i> = 9.1 Hz, 2H), 8.17 (d, <i>J</i> = 1.8 Hz, 1H), 10.70 (br s, 1H), 10.89 (br s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 460 [M + 1]. Anal. (C<sub>26</sub>H<sub>26</sub>ClN<sub>5</sub>O·HCl·0.5H<sub>2</sub>O) C, H, N. HPLC purity 97% at 220 nm.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 7-(2,6-Dimethylphenyl)-5-methyl-<i>N</i>-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine (<b>3</b>)</h3><div class="NLM_p last">A solution of 7-(2,6-dimethylphenyl)-5-methylbenzo[1,2,4]triazin-3-ylamine (1 g, 3.78 mmol) and of 1-[2-(4-bromophenoxy)ethyl]pyrrolidine (2.04 g, 7.56 mmol), tris(dibenzylideneacetone)dipalladium(0) (174 mg, 0.19 mmol), (±)-2,2′-bis(diphenylphosphino)-1,1′-binaphthalene (340 mg, 0.54 mmol), and potassium <i>tert</i>-butoxide (500 mg, 4.46 mmol) in toluene (500 mL) under argon was heated at 100 °C for 24 h. The reaction mixture was concentrated under reduced pressure, dissolved in dimethyl formamide, and purified by preparative HPLC to afford the title compound (0.09 g, 5.2%). <sup>1</sup>H NMR: δ 1.90–2.05 (m, 10 H), 2.64 (s, 3H), 3.14–3.16 (m, 2H), 3.59–3.64 (m, 4H), 4.31 (t, <i>J</i> = 5.2 Hz, 2H), 7.09 (d, <i>J</i> = 9.2 Hz, 2H), 7.18 (d, <i>J</i> = 7.4 Hz, 2H), 7.22–7.24 (m, 1H), 7.60 (s, 1H), 7.91 (s, 1H), 7.98 (d, <i>J</i> = 9.2 Hz, 2H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 454 [M + 1]. Anal. (C<sub>28</sub>H<sub>31</sub>N<sub>5</sub>O·C<sub>6</sub>H<sub>8</sub>O<sub>7</sub>·1.5H <sub>2</sub>O) C, H, N. HPLC purity 99% at 220 nm.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 7-(2,6-Dichlorophenyl)-5-methyl-<i>N</i>-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine (<b>4</b>)</h3><div class="NLM_p last">The title compound was synthesized using a similar procedure described for <b>3</b> to afford the title compound (35%). <sup>1</sup>H NMR: δ 1.88–1.91 (m, 2H), 2.02–2.07 (m, 2H), 2.63 (s, 3H), 3.12–3.17 (m, 2H), 3.58–3.62 (m, 4H), 4.32 (t, <i>J</i> = 4.8 Hz, 2 H), 7.10 (d, <i>J</i> = 9.2 Hz, 2H), 7.51 (t, <i>J</i> = 8.2 Hz, 1H), 7.67 (d, <i>J</i> = 8.2 Hz, 2H), 7.69 (dd, <i>J</i> = 1.0, 1.9 Hz, 1H), 7.98 (d, <i>J</i> = 9.2 Hz, 2H), 8.08 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 494 (M + 1). Anal. (C<sub>26</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>5</sub>O·0.5H<sub>2</sub>O) C, H, N. HPLC 99% pure at 230 nM and 100% pure using ELSD detector.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Procedure for the Deprotection of a Methoxy Group with Boron Tribromide (BBr<sub>3</sub>)</h3><div class="NLM_p last">A solution of methoxy precursor (1.0 mol equiv) and boron tribromide (5–10 mol equiv) in dichloromethane (0.01–0.03 M) was stirred at room temperature until the reaction was complete (4–12 h). The pH of the reaction mixture was adjusted to 7 by treating with a saturated sodium bicarbonate solution and filtered. The solids were washed with water and ether and purified using preparative HPLC to afford pure compounds.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenol (<b>5</b>)</h3><div class="NLM_p last">The methoxy group in 7-(2-chloro-5-methoxyphenyl)-5-methyl-<i>N</i>-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine <b>(26a</b>, 440 mg, 0.90 mmol) was cleaved using boron tribromide as described in the general procedure to afford the title compound (387 mg, 84%), which was converted to the HCl salt. <sup>1</sup> H NMR: δ 1.88–1.92 (m, 2H), 1.97–2.05 (m, 2H), 2.64 (s, 3H), 3.09–3.14 (m, 2H), 3.57–3.61 (m, 4H), 4.36 (t, <i>J</i> = 4.9 Hz, 2H), 6.87 (dd, <i>J</i> = 2.9, 8.8 Hz, 1H), 6.94 (d, <i>J</i> = 2.9 Hz, 1H), 7.09 (d, <i>J</i> = 9.0 Hz, 2H), 7.39 (d, <i>J</i> = 8.8 Hz, 1H), 7.83 (d, <i>J</i> = 1.6 Hz, 1H), 7.98 (d, <i>J</i> = 9.0 Hz, 2H), 8.12 (d, <i>J</i> = 1.6 Hz, 1H), 9.97 (s, 1H), 10.55 (br s, 1H), 10.87 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 476 (M + 1). Anal. (C<sub>26</sub>H<sub>26</sub>ClN<sub>5</sub>O<sub>2</sub>·HCl·0.25H<sub>2</sub>O) C, H, N. HPLC 98% pure at 220 nm, 98% pure using ELSD detector.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 4-{[7-(2-Chloro-5-hydroxyphenyl)-5-methyl-1,2,4-benzotriazin-3-yl]amino}-<i>N</i>-(2-pyrrolidin-1-ylethyl)benzenesulfonamide (<b>6</b>)</h3><div class="NLM_p last">The methoxy group in 4-{[7-(2-chloro-5-methoxyphenyl)-5-methyl-1,2,4-benzotriazin-3-yl]amino}-<i>N</i>-(2-pyrrolidin-1-ylethyl)benzenesulfonamide (<b>26b</b> 0.055 g, 0.099 mmol) was cleaved using boron tribromide as described in the general procedure to afford the title compound as the trifluoroacetate salt (0.013 g, 25% yield). <sup>1</sup>H NMR: δ 1.85–1.88 (m, 2H), 1.95–1.99 (m, 2H), 2.98–3.03 (m, 2H), 3.10–3.14 (m, 2H), 3.21–3.25 (m, 2H), 3.38 (s, 3H), 3.50–3.54 (m, 2H), 6.89 (dd, <i>J</i> = 2.9, 8.7 Hz, 1H), 6.96 (d, <i>J</i> = 2.9 Hz, 1H), 7.41 (d, <i>J</i> = 8.7 Hz, 1H), 7.88 (d, <i>J</i> = 8.9 Hz, 2H), 7.92 (d, <i>J</i> = 1.8 Hz, 1H), 8.21 (d, <i>J</i> = 1.7 Hz, 1H), 8.25 (d, <i>J</i> = 8.8 Hz, 2H), 10.00 (s, 1H), 10.43 (br s, 1H) 11.44 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 539 (M + 1). Anal. (C<sub>26</sub>H<sub>27</sub>ClN<sub>6</sub>O<sub>3</sub>S·HCl·H<sub>2</sub>O) C, H, N. HPLC 97% pure at 220 nm and at 254 nm.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 4-Chloro-3-(5-methyl-3-{[4-(piperazin-1-ylcarbonyl)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenol (<b>7</b>)</h3><div class="NLM_p last">The title compound, was prepared from <i>tert</i>-butyl 4-(4-{[7-(2-chloro-5-methoxyphenyl)-5-methyl-1,2,4-benzotriazin-3-yl]amino}benzoyl)piperazine-1-carboxylate (<b>26c</b>, 40 mg, 0.068 mmol) as described in the general procedure using boron tribromide. Both methyl groups and the <i>tert</i>-butyloxycarbonyl group in <b>26c</b> were cleaved simultaneously under the reaction conditions, and the crude product was purified by preparative HPLC to afford the title compound as an orange solid (32 mg, 99% yield). <sup>1</sup>H NMR: δ 2.69 (s, 3H), 2.70–2.80 (m, 4H), 3.35–3.50 (m, 4H), 6.87 (dd, <i>J</i> = 2.9, 8.7 Hz, 1H), 6.94 (d, <i>J</i> = 2.9 Hz, 1H), 7.41 (d, <i>J</i> = 8.7 Hz, 1H), 7.46 (d, <i>J</i> = 8.7 Hz, 2H), 7.85–7.90 (m, 1H), 8.09 (d, <i>J</i> = 8.6 Hz, 2H), 8.18 (d, <i>J</i> = 1.7 Hz, 1H), 9.93 (br s, 1H), 11.17 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 475 (M + 1). Anal. (C<sub>25</sub>H<sub>23</sub>ClN<sub>6</sub>O<sub>2</sub>·2H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 7-(2-Chloro-5-hydroxyphenyl)-5-methyl-<i>N</i>-[4-(piperidin-4-ylsulfonyl)phenyl]-1,2,4-benzotriazin-3-amine (<b>8</b>)</h3><div class="NLM_p last">The methoxy group and benzyl carboxylate in benzyl 4-[(4-{[7-(2-chloro-5-methoxyphenyl)-5-methyl-1,2-4-benzotriazin-3-yl]amino}phenyl)sulfonyl]piperdine-1-carboxylate (<b>26d</b>, 0.165 g, 0.25 mmol) were cleaved using boron tribromide in dichloromethane (2.5 mL, 2.5 mmol) as described in the general procedure to afford the title compound as a yellow solid (0.028 g, 22%). <sup>1</sup>H NMR: δ 1.68–1.77 (m, 2H), 2.03–2.06 (m, 2H), 2.73 (s, 3H), 2.83–2.88 (m, 2H), 3.05 (s, 1H), 3.52–3.58 (m, 1H), 6.89 (dd, <i>J</i> = 2.9, 8.8 Hz, 1H), 6.95 (d, <i>J</i> = 2.9 Hz, 1H), 7.41 (d, <i>J</i> = 8.7 Hz, 1H), 7.88 (d, <i>J</i> = 8.8 Hz, 2H), 7.94 (s, 1H), 8.23 (d, <i>J</i> = 1.7 Hz, 1H), 8.33 (d, <i>J</i> = 8.8 Hz, 2H), 8.75 (br s, 1H), 10.00 (s, 1H), 11.57 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 510 (M + 1). Anal. (C<sub>25</sub>H<sub>24</sub>ClN<sub>5</sub>O<sub>3</sub>S·C<sub>2</sub>F<sub>3</sub>HO <sub>2</sub>·1.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 7-(2-Chloro-5-hydroxyphenyl)-5-methyl-<i>N</i>-[4-(3-pyrrolidin-1-ylpropyl)]phenyl]-1,2,4-benzotriazin-3-amine (<b>9</b>)</h3><div class="NLM_p last">A suspension of [7-(2-chloro-5-methoxyphenyl)-5-methyl]-1,2,4-benzotriazin-3-amine (0.55 g, 1.8 mmol), 1-[3-(4-bromophenyl)propyl]pyrrolidine (0.60 g, 2.2 mmol), palladium acetate (25 mg, 0.11 mmol), xantphos (0.13 g, 0.22 mmol), and potassium <i>tert</i>-butoxide (0.40 g, 3.6 mmol) in dioxane (3 mL) was heated at reflux for 16 h. The reaction mixture was cooled to room temperature and filtered, and the solids were washed with dichloromethane. The filtrate was concentrated under reduced pressure and purified by flash chromatography (SiO<sub>2</sub>, 10–20% methanol in dichloromehtane) to afford 7-(2-chloro-5-methoxyphenyl)-5-methyl-<i>N</i>-[4-(3-pyrrolidin-1-ylpropyl)]phenyl]-1,2,4-benzotriazin-3-amine as a red solid (0.16 g, 18%). MS (ESI+): <i>m</i>/<i>z</i> 488 (M + 1)<sup>+</sup>. This compound (0.16 g, 0.33 mmol) was treated with boron tribromide as described in the general procedure to cleave the methyl group. The reaction mixture was purified by preparative HPLC to afford the title compound as an orange solid (30 mg, 16%). <sup>1</sup>H NMR: δ 1.80–1.90 (m, 2H), 1.90–2.05 (m, 4H), 2.64 (t, <i>J</i> = 7.6 Hz, 2H), 2.66 (s, 3H), 2.95–3.05 (m, 2H), 3.10–3.20 (m, 2H), 3.50–3.70 (m, 2H), 6.87 (dd, <i>J</i> = 2.9, 8.8 Hz, 1H), 6.93 (d, <i>J</i> = 2.9 Hz, 1H), 7.28 (d, <i>J</i> = 8.5 Hz, 2H), 7.40 (d, <i>J</i> = 8.8 Hz, 1H), 7.85 (t, <i>J</i> = 0.8 Hz, 1H), 7.98 (d, <i>J</i> = 8.5 Hz, 2H), 8.15 (d, <i>J</i> = 1.8 Hz, 1H), 9.55 (br s, 1H), 9.95 (br s, 1H), 10.94 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 474 (M + 1). Anal. (C<sub>27</sub>H<sub>28</sub>ClN<sub>5</sub>O·C<sub>2</sub>F<sub>3</sub>HO<sub>2</sub>·1.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Acetate (<b>10</b>)</h3><div class="NLM_p last">Acetyl chloride (0.092 g, 1.17 mmol) was added dropwise to a solution of 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenol hydrochloride (<b>5</b>, 0.465 g, 0.978 mmol) and triethylamine (0.494 g, 4.89 mmol) in dichloromethane (30 mL) under argon at room temperature and stirred for 24 h. The reaction mixture was quenched with a saturated sodium bicarbonate solution. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated under reduced pressure, and purified on flash chromatography (SiO<sub>2</sub>, dichloromethane/methanol/triethylamine = 85:10:5 (v/v/v)) to afford the title compound as an orange solid (0.409 g, 75%). <sup>1</sup>H NMR: δ 1.67–1.70 (m, 4H), 2.29 (s, 3H), 2.50–2.52 (m, 4H), 2.64 (s, 3H), 2.78 (t, <i>J</i> = 5.9 Hz, 2H), 4.07 (t, <i>J</i> = 6.0 Hz, 2H), 6.99 (dd, <i>J</i> = 7.1, 12.6 Hz, 2H), 7.27 (dd, <i>J</i> = 5.9, 8.8 Hz, 1H), 7.41 (d, <i>J</i> = 2.8 Hz, 1H), 7.67 (d, <i>J</i> = 8.8 Hz, 1H), 7.85 (t, <i>J</i> = 1.3 Hz, 1H), 7.93 (d, <i>J</i> = 9.1 Hz, 2H), 8.17 (d, <i>J</i> = 1.8 Hz, 1H), 10.83 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 520 (M + 3). Anal. (C<sub>28</sub>H<sub>28</sub>ClN<sub>5</sub>O<sub>3</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)-4-phenyl 2-Methylpropanoate (<b>11</b>)</h3><div class="NLM_p last">The title compound was prepared using a procedure similar to that described for <b>10</b>. Compound <b>11</b> was obtained in comparable yield. <sup>1</sup>H NMR: δ 1.24 (d, <i>J</i> = 6.9 Hz, 6H), 1.67–1.71 (m, 4H), 2.52–2.54 (m, 4H), 2.64 (s, 3H), 2.79 (t, <i>J</i> = 5.9 Hz, 2H), 4.07 (t, <i>J</i> = 5.9 Hz, 2H), 6.99 (d, <i>J</i> = 7.1 Hz, 2H), 7.25 (dd, <i>J</i> = 2.9, 8.8 Hz, 1H), 7.41 (d, <i>J</i> = 2.9 Hz, 1H), 7.67 (d, <i>J</i> = 8.8 Hz, 1H), 7.85 (t, <i>J</i> = 1.1 Hz, 1H), 7.93 (d, <i>J</i> = 9.1 Hz, 2H), 8.18 (d, <i>J</i> = 1.9 Hz, 1H), 10.84 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 546 (M + 1). HPLC purity, 95% at 254 nm.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Benzoate (<b>12</b>)</h3><div class="NLM_p last">The title compound was synthesized from 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenol hydrochloride (<b>5</b>, 1.0 g, 2.0 mmol) as described for compound <b>10</b> (0.9 g, 80%). <sup>1</sup>H NMR: δ 1.65–1.72 (m, 4H), 2.50–2.56 (m, 4H), 2.63 (s, 3H), 2.79 (t, <i>J</i> = 5.9 Hz, 2H), 4.07 (t, <i>J</i> = 6.0 Hz, 2H), 7.00 (d, <i>J</i> = 9.1 Hz, 2H), 7.46 (dd, <i>J</i> = 2.9, 8.7 Hz, 1H), 7.60–7.65 (m, 3H), 7.75 (d, <i>J</i> = 8.6 Hz, 1H), 7.76 (t, <i>J</i> = 7.4 Hz, 1H), 7.90 (dd, <i>J</i> = 1.0, 1.8 Hz, 1H), 7.93 (d, <i>J</i> = 9.1 Hz, 2H), 8.16 (d, <i>J</i> = 8.4 Hz, 2H), 8.22 (d, <i>J</i> = 1.8 Hz, 1H), 10.84 (br s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 580 (M + 1). Anal. (C<sub>33</sub>H<sub>30</sub>ClN<sub>5</sub>O<sub>3</sub>·HCl·0.5H<sub>2</sub>O) C, H, N. HPLC 98% pure at 220 nm and 100% pure using ELSD detector.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl 4-Methylbenzoate (<b>13</b>)</h3><div class="NLM_p last">The title compound was prepared similar to the procedure described for <b>10</b>. <sup>1</sup>H NMR: δ 1.68–1.70 (m, 4H), 2.42 (s, 3H), 2.51–2.53 (m, 4H), 2.64 (s, 3H), 2.78 (t, <i>J</i> = 6.0 Hz, 2H), 4.06 (t, <i>J</i> = 6.0 Hz, 2H), 6.99 (d, <i>J</i> = 5.0 Hz, 2H), 7.42 (d, <i>J</i> = 7.5 Hz, 2H), 7.44 (d, <i>J</i> = 2.8 Hz, 1H), 7.58 (d, <i>J</i> = 2.8 Hz, 1H), 7.72 (d, <i>J</i> = 8.7 Hz, 1H), 7.88 (d, <i>J</i> = 0.9 Hz, 1H), 7.92 (d, <i>J</i> = 9.2 Hz, 2H), 8.05 (d, <i>J</i> = 6.6 Hz, 2H), 8.21 (d, <i>J</i> = 1.8 Hz, 1H), 10.83 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 594 (M + 1). HPLC purity, 98% at 254 nm.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Pivalate (<b>14</b>)</h3><div class="NLM_p last">A solution of 4-chloro-3-{5-methyl-3-[4-(2-pyrrolidin-1-ylethoxy)phenylamino]benzo[1,2,4]triazin-7-yl}phenol hydrochloride (<b>5</b>, 1.86 g, 3.91 mmol), triethylamine (3.95 g, 39.1 mmol) in dichloromethane (100 mL) under argon atmosphere was stirred for 10 min. Pivoloyl chloride (0.616 g, 5.09 mmol) was added dropwise to the solution and stirred at room temperature for 2 h. A solution of saturated sodium bicarbonate (25 mL) was added, and the organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated under reduced pressure, and purified using preparative HPLC to afford the title compound (2.14 g, 98% yield). <sup>1</sup>H NMR: δ 1.31 (s, 9H), 1.67–1.69 (m, 4H), 2.51–2.53 (m, 4H), 2.64 (s, 3H), 2.80 (t, <i>J =</i> 5.7 Hz, 2H), 4.07 (t, <i>J =</i> 5.9 Hz, 2H), 7.00 (d, <i>J =</i> 7.1 Hz, 2H), 7.24 (dd, <i>J =</i> 5.9, 8.8 Hz, 1H), 7.39 (d, <i>J =</i> 2.8 Hz, 1H), 7.67 (d, <i>J =</i> 8.7 Hz, 1H), 7.85 (s, 1H), 7.92 (d, <i>J =</i> 9.1 Hz, 2H), 8.18 (d, <i>J =</i> 1.8 Hz, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 560 (M + 1). Anal. (C<sub>31</sub>H<sub>34</sub>ClN<sub>5</sub>O<sub>3</sub>) C, H, N. HPLC 99% pure at 220 nm and 99% pure using ELSD.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Disodium 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-yl-ethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Phosphate (<b>15</b>)</h3><div class="NLM_p last">A solution of 4-chloro-3-{5-methyl-3-[4-(2-pyrrolidin-1-ylethoxy)phenylamino]benzo[1,2,4]triazin-7-yl}phenol (<b>5</b>, 0.51 g, 1.0 mmol), phosphorus oxychloride (0.46 g, 3.0 mmol), and triethylamine (1.0 g, 10 mmol) in dichloromethane (100 mL) was stirred at room temperature for 12 h. An aqueous sodium bicarbonate solution (0.5 g in 6 mL of water) was added to the reaction mixture and stirred at room temperature for 30 min. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated and the solid was washed with water (20 mL), methanol (20 mL), and ether (20 mL) to afford the title compound as a red solid (430 mg, 72%). <sup>1</sup>H NMR: δ 1.86–1.88 (m, 4H), 2.88–3.01 (m, 4H), 3.17 (s, 3H), 3.34 (br s, 2H), 4.14–4.18 (m, 2H), 6.90 (d, <i>J</i> = 8.9 Hz, 2H), 7.21 (dd, <i>J</i> = 2.8, 8.9 Hz, 1H), 7.31 (s, 1H), 7.43 (d, <i>J</i> = 8.8 Hz, 1H), 7.70 (s, 1H), 7.78 (d, <i>J</i> = 8.9 Hz, 2H), 7.96 (s, 1H), 10.65 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 556 (M + 1). Anal. (C<sub>26</sub>H<sub>25</sub>ClN<sub>5</sub>Na<sub>2</sub>O<sub>5</sub>P·H<sub>2</sub>O) C, H, N. HPLC purity >98% at 220 nm.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Glycinate (<b>16</b>)</h3><div class="NLM_p last">4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl(<i>N</i>-butyloxycarbonyl) glycinate (<b>28</b>, 0.012 g, 0.019 mmol) was stirred in a 5% solution of trifluoroacetic acid in dichloromethane for 1 h at room temperature. The reaction mixture was concentrated and purified on preparative HPLC to afford the title compound as the trifluoroacetate salt (0.008 g, 80%). <sup>1</sup>H NMR: δ 1.80–2.10 (m, 4H), 2.64 (s, 3H), 3.10–3.20 (m, 2H), 3.55–3.65 (m, 4H), 4.15 (br s, 2H), 4.31 (t, <i>J</i> = 5.3 Hz, 2H), 7.10 (d, <i>J</i> = 9.2 Hz, 2H), 7.34 (dd, <i>J</i> = 2.9, 8.7 Hz, 1H), 7.46 (d, <i>J</i> = 2.8 Hz, 1H), 7.7 (d, <i>J</i> = 8.7 Hz, 1H), 7.88 (dd, <i>J</i> = 1.4, 1.9 Hz, 1H), 7.98 (d, <i>J</i> = 9.1 Hz, 2H), 8.20 (d, <i>J</i> = 1.8 Hz, 1H), 8.46 (br s, 2H), 9.87 (br s, 1H), 10.92 (br s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 533 (M + 1)<sup>+</sup>. HPLC purity, 97% at 254 nm.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Nicotinate (<b>17</b>)</h3><div class="NLM_p last">A solution of 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenol (<b>5</b>, 320 mg, 0.63 mmol), nicotinyl chloride (122 mg, 0.69 mmol), and triethylamine (0.64 g, 6.3 mmol) in dichloromethane (50 mL) was stirred at room temperature for 12 h. A saturated aqueous sodium bicarbonate solution (100 mL) was added to the reaction mixture, and the organic layer was separated. The aqueous layer was extracted with dichloromethane (2 × 20 mL). The organic layers were combined, washed with brine (100 mL), and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed under reduced pressure and the solid was washed with ether (2 × 30 mL) to afford the title compound as a red solid (177 mg, 49%). <sup>1</sup>H NMR: δ 1.65–1.75 (m, 4H), 2.57 (br s, 4H), 2.65 (s, 3H), 2.83 (br s, 2H), 4.09 (t, <i>J</i> = 5.9 Hz, 2H), 7.00 (d, <i>J</i> = 9.1 Hz, 2H), 7.50 (dd, <i>J</i> = 2.8, 8.7 Hz, 1H), 7.55–7.68 (m, 2H), 7.76 (d, <i>J</i> = 8.7 Hz, 1H), 7.90 (s, 1H), 7.93 (d, <i>J</i> = 9.1 Hz, 2H), 8.22 (s, 1H), 8.40–8.50 (m, 1H), 8.91 (dd, <i>J</i> = 1.7, 4.8 Hz, 1H), 9.28 (d, <i>J</i> = 2.3 Hz, 1H), 10.84 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 581 (M + 1). HPLC purity, 98% at 254 nm.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl 4-(2,6-Dimethylbenzoate) (<b>18</b>)</h3><div class="NLM_p last">A solution of 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenol (<b>5</b>, 0.39 g, 0.768 mmol), 2,6-dimethylbenzoyl chloride (0.168 g, 0.998 mmol), and triethylamine (1.6 mL, 11.5 mmol) in dichloromethane (20 mL) was stirred under argon atmosphere at room temperature for 12 h. The reaction mixture was washed with saturated aqueous sodium bicarbonate solution (20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated under reduced pressure, and purified using flash chromatography (SiO<sub>2</sub>, 10% methanol in dichloromethane) to afford the title compound as a red solid (0.10 g, 21%). <sup>1</sup>H NMR: δ 1.65–1.75 (m, 4H), 2.35–2.45 (m, 6H), 2.55–2.60 (m, 4H), 2.66 (s, 3H), 2.80–2.90 (br s, 2H), 4.09 (t, <i>J</i> = 5.9 Hz, 2H), 7.01 (d, <i>J</i> = 9.2 Hz, 2H), 7.19 (d, <i>J</i> = 7.6 Hz, 2H), 7.34 (t, <i>J</i> = 7.7 Hz, 1H), 7.47 (dd, <i>J</i> = 3.0, 8.8 Hz, 1H), 7.59 (d, <i>J</i> = 2.8 Hz, 1H), 7.77 (d, <i>J</i> = 8.8 Hz, 1H), 7.90–8.01 (m, 3H), 8.23 (d, <i>J</i> = 1.8 Hz, 1H), 10.86 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 609 (M + 1)<sup>+</sup>. HPLC purity 95% using ELSD.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl 4-(2,6-Dichlorobenzoate) (<b>19</b>)</h3><div class="NLM_p last">A solution of 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenol (<b>5</b> 0.25 g, 0.53 mmol), 2,6-dichlorobenzoyl chloride (0.144 g, 0.69 mmol), and triethylamine (0.074 mL, 5.3 mmol) in dichloromethane (5 mL) was stirred under argon atmosphere at room temperature for 24 h. The reaction mixture was concentrated under reduced pressure and purified using flash chromatography (SiO<sub>2</sub>, 10% methanol in dichloromethane) to afford the title compound as a red solid (0.30 g, 94%). <sup>1</sup>H NMR: δ 1.55–1.65 (m, 4H), 2.52–2.58 (m, 4H), 2.65 (s, 3H), 2.75–2.85 (m, 2H), 4.08 (t, <i>J</i> = 5.9 Hz, 2H), 7.01 (dd, <i>J</i> = 2.0, 7.1 Hz, 2H), 7.45 (d, <i>J</i> = 11.4 Hz, 1H), 7.51 (d, <i>J</i> = 2.8 Hz, 1H), 7.60–7.65 (m, 1H), 7.69 (s, 1H), 7.71 (d, <i>J</i> = 1.6 Hz, 1H), 7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.89 (dd, <i>J</i> = 0.9, 1.8 Hz, 1H), 7.94 (d, <i>J</i> = 9.1 Hz, 2H), 8.23 (d, <i>J</i> = 1.8 Hz, 1H), 10.86 (br s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 650 (M + 3). HPLC purity, 98% at 254 nm.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl 4-(Morpholin-4-ylmethyl)benzoate (<b>20</b>)</h3><div class="NLM_p last">A solution of 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenol (<b>5</b>, 0.77 g, 1.5 mmol), 4-(morpholinomethyl)benzoic acid (1.06 g, 4.8 mmol), <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (2.36 g, 12.31 mmol), and 4-dimethylaminopyridine (0.225 g, 1.85 mmol) in dimethylformamide (60 mL) was stirred under argon atmosphere at room temperature for 12 h. The reaction mixture was concentrated, suspended in dichloromethane, and washed with saturated sodium bicarbonate solution and brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated under reduced pressure, and purified (SiO<sub>2</sub>, 10% methanol in dichloromethane) to afford the title compound (1.29 g, 97%). <sup>1</sup>H NMR: δ 1.60–1.75 (m, 4H), 2.30–2.40 (m, 4H), 2.50–2.60 (m, 4H), 2.64 (s, 3H), 2.80 (t, <i>J</i> = 5.8 Hz, 2H), 3.50–3.65 (m, 6H), 4.08 (t, <i>J</i> = 5.8 Hz, 2H), 7.00 (d, <i>J</i> = 9.1 Hz, 2H), 7.43 (dd, <i>J</i> = 2.9, 8.8 Hz, 1H), 7.55 (d, <i>J</i> = 8.5 Hz, 2H), 7.59 (d, <i>J</i> = 2.9 Hz, 1H), 7.73 (d, <i>J</i> = 8.7 Hz, 1H), 7.88 (d, <i>J</i> = 0.95 Hz, 1H), 7.93 (d, <i>J</i> = 9.1 Hz, 2H), 8.11 (d, <i>J</i> = 6.6 Hz, 2H), 8.21 (d, <i>J</i> = 1.9 Hz, 1H), 10.84 (br s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 679 (M + 1). HPLC 98% pure at 220 nm.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 7-Bromo-5-methylbenzo[1,2,4]triazin-3-ylamine 1-Oxide (<b>22</b>)</h3><div class="NLM_p last">A mixture of 4-bromo-2-methyl-6-nitroaniline (1 g, 4.33 mmol), cyanamide (0.5 g, 12 mmol), and pyridine hydrochloride (5 g, 43 mmol) was heated at 100 °C for 12 h. The reaction mixture was cooled, treated with 10% sodium hydroxide solution (4 mL, 10 mmol), and heated at 100 °C for 2 h. The reaction mixture was cooled to room temperature and filtered. The solid was washed with water (2 × 25 mL), acetone (2 × 5 mL), and diethyl ether (2 × 10 mL) to afford the title compound (0.4 g, 36%). <sup>1</sup> H NMR: δ 2.45 (s, 3 H), 7.49 (s, 2H), 7.81 (s, 1 H), 8.11 (d, <i>J</i> = 1.4 Hz, 1 H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 255 (M + 1).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 7-Bromo-5-methyl-1,2,4-benzotriazin-3-amine (<b>23</b>)</h3><div class="NLM_p last">A solution of 7-bromo-5-methylbenzo[1,2,4]triazin-3-ylamine 1-oxide (<b>22</b>, 4.26 g, 16.7 mmol) and Raney nickel (10% by weight) in ethanol (160 mL) was stirred at room temperature under positive pressure of hydrogen for 10 h. The reaction mixture was filtered, concentrated, and purified using flash chromatography (SiO<sub>2</sub>, 50% ethyl acetate in hexanes) to yield the title compound as a solid (3.9 g, 97%). <sup>1</sup>H NMR: δ 2.48 (s, 3H), 7.79 (br s, 3H), 8.25 (d, <i>J</i> = 1.8 Hz, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 239 (M + 1).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 7-(2-Chloro-5-methoxyphenyl)-5-methyl-1,2,4-benzotrizine-3-amine (<b>24a</b>)</h3><div class="NLM_p last">A solution of 7-bromo-5-methyl-1,2,4-benzotriazin-3-amine (<b>23</b>, 8 g, 33.5 mmol), 2-chloro-5-methoxyphenylboronic acid (9.3 g, 50.2 mmol), tetrakis(triphenylphosphine)palladium(0) (3.9 g, 3.3 mmol), and Na<sub>2</sub>CO<sub>3</sub> (14.2 g, 134 mmol) in DME/EtOH/water (6:1:1, 335 mL) under argon was heated at 100 °C for 4 h. The reaction mixture was cooled to room temperature, diluted with dichloromethane (100 mL), filtered, and washed with water (3 × 100 mL) and ether (3 × 100 mL) to afford the title compound as a green solid (8.37 g, 84%). <sup>1</sup>H NMR: δ 2.54 (s, 3H), 3.82 (s, 3H), 7.03 (dd, <i>J</i> = 3.1, 8.8 Hz, 1H), 7.10 (d, <i>J</i> = 3.1 Hz, 1H), 7.50 (d, <i>J</i> = 8.8 Hz, 1H), 7.72 (br s, 2H), 7.74 (s, 1H), 8.07 (d, <i>J</i> = 1.8 Hz, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 301 (M + 1).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 7-Phenyl-5-methyl-1,2,4-benzotrizine-3-amine (<b>24b</b>)</h3><div class="NLM_p last">The title compound was obtained using the procedure described for <b>24a</b> in comparable yield. <sup>1</sup>H NMR: δ 2.57 (s, 3H), 7.30–7.50 (m, 3H), 7.66 (br s, 2H), 7.80−7.90 (m, 2H), 8.06 (dd, <i>J</i> = 1.1, 2.2 Hz, 1H), 8.29 (d, <i>J</i> = 1.8 Hz, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 237 (M + 1).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 7-(2-Chlorophenyl)-5-methyl-1,2,4-benzotrizine-3-amine (<b>24c</b>)</h3><div class="NLM_p last">A solution of 7-bromo-5-methyl-1,2,4-benzotriazin-3-amine (1 g, 4.18 mmol), 2-chlorophenylboronic acid (0.98 g, 6.28 mmol), tetrakis(triphenylphosphine)palladium(0) (0.483 g, 0.42 mmol), and sodium carbonate (1.77 g, 16.7 mmol) in dimethoxyethane/ethanol/water (6:1:1, 32 mL) was heated at reflux for 12 h. The reaction mixture was cooled, diluted with dichloromethane (30 mL), and filtered. The solid was washed with water (25 mL) and ether (25 mL) and dried to afford the title compound (0.32 g 28%). <sup>1</sup>H NMR: δ 2.54 (s, 3H), 7.40–7.50 (m, 2H), 7.56 (dd, <i>J</i> = 2.2, 7.1 Hz, 1H), 7.62 (dd, <i>J</i> = 2.2, 7.0 Hz, 1H), 7.72 (br s, 2H), 7.44 (s, 1H), 8.06 (d, <i>J</i> = 1.7 Hz, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 271 (M + 1).</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 7-(2,6-Dimethylphenyl)-5-methyl-1,2,4-benzotrizine-3-amine (<b>24d</b>)</h3><div class="NLM_p last">The title compound was obtained using the procedure described for <b>24c</b> in comparable yield. <sup>1</sup>H NMR: δ 2.03 (s, 6H), 2.53 (s, 3H), 7.10−7.20 (m 3H), 7.46 (s, 1H), 7.61 (br s, 2H), 7.78 (d, <i>J</i> = 1.9 Hz, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 265 (M + 1).</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 7-(2,6-Dichlorophenyl)-5-methyl-1,2,4-benzotrizine-3-amine (<b>24e</b>)</h3><div class="NLM_p last">The title compound was obtained using the procedure described for <b>24c</b> in comparable yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 2.53 (s, 3H), 7.49 (t, <i>J</i> = 7.8 Hz, 1H), 7.56 (t, <i>J</i> = 0.73 Hz, 1H), 7.63 (s, 1H), 7.65 (s, 1H), 7.77 (br s, 2H), 7.95 (d, <i>J</i> = 1.9 Hz, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 305 (M + 1).</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>tert</i>-Butyl 4-(4-Bromobenzoyl)piperazine-1-carboxylate (<b>25c</b>)</h3><div class="NLM_p last">A solution of 4-bromobenzoyl chloride (1.0 g, 4.5 mmol), <i>tert</i>-butylpiperazine 1-carboxylate (1.1 g, 5.9 mmol), and triethylamine (1.5 mL, 11 mmol) in dichloromethane (15 mL) was stirred at room temperature for 15 h. The reaction mixture was diluted with ethyl acetate (100 mL), washed with saturated sodium bicarbonate solution (2 × 25 mL) and brine (2 × 25 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure to give a tan solid. The solid was triturated in hexanes/diethyl ether (10:1 v/v) and washed with diethyl ether (25 mL) to afford the title compound as a white solid (1.6 g, 95%). <sup>1</sup> H NMR: δ 1.40 (s, 9H), 3.20–3.60 (m, 8H), 7.37 (d, <i>J</i> = 8.3 Hz, 2H), 7.65 (d, <i>J</i> = 8.4 Hz, 2H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 393 (M + Na).</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-[3-(4-Bromophenyl)propyl]pyrrolidine (<b>25e</b>)</h3><div class="NLM_p last">A solution of bromo-4-(3-bromopropyl)benzene (<b>27</b>, 3.5 g, 13 mmol), pyrrolidine (2.1 mL, 25 mmol), and cesium carbonate (8.2 g, 25 mmol) in dioxane (40 mL) was stirred at room temperature under argon for 15 h. The reaction mixture was poured onto water (200 mL) and extracted with ethyl acetate (3 × 100 mL). The organic layer was separated, washed with brine (2 × 50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated under reduced pressure, and purified by flash chromatography (SiO<sub>2</sub>, 10−25% methanol in dichloromethane containing 2% triethylamine) to afford the title compound as a pale-orange oil (1.8 g, 53%). <sup>1</sup>H NMR: δ 1.60–1.65 (m, 6H), 2.35 (t, <i>J</i> = 7.3 Hz, 2H), 2.35–2.43 (m, 4H), 2.57 (t, <i>J</i> = 7.7 Hz, 2H), 7.16 (d, <i>J</i> = 8.3 Hz, 2H), 7.44 (d, <i>J</i> = 8.4 Hz, 2H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 268 (M + 1).</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 7-(2-Chloro-5-methoxyphenyl)-5-methyl-<i>N</i>-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine (<b>26a</b>)</h3><div class="NLM_p last">A solution of 7-(2-chloro-5-methoxyphenyl)-5-methyl-1,2,4-benzotrizine-3-amine (<b>24a</b>, 500 mg, 1.66 mmol), <i>N</i>-(2-chloroethyl)pyrrolidine (674 mg, 2.49 mmol), cesium carbonate (2.16 g, 6.65 mmol), tris(dibenzylideneacetone)dipalladium (152 mg, 0.17 mmol), and 4,5-bis(diphenylphosphino)-9,9-dimethyxanthene (xantphos, 287 mg, 0.50 mmol) in 1,4-dioxane (20 mL) was heated at reflux for 4 h under argon. The solid was filtered and washed with ethyl acetate (100 mL). The filtrate was washed with brine (1 × 100 mL). The organic solution was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to 5 mL. Hexanes (50 mL) were added to the organic phase and the solid was filtered and purified by flash chromatography (SiO<sub>2</sub>, using dichloromethane/methanol/28% aqueous ammonia, 100:10:2.5) to afford the title compound as a yellow solid (440 mg, 54%). <sup>1</sup>H NMR: δ 1.67–1.72 (m, 4H), 2.50–2.53 (m, 4H), 2.64 (s, 3H), 2.79 (t, <i>J</i> = 11.8 Hz, 2H), 3.83 (s, 3H), 4.07 (t, <i>J</i> = 5.9 Hz, 2H), 7.00 (d, <i>J</i> = 9.1 Hz, 2H), 7.04 (dd, <i>J</i> = 3.0, 4.4 Hz, 1H), 7.13 (d, <i>J</i> = 3.0 Hz, 1H), 7.52 (d, <i>J</i> = 8.9 Hz, 1H), 7.85 (d, <i>J</i> = 0.7 Hz, 1H), 7.92 (d, <i>J</i> = 9.0 Hz, 1H), 8.17 (d, <i>J</i> = 1.5 Hz, 1H), 10.81 (br s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 490 (M + 1).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-{[7-(2-Chloro-5-methoxyphenyl)-5-methyl-1,2,4-benzotriazin-3-yl]amino}-<i>N</i>-(2-pyrrolidin-1-ylethyl)benzenesulfonamide (<b>26b</b>)</h3><div class="NLM_p last">A solution of 7-(2-chloro-5-methoxyphenyl)-5-methyl-1,2,4-benzotrizine-3-amine (<b>24a</b>, 0.157 g, 0.523 mmol), 4-bromo-<i>N</i>-(2-pyrrolidin-1-ylethyl)benzenesulfonamide (0.261 g, 0.785 mmol), cesium carbonate (0.512 g, 1.57 mmol), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (0.061 g, 0.10 mmol), and tris(dibenzylideneacetone)dipalladium (0.048 g, 0.052mmol) in dioxane (5 mL) was flushed with argon and heated at reflux for 18 h. The hot reaction mixture was filtered, diluted with ethyl acetate, and washed with brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to provide a solid. The solid was dissolved in dichloromethane and precipitated with hexanes to afford a yellow powder (0.276 g, 95% yield). <sup>1</sup>H NMR: δ 1.63–1.67 (m, 4H), 2.35–2.42 (br s, 4H), 2.47 (br s, 2H), 2.71 (s, 3H), 2.87 (t, <i>J</i> = 6.9 Hz, 2H), 3.83 (s, 3H), 7.06 (dd, <i>J</i> = 3.1, 8.9 Hz, 1H), 7.14 (d, <i>J</i> = 3.1 Hz, 1H), 7.53 (d, <i>J</i> = 8.9 Hz, 1H), 7.84 (d, <i>J</i> = 5.1 Hz, 2H), 7.95 (d, <i>J</i> = 0.9 Hz, 1H), 8.21 (d, <i>J</i> = 5.2 Hz, 2H), 8.27 (d, <i>J</i> = 1.8 Hz, 1H), 11.39 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 553.3 (M + 1).</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>tert</i>-Butyl 4-(4-{[7-(2-Chloro-5-methoxyphenyl)-5-methyl-1,2,4-benzotriazin-3-yl]amino}benzoyl)piperazine-1-carboxylate (<b>26c</b>)</h3><div class="NLM_p last">A suspension of 7-(2-chloro-5-methoxyphenyl)-5-methylbenzo[1,2,4]triazin-3-ylamine (0.10 g, 0.33 mmol), <i>tert</i>-butyl 4-(4-bromobenzoyl)piperazine-1-carboxylate (0.16 g, 0.44 mmol), palladium acetate (4 mg, 0.018 mmol), xantphos (20 mg, 0.035 mmol), and potassium <i>tert</i>-butoxide (0.10 g, 0.89 mmol) in xylene (3 mL) was heated in a microwave reactor at 160 °C for 15 min. After cooling to room temperature, the mixture was filtered and the solids were washed with dichloromethane. The filtrate was concentrated and purified using flash chromatography (SiO<sub>2</sub>, 40% ethyl acetate in hexanes) to afford the title compound as an orange solid (45 mg, 23%). <sup>1</sup>H NMR: δ 1.42 (s, 9H), 2.70 (s, 3H), 3.35–3.45 (m, 4H), 3.45–3.55 (m, 4H), 3.84 (s, 3H), 7.06 (dd, <i>J</i> = 2.9, 8.7 Hz, 1H), 7.15 (d, <i>J</i> = 2.9 Hz, 1H), 7.49 (d, <i>J</i> = 8.7 Hz, 1H), 7.53 (d, <i>J</i> = 8.7 Hz, 2H), 7.93 (t, <i>J</i> = 1.0 Hz, 1H), 8.11 (d, <i>J</i> = 8.6 Hz, 2H), 8.25 (d, <i>J</i> = 1.7 Hz, 1H), 11.21 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 589 (M + 1).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Benzyl 4-[(4-{[7-(2-Chloro-5-methoxyphenyl)-5-methyl-1,2-4-benzotriazin-3-yl]amino}phenyl)sulfonyl]piperdine-1-carboxylate (<b>26d</b>)</h3><div class="NLM_p last">A solution of 7-(2-chloro-5-methoxyphenyl)-5-methylbenzo[1,2,4]triazin-3-ylamine (0.13 g, 0.44 mmol), benzyl 4-(4-bromobenzenesulfonyl)piperdine-1-carboxylate (0.232 g, 0.53 mmol), cesium carbonate (0.432 g, 1.33 mmol), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthane (0.051 g, 0.088 mmol), and tris(dibenzylideneacetone)dipalladium (0.04 g, 0.044 mmol) in dioxane (12 mL) was heated at reflux under argon for 18 h. The reaction mixture was cooled and diluted with water (12 mL). The solid was filtered and washed with water (20 mL) and ether (20 mL) to afford the title compound as a yellow solid (0.27 g, 93% yield). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 658 (M + 1).</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Bromo-4-(3-bromopropyl)benzene (<b>27</b>)</h3><div class="NLM_p last">Triphenylphosphine (6.3 g, 24 mmol) and then carbon tetrabromide (8.0 g, 24 mmol) were added to a solution of bromo-4-(3-hydroxypropyl)benzene (4.0 g, 19 mmol) in tetrahydrofuran (30 mL) at 0 °C under an argon atmosphere. The mixture was stirred at 0 °C for 15 min and then at room temperature for an additional 15 h. The solvent was removed under reduced pressure and purified by flash chromatography (SiO<sub>2</sub>, hexanes) to afford the title compound as a colorless oil (3.5 g, 66%). <sup>1</sup> H NMR: δ 2.03–2.12 (m, 2H), 2.68 (t, <i>J</i> = 7.5 Hz, 2H), 3.49 (t, <i>J</i> = 6.5 Hz, 2H), 7.19 (d, <i>J</i> = 8.3 Hz, 2H), 7.47 (d, <i>J</i> = 8.3 Hz, 2H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 279 (M + 1).</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl-<i>N</i>-butyloxycarbonyl Glycinate (<b>28</b>)</h3><div class="NLM_p last">A solution of 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenol (<b>5</b>, 0.25 g, 0.526 mmol), <i>N</i>-<i>tert</i>-butyloxycarbonylglycine (0.37 g, 2.11 mmol), <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (1 g, 5.26 mmol), and 4-dimethylaminopyridine (65 mg, 0.526 mmol) in dimethylformamide (25 mL) was stirred at room temperature for 18 h. The reaction mixture was concentrated and purified by flash chromatography (SiO<sub>2</sub>, 10% methanol in dichloromethane) to afford the title compound (0.085 g, 26%). <sup>1</sup>H NMR: δ 1.39 (s, 9H), 1.87–1.88 (m, 4H), 2.64 (s, 3H), 3.10–3.14 (m, 4H), 4.00 (d, <i>J</i> = 5.9 Hz, 2H), 4.29 (t, <i>J</i> = 4.7 Hz, 2H), 7.06 (d, <i>J</i> = 8.9 Hz, 2H), 7.26 (dd, <i>J</i> = 2.8, 8.7 Hz, 1H), 7.39 (d, <i>J</i> = 2.7 Hz, 1H), 7.46 (t, <i>J</i> = 6.0 Hz, 1H), 7.70 (d, <i>J</i> = 8.7 Hz, 1H), 7.85 (t, <i>J</i> = 0.9 Hz, 1H), 7.96 (d, <i>J</i> = 9.0 Hz, 2H), 8.18 (s, 1H), 10.89 (s, 1H). MS-ESI<sup>+</sup><i>m</i>/<i>z</i> 633 (M + 1).</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Chemical Stability Studies of Prodrugs <b>10</b>–<b>20</b></h3><div class="NLM_p last">Chemical stability of various prodrugs (<b>10</b>−<b>20</b>) was measured in a formulation solution containing 0.5% of compounds and 0.5% HPMC/5% dextrose at pH 6.7. The vials were closed and heated in an autoclave at 120 °C for 1 h. The solutions were cooled to room temperature and analyzed on Shimadzu HPLC systems equipped with LC-10ATvp pumps, SIL-10ADvp autoinjector, SPD-M10Avp diode array, an ELSD-LT detectors, and Agilent C-18 Zorbax 250 mm × 4.6 mm column with 5 μm particle size. The analytical gradient consisted of 15% acetonitrile in water ramping up to 90% acetonitrile, both containing 0.05% trifluoroacetic acid.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Hydrolysis of Prodrugs in Rabbit Eye Homogenates</h3><div class="NLM_p last">Two eyeballs (6.37 g) from a Dutch-Belted rabbit were collected and homogenized in 20 mL of 1× radioimmunoprecipitation (RIPA) buffer (diluted from 10× RIPA buffer, Upstate Biotechnology, Inc. Charlottesville, VA). Prodrugs <b>12</b>, <b>14</b>, <b>18</b>, and <b>19</b> were dissolved in dimethyl sulfoxide (1 mg/mL) and added to 3 mL of the homogenate solution with a final concentration of 5 µg/mL. The solutions were kept at 37 °C. The homogenates were sampled at 0, 0.25, 1, 2, and 6 h. The reaction of one aliquot of the mixtures was terminated at the above time points by addition of an equal volume of cold acetonitrile (with 1 µM of the internal standard) and centrifugation. The acetonitrile was collected and analyzed immediately. Rate of hydrolysis of prodrugs was conducted by measuring the conversion of prodrugs to <b>5</b> in extracts of ocular tissues. Compounds <b>12</b>, <b>14</b>, <b>18</b>, and <b>19</b> incubated in RIPA buffer at 37 °C for 120 min were used as controls. The supernatants of reaction mixtures were analyzed for prodrugs (<b>12</b>, <b>14</b>, <b>18</b>, and <b>19</b>) and <b>5</b>. The samples were analyzed using API3000 liquid chromatography equipped with an MS/MS (triple quadrupole) spectrometer, Zorbax SB 75 mm × 2.1 mm, 3.5 µm column at 40 °C, using water and acetonitrile as mobile phase, both containing 0.05% trifluoroacetic acid. Hydrolysis rates were calculated using first-order kinetics.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Structure Based Modeling Studies</h3><div class="NLM_p last">While several crystal structures of the unphosphorylated form of Src are available (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2src">2src</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1fmk">1fmk</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1y57">1y57</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ptk">2ptk</a>), it is known that kinases in the Src family undergo conformational change upon phosphorylation, casting doubt on the relevance of these crystal forms to drug discovery. We felt that the crystal structure of the inactive form of Src is not useful for modeling studies. The fully activated catalytic domain of human Src kinase was built on the basis of available crystal structures of activated Lck. The catalytic domains of Src and Lck exhibit 67% sequence identity over 273 residues without gaps in the alignment with significantly higher homology exhibited in the ATP binding site. The model was built using the interactive programs InsightII and Homology from Accelrys. Compound <b>5</b> was docked initially into the active site using an automated modeling program BioDock (NIH SBIR Grant 1R43GM071055) and subsequently using interactive modeling in InsightII. Models with and without ligands were subjected to energetic refinement including solvent using the Accelerys program Discover. Visualization was generated using the program BioInterpreter (NIH SBIR Grant 5R44GM061465). After comparison of available crystal structures for VEGFr2 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ywn">1ywn</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1vr2">1vr2</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1y6a">1y6a</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1y6b">1y6b</a>), the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ywn">1ywn</a> crystal structure was selected for modeling because of its closest resemblance to protein used in enzymatic assay. When <b>5</b> was docked into the pocket, it exhibited a critical hydrogen bond from the hydroxyphenyl of <b>5</b> to Glu885 on the αC-helix residue on the protein.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> In Vitro Src Kinase Inhibition Assay</h3><div class="NLM_p last">The IC<sub>50</sub> values for compounds were determined using a luminescence-based kinase assay with recombinant Src obtained from Invitrogen. In white, flat-bottomed 96-well plates (Nunc) parallel assays were run at room temperature at a final volume of 50 µL. Each well contained 40 µL of buffer consisting of 40 mM Tris buffer, pH 7.4, containing 50 mM MgCl<sub>2</sub>, 800 µM EDTA, 350 µM Triton X-100, 2 mM β-mercaptoethanol, 250 µM peptide substrate (PTK2, Promega), and an appropriate amount of Src (75–25 ng/well) such that the assay was linear over 60 min. The final concentrations of compounds for IC<sub>50</sub> value determinations ranged from 1000 to 0.01 µM by adding the appropriate amount of compound in 2.5 µL of DMSO; the DMSO present in each assay was constant at 5%. The reaction was initiated by the addition of 10 µL of ATP to a final assay concentration of 3 µM. After the reaction had proceeded for 60 min, 50 µL of Kinase-Glo reagent (Promega) was added to terminate the reaction. This solution was then allowed to proceed for an additional 10 min to maximize the luminescence reaction. Values were then measured using an Ultra 384 instrument (Tecan) set for luminosity measurements. Two control reactions were also run: one reaction containing no compound and the second containing neither inhibitor nor peptide substrate. IC<sub>50</sub> values were derived from experimental data using the nonlinear curve fitting capabilities of Prism (version 4, GraphPad Software).</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> In Vitro VEGFr2 Kinase Inhibition Assay</h3><div class="NLM_p last">The IC<sub>50</sub> values for compounds were determined using a luminescence-based kinase assay with recombinant VEGFr2 obtained from Invitrogen. In white, flat-bottomed 96-well plates (Nunc) parallel assays were run at room temperature at a final volume of 50 µL. Each well contained 40 µL of buffer consisting of 40 mM Tris buffer, pH 7.4, containing 50 mM MgCl<sub>2</sub>, 800 µM EDTA, 350 µM Triton X-100, 2 mM β-mercaptoethanol, 500 µg/mL poly-E4Y (Sigma) for VEGFr2 and an appropriate amount of VEGFr2 such that the assay was linear over 60 min. The final concentrations of compounds for IC<sub>50</sub> value determinations ranged from 10 to 0.001 µM by adding the appropriate amount of compound in 2.5 µL of DMSO; the DMSO present in each assay was constant at 5%. The reaction was initiated by the addition of 10 µL of ATP to a final assay concentration of 3 µM. After the reaction had proceeded for 60 min, 50 µL of Kinase-Glo reagent (Promega) was added to terminate the reaction. This solution was then allowed to proceed for an additional 10 min to maximize the luminescence reaction. Values were then measured using an Ultra 384 instrument (Tecan) set for luminosity measurements. Two control reactions were also run: one reaction containing no compound and the second containing neither inhibitor nor peptide substrate. IC<sub>50</sub> values were derived from experimental data using the nonlinear curve fitting capabilities of Prism (version 4, GraphPad Software).</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> In Vitro YES Kinase Inhibition Assay</h3><div class="NLM_p last">The IC<sub>50</sub> values for compounds were determined using a luminescence-based kinase assay with recombinant YES obtained from Invitrogen. In white, flat-bottomed 96-well plates (Nunc) parallel assays were run at room temperature at a final volume of 50 µL. Each well contained 40 µL of buffer consisting of 40 mM Tris buffer, pH 7.4, containing 50 mM MgCl<sub>2</sub>, 800 µM EDTA, 350 µM Triton X-100, 2 mM β-mercaptoethanol, 250 µM peptide substrate (PTK2, Promega), and an appropriate amount of YES (75–25 ng/well) such that the assay was linear over 60 min. The final concentrations of compounds for IC<sub>50</sub> value determinations ranged from 1000 to 0.01 µM by adding the appropriate amount of compound in 2.5 µL of DMSO; the DMSO present in each assay was constant at 5%. The reaction was initiated by the addition of 10 µL of ATP to a final assay concentration of 3 µM. After the reaction had proceeded for 60 min, 50 µL of Kinase-Glo reagent (Promega) was added to terminate the reaction. This solution was then allowed to proceed for an additional 10 min to maximize the luminescence reaction. Values were then measured using an Ultra 384 instrument (Tecan) set for luminosity measurements. Two control reactions were also ran: one reaction containing no compound and the second containing neither inhibitor nor peptide substrate. IC<sub>50</sub> values were derived from experimental data using the nonlinear curve fitting capabilities of Prism (version 4, GraphPad Software).</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> In Vitro VEGF-Mediated Proliferation in Human Retinal Microvascular Endothelial Cell Assay</h3><div class="NLM_p last">For the cellular proliferation assays, human retinal microvascular endothelial cells (Cell Systems; Kirkland, WA) were plated at a density of ∼1.5 × 10<sup>3</sup> cells/well in a 96-well plate (Corning; Corning, NY) and allowed to adhere for approximately 5–6 h. Medium was then changed into CSC-Maintenance Medium (Cell Systems; Kirkland, WA) and incubated for approximately 48 h at 37 °C/5% CO<sub>2</sub>. As indicated by the manufacturer, this specialized medium contains 10% FBS but no growth factor and renders proliferating cells into a quiescent state. The cells were then pretreated with varying concentrations of <b>5</b> (5−0.00229 or 2−0.00195 µM) or DMSO (as a vehicle control) prepared in basal CSC medium containing 10% FBS and 50 µg/mL heparin for approximately 60 min at 37 °C/5% CO<sub>2</sub>. Human recombinant VEGF (Peprotech; Rocky Hill, NJ) was then added to a final concentration of 50 ng/mL, and cells were incubated for 48 h, at which time cell proliferation was quantified using the Cell Proliferation Kit (Roche; Alameda, CA) as described by the manufacturer. Briefly, for one 96-well plate, 100 µL of electron-coupling reagent was added to 5 mL of XTT labeling solution. A 50 µL sample of this solution was then added to each well, and the reaction was allowed to develop at 37 °C/5% CO<sub>2</sub>. The colored formazan product that is generated by metabolically active cells was measured spectrophotometrically using the SpectraMax spectrophotometer (Molecular Devices; Sunnyvale, CA) at 492 nm with correction at 690 nm. IC<sub>50</sub> values were determined using the GraphPad Prism 4.0 software (San Diego, CA), with the corrected absorbance values plotted on <i>y</i>-axis (linear scale) and logarithmic values of concentration (µM) on the <i>x</i>-axis. Data were subjected to a nonlinear regression fit analysis and the concentrations at which endothelial cell proliferation was inhibited by 50% determined.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Pharmacokinetic Studies of <b>12</b> in Mouse Ocular Tissue after a Single Topical Instillation</h3><div class="NLM_p">The 0.7% w/v formulation of <b>5</b> was prepared as follows. The hydrochloride salt of <b>5</b> (31.16 mg) was mixed with PL90G liposome (970 mg) and dissolved in ethanol (2 mL). The solution was evaporated to dryness under reduced pressure and resuspended in water (2.7 g) containing 3% (w/v) propylene glycol. The solution pH was adjusted to 6.1 with 1 N NaOH, the mixture was homogenized using a sonicator probe (model GE-130), the osmolality of the solution was adjusted to 355 mOsm, and the mixture was filtered through a 0.22 µm PVDF syringe filter (Millipore). The 1.8% w/v formulations of <b>12</b> was prepared as follows. Compound <b>12</b> (26.44) was mixed with PL90G liposome (386.97 mg) and dissolved in 2 mL of ethanol. The solution was evaporated to dryness under reduced pressure and resuspended in water (923.55 mg) containing 3% (w/v) propylene glycol. The pH was adjusted to 6.2 with 1 N HCl. The mixture was homogenized using a sonicator probe (model GE-130), and osmolality was adjusted to 327 mOsm and filtered through a 0.45 µm PVDF syringe filter (Millipore). Twenty male mice (C57BL/6) were given one 10 µL drop of 0.7% of <b>5</b>. Composite sampling was employed to generate tissue concentration−time profiles for <b>5</b> over the following time course (<i>N</i> = 4/time point): 0.5, 1, 3, 7, and 24 h postinstillation. Both eyes were removed from each mouse and dissected to obtain the cornea, retina, and eye cup (sclera and choroid). Plasma samples were also obtained from each mouse at the time of euthanasia. Ten male mice were given one 10 µL drop of the solution of <b>12</b>. Composite sampling was employed to generate tissue concentration−time profiles for <b>12</b> and <b>5</b> over the following time course (<i>N</i> = 2/time point): 0.5, 1, 3, 7, and 24 h postinstillation. Both eyes were removed from each mouse and dissected to obtain the cornea, retina, and eye cup. Plasma samples were also obtained from each mouse at the time of euthanasia. Individual eye tissue samples were combined and weighed. The weighed tissues were homogenized in 0.5 mL of RIPA buffer using FP120 FastPrep (ThermoSavant) and extracted with 0.5 mL of acetonitrile (containing internal standard). The supernatants (800 µL) were dried and reconstituted into 400 µL of 8:2 dimethyl sulfoxide (DMSO)/water for analysis. Plasma samples were extracted by addition of a 2-fold excess of acetonitrile containing internal standard followed by centrifugation. The supernatants were isolated for analysis. Processed plasma and ocular tissue samples were quantitated by LC/MS/MS against externals calibration standards prepared in naive mouse tissues. Matrix calibration standards and quality control (QC) samples were prepared by adding stock solutions of <b>5</b> or <b>12</b> into a series of aliquots of blank mouse plasma (for plasma analysis) or blank mouse ocular tissue (for ocular tissue analysis). The final concentrations ranged from 0.5 to100 ng/mL for plasma analyses and from 0.125 to 500 ng/mL for ocular tissue analyses.</div><div class="NLM_p last">The LC/MS/MS system consisted of an Sciex API3000 triple quadrupolar mass spectrometer (MDS Sciex), an Agilent 1100 HPLC system (Agilent Technologies, Inc.), and a CTC autosampler (Leap Technologies). The LC separations were performed on a Zorbax SB 75 mm × 2.1 mm, 3.5 µm reverse phase HPLC column (Agilent Technologies, Inc.). The column temperature was kept at 40 °C. Mobile phase A consisted of 0.05% trifluoroacetic acid (TFA) in water, and mobile phase B consisted of 0.05% TFA in acetonitrile. The flow rate was kept constant at 0.25 mL/min. Following a 30 µL sample injection, mobile B was held at 5% for 3 min followed by a linear increase to 70% mobile phase B over 5 min. The mass spectrometric detection of <b>12</b> and <b>5</b> was achieved using electrospray ionization operating in positive ionization mode. The molecular ion transitions of <i>m</i>/<i>z</i>: 476.18 → 98.2 and <i>m</i>/<i>z</i>: 580.17 → 98.2 were monitored in MRM mode for <b>5</b> and <b>12</b>, respectively. Pharmacokinetic parameters were estimated using WinNonlin (version 4.1) based on mean concentrations for each time point and individual tissue. The time to maximum concentration (<i>T</i><sub>max</sub>) and the maximum concentration (<i>C</i><sub>max</sub>) were determined on the basis of measured concentrations. The area under the curve, AUC<sub>last</sub>, was calculated from mean concentration data using the linear trapezoidal rule. No standard deviations are given, since the data represent the combined exposure from only two to four eyes.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Laser-Induced Choroidal Neovascularization in Mice</h3><div class="NLM_p last">Compound <b>12</b> was prepared as a solution as described above. Laser-photocoagulation-induced rupture of Bruch’s membrane was used to generate CNV as previously described.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Briefly, 4- to 5-week-old female C57BL/6J mice were anesthetized with ketamine hydrochloride (100 mg/kg body weight), and the pupils were dilated with 1% tropicamide (Alcon Laboratories, Inc.; Forth Worth, TX). Three burns of 532 nm diode laser photocoagulation (75 µm spot size, 0.1 s duration, 120 mW) were delivered to each retina by using the slit lamp delivery system of a photocoagulator (OcuLight, Iridex; Mountain View, CA) and a hand-held coverslip as a contact lens. Burns were performed in the 9, 12, and 3 o’clock positions of the posterior pole of the retina. Production of a bubble at the time of laser treatment, which indicates rupture of Bruch’s membrane, is an important factor in obtaining CNV.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Only burns in which a bubble was produced were included in the study. Body weights were monitored throughout the experiment, and the CNV area was measured on day 14 as described below. For topical administration, eight mice/group were given one 10 µLdrop of the formulation vehicle, 0.61% w/v <b>12</b>, or 1.83% w/v <b>12</b> three times a day (t.i.d.), with each dose separated by 4 h and no treatment in the fellow eye. One group of mice had a rupture to Bruch’s membrane and no treatment to either eye. Two weeks after the rupture of Bruch’s membrane, mice were anesthetized and perfused with fluorescein-labeled dextran (2 × 10<sup>6</sup> average molecular weight, Sigma-Aldrich; St. Louis, MO) and choroidal flatmounts were prepared as previously described.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Briefly, the eyes were removed and fixed for 1 h in 10% phosphate-buffered formalin and the cornea and lens were removed. The entire retina was carefully dissected from the eye cup. Radial cuts were made from the edge of the eye cup to the equator in all four quadrants and flat-mounted in aqueous mounting medium (Aquamount, BDH; Poole, U.K.). Flat-mounts were examined by fluorescence microscopy (Axioskop, Carl Zeiss Meditec; Thornwood, NY), and images were digitized with a three charge coupled device (CCD) color video camera (IK-TU40A, Toshiba; Tokyo, Japan) and a frame grabber. Image-analysis software (Image-Pro Plus, Media Cybernetics; Silver Spring, MD) was used to measure the area of each CNV lesion. Statistical comparisons were made using a linear mixed model.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Probabilities for comparison of treatments were adjusted for multiple comparisons by the Dunnett method.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58"><a href="/doi/suppl/10.1021/jm7011276">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis results and details of the effects of <b>5</b> on target kinases and topically applied <b>5</b> and <b>12</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm7011276/suppl_file/jm7011276-file002.pdf">jm7011276-file002.pdf (516.37 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm7011276" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07435" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07435" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Moorthy S. S. Palanki</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4c1c2d202d2227250c382d3e2b292b2922622f2321"><span class="__cf_email__" data-cfemail="8fdfeee3eee1e4e6cffbeefde8eae8eae1a1ece0e2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hideo Akiyama</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Campochiaro</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianguo Cao</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chun P. Chow</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luis Dellamary</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Doukas</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Fine</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Colleen Gritzen</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. Hood</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Hu</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shu Kachi</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinshan Kang</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boris Klebansky</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ahmed Kousba</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Lohse</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chi Ching Mak</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Martin</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew McPherson</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ved P. Pathak</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel Renick</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Soll</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naoyasu Umeda</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shiyin Yee</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katsutoshi Yokoi</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Binqi Zeng</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Zhu</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Glenn Noronha</span> - <span class="hlFld-Affiliation affiliation">TargeGen, Inc., 9380 Judicial Drive, San Diego, California 92121, Department of Ophthalmology, Johns Hopkins Hospital School of Medicine, 719 Maumenee, 600 N. Wolfe Street, Baltimore, Maryland 21287, and BioPredict, Inc., 660 Kinderkamack Road, Oradell, New Jersey 07649</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08033" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08033" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Barbara Robinson and Linda Hwang for valuable discussions and technical assistance.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81385" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81385" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 59 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">De Jong, P. T.</span><span> </span><span class="NLM_article-title">Age-related macular degeneration</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1474</span><span class="NLM_x">–</span> <span class="NLM_lpage">1485</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1056%2FNEJMra062326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=17021323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGgtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1474-1485&author=P.+T.+De+Jong&title=Age-related+macular+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: Age-related macular degeneration</span></div><div class="casAuthors">de Jong, Paulus T. V. M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1474-1485</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  SINCE 1874, WHEN IT WAS FIRST DESCRIBED IN THE MEDICAL LITERATURE AS "sym. central choroidoretinal disease occurring in senile persons," age-related macular degeneration has also been referred to as senile, or diski-form, macular degeneration, among many other terms.  About 25 years ago, the term "age-related maculopathy" was coined and its end stage was acknowledged as age-related macular degeneration.  In this review, the author use the commonly accepted age-related macular degeneration, although the author have reservations about its appropriateness.  Topics discussed include: the outer retina and adjacent tissues; the retinal-pigment epithelium; Phagocytosis by RPE cells; Bruch's membrane; Ruysch's complex; genetics; smoking; light-induced toxic effects; and converging risk factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8AFwko1o2qbVg90H21EOLACvtfcHk0lgHSJpKkhJUqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGgtrjM&md5=498f520dd9e50616700812f7e648a9fd</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJMra062326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra062326%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BJong%26aufirst%3DP.%2BT.%26atitle%3DAge-related%2520macular%2520degeneration%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1474%26epage%3D1485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Rattner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathans, J.</span><span> </span><span class="NLM_article-title">Macular degeneration: recent advances and therapeutic opportunities</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">860</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1038%2Fnrn2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=17033682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFShtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=860-872&author=A.+Rattnerauthor=J.+Nathans&title=Macular+degeneration%3A+recent+advances+and+therapeutic+opportunities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Macular degeneration: recent advances and therapeutic opportunities</span></div><div class="casAuthors">Rattner, Amir; Nathans, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">860-872</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The central retina mediates high acuity vision, and its progressive dysfunction due to macular degeneration is the leading cause of visual disability among adults in industrialized societies.  A summary of recent progress in understanding the pathophysiol. of macular degeneration is given, and the implications of this new knowledge for treatment and prevention are discussed.  The past decade has witnessed remarkable advances in this field, including the development of new, noninvasive retinal imaging technologies, the development of animal models for macular disease, and the isolation of many of the genes responsible for both early- and late-onset macular diseases.  These advances have set the stage for the development of effective mechanism-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq03vnpUksgkbVg90H21EOLACvtfcHk0ljBG9bt6wnwiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFShtrnL&md5=c818a393a17d8926426b8a14cac34594</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrn2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2007%26sid%3Dliteratum%253Aachs%26aulast%3DRattner%26aufirst%3DA.%26aulast%3DNathans%26aufirst%3DJ.%26atitle%3DMacular%2520degeneration%253A%2520recent%2520advances%2520and%2520therapeutic%2520opportunities%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D860%26epage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Shweiki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshet, E.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1992&pages=843-845&author=D.+Shweikiauthor=A.+Itinauthor=D.+Sofferauthor=E.+Keshet&title=Vascular+endothelial+growth+factor+induced+by+hypoxia+may+mediate+hypoxia-initiated+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShweiki%26aufirst%3DD.%26aulast%3DItin%26aufirst%3DA.%26aulast%3DSoffer%26aufirst%3DD.%26aulast%3DKeshet%26aufirst%3DE.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520induced%2520by%2520hypoxia%2520may%2520mediate%2520hypoxia-initiated%2520angiogenesis%26jtitle%3DNature%26date%3D1992%26volume%3D359%26spage%3D843%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Forsythe, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koos, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenza, G. L.</span><span> </span><span class="NLM_article-title">**Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4604</span><span class="NLM_x">–</span> <span class="NLM_lpage">4613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=8756616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADyaK28XltFKjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=4604-4613&author=J.+A.+Forsytheauthor=B.+H.+Jiangauthor=N.+V.+Iyerauthor=A.+Fatonauthor=S.+W.+Leungauthor=R.+D.+Koosauthor=G.+L.+Semenza&title=**Activation+of+vascular+endothelial+growth+factor+gene+transcription+by+hypoxia-inducible+factor+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1</span></div><div class="casAuthors">Forsythe, Jo A.; Jiang, Bing-Hua; Iyer, Narayan V.; Agani, Faton; Leung, Sandra W.; Koos, Robert D.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4604-4613</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Expression of vascular endothelial growth factor (VEGF) is induced in cells exposed to hypoxia or ischemia.  Neovascularization stimulated by VEGF occurs in severals important clin. contexts, including myocardial ischemia, retinal disease, and tumor growth.  Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric basic helix-loop-helix protein that activates transcription of the human erythropoietin gene in hypoxic cells.  Here we demonstrate the involvement of HIF-1 in the activation of VEGF transcription.  VEGF 5'-flanking sequences mediated transcriptional activation of reporter gene expression in hypoxic Hep3B cells.  A 47-bp sequence located 985 to 939 bp 5' to the VEGF transcription initiation site mediated hypoxia-inducible reporter gene expression directed by a simian virus 40 promoter element that was otherwise minimally responsive to hypoxia.  When reporters contg. VEGF sequences, in the context of the native VEGF or heterologous simian virus 40 promoter, were cotransfected with expression vectors encoding HIF-1α and HIF-1β (ARNT [aryl hydrocarbon receptor nuclear translocator]), reporter gene transcription was much greater in both hypoxic and nonhypoxic cells than in cells transfected with the reporter alone.  A HIF-1 binding site was demonstrated in the 47-bp hypoxia response element, and a 3-bp substitution eliminated the ability of the element to bind HIF-1 and to activate transcription in response to hypoxia and/or recombinant HIF-1.  Cotransfection of cells with an expression vector encoding a dominant neg. form of HIF-1α inhibited the activation of reporter transcription in hypoxic cells in a dose-dependent manner.  VEGF mRNA was not induced by hypoxia in mutant cells that do not express the HIF-1β (ARNT) subunit.  These findings implicate HIF-1 in the activation of VEGF transcription in hypoxic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWR5k0flrm27Vg90H21EOLACvtfcHk0ljBG9bt6wnwiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltFKjsrc%253D&md5=d699f194fc5edae7b2b6a5ce97359808</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForsythe%26aufirst%3DJ.%2BA.%26aulast%3DJiang%26aufirst%3DB.%2BH.%26aulast%3DIyer%26aufirst%3DN.%2BV.%26aulast%3DFaton%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DS.%2BW.%26aulast%3DKoos%26aufirst%3DR.%2BD.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3D%252A%252AActivation%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520gene%2520transcription%2520by%2520hypoxia-inducible%2520factor%25201%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D4604%26epage%3D4613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Aiello, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigg, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyt, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jampel, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquale, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieme, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, G. L.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">1480</span><span class="NLM_x">–</span> <span class="NLM_lpage">1487</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1056%2FNEJM199412013312203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=7526212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADyaK2M%252FlvFamsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1994&pages=1480-1487&author=L.+P.+Aielloauthor=R.+L.+Averyauthor=P.+G.+Arriggauthor=B.+A.+Keytauthor=H.+D.+Jampelauthor=S.+T.+Shahauthor=L.+R.+Pasqualeauthor=H.+Thiemeauthor=M.+A.+Iwamotoauthor=J.+E.+Parkauthor=H.+V.+Nguyenauthor=L.+M.+Aielloauthor=N.+Ferraraauthor=G.+L.+King&title=Vascular+endothelial+growth+factor+in+ocular+fluid+of+patients+with+diabetic+retinopathy+and+other+retinal+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders</span></div><div class="casAuthors">Aiello L P; Avery R L; Arrigg P G; Keyt B A; Jampel H D; Shah S T; Pasquale L R; Thieme H; Iwamoto M A; Park J E</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1480-7</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Retinal ischemia induces intraocular neovascularization, which often leads to glaucoma, vitreous hemorrhage, and retinal detachment, presumably by stimulating the release of angiogenic molecules.  Vascular endothelial growth factor (VEGF) is an endothelial-cell-specific angiogenic factor whose production is increased by hypoxia.  METHODS:  We measured the concentration of VEGF in 210 specimens of ocular fluid obtained from 164 patients undergoing intraocular surgery, using both radioimmuno-assays and radioreceptor assays.  Vitreous proliferative potential was measured with in vitro assays of the growth of retinal endothelial cells and with VEGF-neutralizing antibody.  RESULTS:  VEGF was detected in 69 of 136 ocular-fluid samples from patients with diabetic retinopathy, 29 of 38 samples from patients with neovascularization of the iris, and 3 of 4 samples from patients with ischemic occlusion of the central retinal vein, as compared with 2 of 31 samples from patients with no neovascular disorders (P < 0.001, P < 0.001, and P = 0.006, respectively).  The mean (+/- SD) VEGF concentration in 70 samples of ocular fluid from patients with active proliferative diabetic retinopathy (3.6 +/- 6.3 ng per milliliter) was higher than that in 25 samples from patients with nonproliferative diabetic retinopathy (0.1 +/- 0.1 ng per milliliter, P = 0.008), 41 samples from patients with quiescent proliferative diabetic retinopathy (0.2 +/- 0.6 ng per milliliter, P < 0.001), or 31 samples from nondiabetic patients (0.1 +/- 0.2 ng per milliliter, P = 0.003).  Concentrations of VEGF in vitreous fluid (8.8 +/- 9.9 ng per milliliter) were higher than those in aqueous fluid (5.6 +/- 8.6 ng per milliliter, P = 0.033) in all 10 pairs of samples obtained simultaneously from the same patient; VEGF concentrations in vitreous fluid declined after successful laser photocoagulation.  VEGF stimulated the growth of retinal endothelial cells in vitro, as did vitreous fluid containing measurable VEGF.  Stimulation was inhibited by VEGF-neutralizing antibodies.  CONCLUSIONS:  Our data suggest that VEGF plays a major part in mediating active intraocular neovascularization in patients with ischemic retinal diseases, such as diabetic retinopathy and retinal-vein occlusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuQPc8Cq5uLhWfpMXQLRstfW6udTcc2ebOBsKWfLbltLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FlvFamsA%253D%253D&md5=0711104bb524c018047b810c879aa08e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJM199412013312203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199412013312203%26sid%3Dliteratum%253Aachs%26aulast%3DAiello%26aufirst%3DL.%2BP.%26aulast%3DAvery%26aufirst%3DR.%2BL.%26aulast%3DArrigg%26aufirst%3DP.%2BG.%26aulast%3DKeyt%26aufirst%3DB.%2BA.%26aulast%3DJampel%26aufirst%3DH.%2BD.%26aulast%3DShah%26aufirst%3DS.%2BT.%26aulast%3DPasquale%26aufirst%3DL.%2BR.%26aulast%3DThieme%26aufirst%3DH.%26aulast%3DIwamoto%26aufirst%3DM.%2BA.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BV.%26aulast%3DAiello%26aufirst%3DL.%2BM.%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DKing%26aufirst%3DG.%2BL.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520in%2520ocular%2520fluid%2520of%2520patients%2520with%2520diabetic%2520retinopathy%2520and%2520other%2520retinal%2520disorders%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1994%26volume%3D331%26spage%3D1480%26epage%3D1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pe’er, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shweiki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnessin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshet, E.</span><span> </span><span class="NLM_article-title">Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1995&pages=638-645&author=J.+Pe%E2%80%99erauthor=D.+Shweikiauthor=A.+Itinauthor=I.+Hemoauthor=H.+Gnessinauthor=E.+Keshet&title=Hypoxia-induced+expression+of+vascular+endothelial+growth+factor+by+retinal+cells+is+a+common+factor+in+neovascularizing+ocular+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPe%25E2%2580%2599er%26aufirst%3DJ.%26aulast%3DShweiki%26aufirst%3DD.%26aulast%3DItin%26aufirst%3DA.%26aulast%3DHemo%26aufirst%3DI.%26aulast%3DGnessin%26aufirst%3DH.%26aulast%3DKeshet%26aufirst%3DE.%26atitle%3DHypoxia-induced%2520expression%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520by%2520retinal%2520cells%2520is%2520a%2520common%2520factor%2520in%2520neovascularizing%2520ocular%2520diseases%26jtitle%3DLab.%2520Invest.%26date%3D1995%26volume%3D72%26spage%3D638%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Wand, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendahl, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiroz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S. S.</span><span> </span><span class="NLM_article-title">AAV-mediated expression of vascular endothelial growth factor induces choroidal neovasculariaztion in rat</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1167%2Fiovs.02-0281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=12556414" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=781-790&author=F.+Wandauthor=K.+G.+Rendahlauthor=W.+C.+Manningauthor=D.+Quirozauthor=M.+Coyneauthor=S.+S.+Miller&title=AAV-mediated+expression+of+vascular+endothelial+growth+factor+induces+choroidal+neovasculariaztion+in+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1167%2Fiovs.02-0281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.02-0281%26sid%3Dliteratum%253Aachs%26aulast%3DWand%26aufirst%3DF.%26aulast%3DRendahl%26aufirst%3DK.%2BG.%26aulast%3DManning%26aufirst%3DW.%2BC.%26aulast%3DQuiroz%26aufirst%3DD.%26aulast%3DCoyne%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DS.%2BS.%26atitle%3DAAV-mediated%2520expression%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520induces%2520choroidal%2520neovasculariaztion%2520in%2520rat%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2003%26volume%3D44%26spage%3D781%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Reich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosnot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolentino, M. J.</span><span> </span><span class="NLM_article-title">Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model</span> <span class="citation_source-journal">Mol. Vision</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=12789138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1yhtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=210-216&author=S.+J.+Reichauthor=J.+Fosnotauthor=A.+Kurokiauthor=W.+Tangauthor=X.+Yangauthor=A.+M.+Maguireauthor=J.+Bennettauthor=M.+J.+Tolentino&title=Small+interfering+RNA+%28siRNA%29+targeting+VEGF+effectively+inhibits+ocular+neovascularization+in+a+mouse+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocularneovascularization in a mouse model</span></div><div class="casAuthors">Reich, Samuel J.; Fosnot, Joshua; Kuroki, Akiko; Tang, Waixing; Yang, Xiangyang; Maguire, Albert M.; Bennett, Jean; Tolentino, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Vision</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">210-216</span>CODEN:
                <span class="NLM_cas:coden">MVEPFB</span>;
        ISSN:<span class="NLM_cas:issn">1090-0535</span>.
    
            (<span class="NLM_cas:orgname">Molecular Vision</span>)
        </div><div class="casAbstract">The purpose of this study was to demonstrate the feasibility of RNA interference mediated by siRNA in retinal cells in vitro and in the murine retina in vivo.  SiRNAs specific for enhanced green fluorescent protein (EGFP) and murine and human vascular endothelial growth factor (VEGF) were designed.  In vitro studies in human cell lines entailed modulation of endogenous VEGF levels through chem. induced hypoxia.  Effects of siRNA treatment on these levels were measured by ELISA.  In vivo studies evaluating effects of siRNA on levels of EGFP and VEGF were performed by co-injecting recombinant viruses carrying EGFP or hVEGF cDNAs along with the appropriate siRNAs subretinally in mice.  Addnl. studies aimed at blocking prodn. of endogenous mVEGF were performed using laser-induced choroidal neovascularization (CNV) in mice.  Effects of in vivo treatments were evaluated ophthalmoscopically. Retinal/choroidal flat mounts were evaluated after perfusion with dextran-fluorescein.  Alternatively, retinas were evaluated in histol. sections or VEGF levels were measured in intact eyes using ELISA.  Successful delivery of siRNA to the subretinal space was confirmed by observing significantly reduced levels of EGFP in eyes treated with Ad.CMV.EGFP plus EGFP-directed siRNA.  SiRNAs directed against hVEGF effectively and specifically inhibit hypoxia-induced VEGF levels in human cell lines and after adenoviral induced hVEGF transgene expression in vivo.  In addn., subretinal delivery of siRNA directed against murine Vegf significantly inhibited CNV after laser photocoagulation.  Conclusions: Delivery of siRNA can be used in vitro and in vivo to target specific RNAs and to reduce the levels of the specific protein product in the targeted cells.  This work suggests that RNA interference has potential for application to studies of retinal biol. and for the treatment of a variety of retinal diseases,including those involving abnormal blood vessel growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE7ARwnY-FW7Vg90H21EOLACvtfcHk0lhPZM65J0ZTiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1yhtb4%253D&md5=56e41fe856c0a61d32a1df66878c0258</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DS.%2BJ.%26aulast%3DFosnot%26aufirst%3DJ.%26aulast%3DKuroki%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DMaguire%26aufirst%3DA.%2BM.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DTolentino%26aufirst%3DM.%2BJ.%26atitle%3DSmall%2520interfering%2520RNA%2520%2528siRNA%2529%2520targeting%2520VEGF%2520effectively%2520inhibits%2520ocular%2520neovascularization%2520in%2520a%2520mouse%2520model%26jtitle%3DMol.%2520Vision%26date%3D2003%26volume%3D9%26spage%3D210%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Bainbridge, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagherzadeh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selwood, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zachary, I.</span><span> </span><span class="NLM_article-title">A peptide encoded by exon 6 of VEGF (EG3306) inhibits VEGF-induced angiogenesis in vitro and ischaemic retinal neovascularisation <i>in vivo</i></span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=793-799&author=J.+W.+Bainbridgeauthor=H.+Jiaauthor=A.+Bagherzadehauthor=D.+Selwoodauthor=R.+R.+Aliauthor=I.+Zachary&title=A+peptide+encoded+by+exon+6+of+VEGF+%28EG3306%29+inhibits+VEGF-induced+angiogenesis+in+vitro+and+ischaemic+retinal+neovascularisation+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBainbridge%26aufirst%3DJ.%2BW.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DBagherzadeh%26aufirst%3DA.%26aulast%3DSelwood%26aufirst%3DD.%26aulast%3DAli%26aufirst%3DR.%2BR.%26aulast%3DZachary%26aufirst%3DI.%26atitle%3DA%2520peptide%2520encoded%2520by%2520exon%25206%2520of%2520VEGF%2520%2528EG3306%2529%2520inhibits%2520VEGF-induced%2520angiogenesis%2520in%2520vitro%2520and%2520ischaemic%2520retinal%2520neovascularisation%2520in%2520vivo%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D302%26spage%3D793%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Aiello, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. E.</span><span> </span><span class="NLM_article-title">Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">10457</span><span class="NLM_x">–</span> <span class="NLM_lpage">10461</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=10457-10461&author=L.+P.+Aielloauthor=E.+A.+Pierceauthor=E.+D.+Foleyauthor=H.+Takagiauthor=H.+Chenauthor=L.+Riddleauthor=N.+Ferraraauthor=G.+L.+Kingauthor=L.+E.+Smith&title=Suppression+of+retinal+neovascularization+in+vivo+by+inhibition+of+vascular+endothelial+growth+factor+%28VEGF%29+using+soluble+VEGF-receptor+chimeric+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAiello%26aufirst%3DL.%2BP.%26aulast%3DPierce%26aufirst%3DE.%2BA.%26aulast%3DFoley%26aufirst%3DE.%2BD.%26aulast%3DTakagi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DRiddle%26aufirst%3DL.%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DKing%26aufirst%3DG.%2BL.%26aulast%3DSmith%26aufirst%3DL.%2BE.%26atitle%3DSuppression%2520of%2520retinal%2520neovascularization%2520in%2520vivo%2520by%2520inhibition%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520%2528VEGF%2529%2520using%2520soluble%2520VEGF-receptor%2520chimeric%2520proteins%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D10457%26epage%3D10461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damico, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shams, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R.</span><span> </span><span class="NLM_article-title">Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration</span> <span class="citation_source-journal">Retina</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1097%2F01.iae.0000242842.14624.e7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=17031284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADC%252BD28rpvFyisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=859-870&author=N.+Ferraraauthor=L.+Damicoauthor=N.+Shamsauthor=H.+Lowmanauthor=R.+Kim&title=Development+of+ranibizumab%2C+an+anti-vascular+endothelial+growth+factor+antigen+binding+fragment%2C+as+therapy+for+neovascular+age-related+macular+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration</span></div><div class="casAuthors">Ferrara Napoleone; Damico Lisa; Shams Naveed; Lowman Henry; Kim Robert</div><div class="citationInfo"><span class="NLM_cas:title">Retina (Philadelphia, Pa.)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">859-70</span>
        ISSN:<span class="NLM_cas:issn">0275-004X</span>.
    </div><div class="casAbstract">BACKGROUND:  Angiogenesis is a key aspect of the wet form of age-related neovascular (AMD), the leading cause of blindness in the elderly population.  Substantial evidence indicated that vascular endothelial growth factor (VEGF)-A is a major mediator of angiogenesis and vascular leakage in wet AMD.  VEGF-A is the prototype member of a gene family that includes also PlGF, VEGF-B, VEGF-C, VEGF-D and the orf virus-encoded VEGF-E.  Several isoforms of VEGF-A can be generated due to alternative mRNA splicing.  Various VEGF inhibitors have been clinically developed.  Among these, ranibizumab is a high affinity recombinant Fab that neutralizes all isoforms of VEGF-A.  The article briefly reviews the biology of VEGF and then focuses on the path that led to clinical development of ranibizumab.  RESULTS:  The safety and efficacy of ranibizumab in the treatment of neovascular AMD have been evaluated in two large phase III, multicenter, randomized, double-masked, controlled pivotal trials in different neovascular AMD patient populations.  Combined, the trial results indicate that ranibizumab results not only in a slowing down of vision loss but also in a significant proportion of patients experiencing a clinically meaningful vision gain.  The visual acuity benefit over control was observed regardless of CNV lesion type.  Furthermore, the benefit was associated with a low rate of serious adverse events.  CONCLUSIONS:  Ranibizumab represents a novel therapy that, for the first time, appears to have the potential to enable many AMD patients to obtain a meaningful and sustained gain of vision.  On June 30 2006, ranibizumab was approved by the US Food and Drug Administration for the treatment of wet AMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQc5sTUAVP5StHxxy173TfNfW6udTcc2eZjjGVjjUiz0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rpvFyisQ%253D%253D&md5=9a134ad45e80dbd723a66f48b8811500</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1097%2F01.iae.0000242842.14624.e7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.iae.0000242842.14624.e7%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DDamico%26aufirst%3DL.%26aulast%3DShams%26aufirst%3DN.%26aulast%3DLowman%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DR.%26atitle%3DDevelopment%2520of%2520ranibizumab%252C%2520an%2520anti-vascular%2520endothelial%2520growth%2520factor%2520antigen%2520binding%2520fragment%252C%2520as%2520therapy%2520for%2520neovascular%2520age-related%2520macular%2520degeneration%26jtitle%3DRetina%26date%3D2006%26volume%3D26%26spage%3D859%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Rosenfeld, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heier, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. Y.</span><span> </span><span class="NLM_article-title">Ranibizumab for neovascular age-related macular degeneration</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1056%2FNEJMoa054481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=17021318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGgtr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1419-1431&author=P.+J.+Rosenfeldauthor=D.+M.+Brownauthor=J.+S.+Heierauthor=D.+S.+Boyerauthor=P.+K.+Kaiserauthor=C.+Y.+Chungauthor=R.+Y.+Kim&title=Ranibizumab+for+neovascular+age-related+macular+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Ranibizumab for neovascular age-related macular degeneration</span></div><div class="casAuthors">Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaiser, Peter K.; Chung, Carol Y.; Kim, Robert Y.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1419-1431</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Ranibizumab - a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A - has been evaluated for the treatment of neovascular age-related macular degeneration.  METHODS: In this multicenter, 2-yr, double-blind, sham-controlled study, we randomly assigned patients with age-related macular degeneration with either minimally classic or occult (with no classic lesions) choroidal neovascularization to receive 24 monthly intravitreal injections of ranibizumab (either 0.3 mg or 0.5 mg) or sham injections.  The primary end point was the proportion of patients losing fewer than 15 letters from baseline visual acuity at 12 mo.  RESULTS: We enrolled 716 patients in the study.  At 12 mo, 94.5% of the group given 0.3 mg of ranibizumab and 94.6% of those given 0.5 mg lost fewer than 15 letters, as compared with 62.2% of patients receiving sham injections (P < 0.001 for both comparisons).  Visual acuity improved by 15 or more letters in 24.8% of the 0.3-mg group and 33.8% of the 0.5-mg group, as compared with 5.0% of the sham-injection group (P < 0.001 for both doses).  Mean increases in visual acuity were 6.5 letters in the 0.3-mg group and 7.2 letters in the 0.5-mg group, as compared with a decrease of 10.4 letters in the sham-injection group (P < 0.001 for both comparisons).  The benefit in visual acuity was maintained at 24 mo.  During 24 mo, presumed endophthalmitis was identified in five patients (1.0%) and serious uveitis in six patients (1.3%) given ranibizumab.  CONCLUSIONS: Intravitreal administration of ranibizumab for 2 years prevented vision loss and improved mean visual acuity, with low rates of serious adverse events, in patients with minimally classic or occult (with no classic lesions) choroidal neovascularization secondary to age-related macular degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXzgb9csG98rVg90H21EOLACvtfcHk0lg1Ee4_cxSkRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGgtr3M&md5=810a3aa65cbc439b42c31e4fe23045b2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa054481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa054481%26sid%3Dliteratum%253Aachs%26aulast%3DRosenfeld%26aufirst%3DP.%2BJ.%26aulast%3DBrown%26aufirst%3DD.%2BM.%26aulast%3DHeier%26aufirst%3DJ.%2BS.%26aulast%3DBoyer%26aufirst%3DD.%2BS.%26aulast%3DKaiser%26aufirst%3DP.%2BK.%26aulast%3DChung%26aufirst%3DC.%2BY.%26aulast%3DKim%26aufirst%3DR.%2BY.%26atitle%3DRanibizumab%2520for%2520neovascular%2520age-related%2520macular%2520degeneration%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1419%26epage%3D1431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Brown, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michels, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soubrane, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heier, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span> </span><span class="NLM_article-title">Ranibizumab versus verteporfin for neovascular age-related macular degeneration</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1432</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1056%2FNEJMoa062655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=17021319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGgtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1432-1444&author=D.+M.+Brownauthor=P.+K.+Kaiserauthor=M.+Michelsauthor=G.+Soubraneauthor=E.+S.+Heierauthor=R.+Y.+Kimauthor=J.+P.+Syauthor=S.+Schneider&title=Ranibizumab+versus+verteporfin+for+neovascular+age-related+macular+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Ranibizumab versus verteporfin for neovascular age-related macular degeneration</span></div><div class="casAuthors">Brown, David M.; Kaiser, Peter K.; Michels, Mark; Soubrane, Gisele; Heier, Effrey S.; Kim, Robert Y.; Sy, Judy P.; Schneider, Susan</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1432-1444</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: We compared ranibizumab - a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A - with photodynamic therapy with verteporfin in the treatment of predominantly classic neovascular age-related macular degeneration.  METHODS: During the first year of this 2-yr, multicenter, double-blind study, we randomly assigned patients in a 1:1:1 ratio to receive monthly intravitreal injections of ranibizumab (0.3 mg or 0.5 mg) plus sham verteporfin therapy or monthly sham injections plus active verteporfin therapy.  The primary end point was the proportion of patients losing fewer than 15 letters from baseline visual acuity at 12 mo.  RESULTS: Of the 423 patients enrolled, 94.3% of those given 0.3 mg of ranibizumab and 96.4% of those given 0.5 mg lost fewer than 15 letters, as compared with 64.3% of those in the verteporfin group (P < 0.001 for each comparison).  Visual acuity i.m.- proved by 15 letters or more in 35.7% of the 0.3-mg group and 40.3% of the 0.5-mg group, as compared with 5.6% of the verteporfin group (P < 0.001 for each comparison).  Mean visual acuity increased by 8.5 letters in the 0.3-mg group and 11.3 letters in the 0.5-mg group, as compared with a decrease of 9.5 letters in the verteporfin group (P < 0.001 for each comparison).  Among 140 patients treated with 0.5 mg of ranibizumab, presumed endophthalmitis occurred in 2 patients (1.4%) and serious uveitis in 1 (0.7%).  CONCLUSIONS: Ranibizumab was superior to verteporfin as intravitreal treatment of predominantly classic neovascular age-related macular degeneration, with low rates of serious ocular adverse events.  Treatment improved visual acuity on av. at 1 yr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu19lFQmxb77Vg90H21EOLACvtfcHk0lg1Ee4_cxSkRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGgtrrI&md5=1acef0cfe4198d3aac6f7bffb048307b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa062655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa062655%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BM.%26aulast%3DKaiser%26aufirst%3DP.%2BK.%26aulast%3DMichels%26aufirst%3DM.%26aulast%3DSoubrane%26aufirst%3DG.%26aulast%3DHeier%26aufirst%3DE.%2BS.%26aulast%3DKim%26aufirst%3DR.%2BY.%26aulast%3DSy%26aufirst%3DJ.%2BP.%26aulast%3DSchneider%26aufirst%3DS.%26atitle%3DRanibizumab%2520versus%2520verteporfin%2520for%2520neovascular%2520age-related%2520macular%2520degeneration%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1432%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Nguyen, Q. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatlipinar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinlan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer-Galler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor is a critical stimulus for diabetic macular edema</span> <span class="citation_source-journal">Am. J. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1016%2Fj.ajo.2006.06.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=17046701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12msLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2006&pages=961-969&author=Q.+D.+Nguyenauthor=S.+Tatlipinarauthor=S.+M.+Shahauthor=J.+A.+Hallerauthor=E.+Quinlanauthor=J.+Sungauthor=I.+Zimmer-Gallerauthor=D.+V.+Doauthor=P.+A.+Campochiaro&title=Vascular+endothelial+growth+factor+is+a+critical+stimulus+for+diabetic+macular+edema"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema</span></div><div class="casAuthors">Nguyen, Quan Dong; Tatlipinar, Sinan; Shah, Syed Mahmood; Haller, Julia A.; Quinlan, Edward; Sung, Jennifer; Zimmer-Galler, Ingrid; Do, Diana V.; Campochiaro, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Ophthalmology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">961-969</span>CODEN:
                <span class="NLM_cas:coden">AJOPAA</span>;
        ISSN:<span class="NLM_cas:issn">0002-9394</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Purpose: The role of vascular endothelial growth factor (VEGF) in diabetic macular edema (DME) was tested with ranibizumab, a specific antagonist of VEGF.  Design: A nonrandomized clin. trial.  Methods: Ten patients with chronic DME received intraocular injections of 0.5 mg of ranibizumab at baseline and at one, two, four, and six months.  The primary outcome was change in foveal thickness between baseline and seven months, and the secondary outcome measures were changes from baseline in visual acuity and macular vol.  Results: Mean values at baseline were 503 μm for foveal thickness, 9.22 mm3 for macular vol., and 28.1 letters (20/80) read on an Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity chart.  At seven months (one month after the fifth injection), the mean foveal thickness was 257 μm, which was a redn. of 246 μm (85% of the excess foveal thickness present at baseline; P = .005 by Wilcoxon signed-rank test for likelihood that this change is due to ranibizumab rather than chance).  The macular vol. was 7.47 mm3, which was a redn. of 1.75 mm3 (77% of the excess macular vol. at baseline; P = .009).  Mean visual acuity was 40.4 letters (20/40), which was an improvement of 12.3 letters (P = .005).  The injections were well-tolerated with no ocular or systemic adverse events.  Conclusion: Intraocular injections of ranibizumab significantly reduced foveal thickness and improved visual acuity in 10 patients with DME, which demonstrated that VEGF is an important therapeutic target for DME.  A randomized, controlled, double-masked trial is needed to test whether intraocular injections of ranibizumab provide long-term benefit to patients with DME.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraQ4X1zj_2PLVg90H21EOLACvtfcHk0lg1Ee4_cxSkRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12msLfE&md5=1eaf14ff1ca9d7b98f917d48f841c1f7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ajo.2006.06.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajo.2006.06.068%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DQ.%2BD.%26aulast%3DTatlipinar%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DS.%2BM.%26aulast%3DHaller%26aufirst%3DJ.%2BA.%26aulast%3DQuinlan%26aufirst%3DE.%26aulast%3DSung%26aufirst%3DJ.%26aulast%3DZimmer-Galler%26aufirst%3DI.%26aulast%3DDo%26aufirst%3DD.%2BV.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520is%2520a%2520critical%2520stimulus%2520for%2520diabetic%2520macular%2520edema%26jtitle%3DAm.%2520J.%2520Ophthalmol.%26date%3D2006%26volume%3D142%26spage%3D961%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Fernando, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, H. I.</span><span> </span><span class="NLM_article-title">Targeted therapy of colorectal cancer: clinical experience with bevacizumab</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=1-18&author=N.+H.+Fernandoauthor=H.+I.+Hurwitz&title=Targeted+therapy+of+colorectal+cancer%3A+clinical+experience+with+bevacizumab"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernando%26aufirst%3DN.%2BH.%26aulast%3DHurwitz%26aufirst%3DH.%2BI.%26atitle%3DTargeted%2520therapy%2520of%2520colorectal%2520cancer%253A%2520clinical%2520experience%2520with%2520bevacizumab%26jtitle%3DOncologist%26date%3D2004%26volume%3D1%26spage%3D1%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, R. L. ;E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hylton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudge, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood−retinal barrier</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1002%2Fjcp.10246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=12652651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislOmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2003&pages=241-248&author=Y.+Saishinauthor=Y.+Saishinauthor=K.+Takahashiauthor=R.+L.+%3BE.+Silvaauthor=D.+Hyltonauthor=J.+S.+Rudgeauthor=S.+J.+Wiegandauthor=P.+A.+Campochiaro&title=VEGF-TRAPR1R2+suppresses+choroidal+neovascularization+and+VEGF-induced+breakdown+of+the+blood%E2%88%92retinal+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier</span></div><div class="casAuthors">Saishin, Yoshitsugu; Saishin, Yumiko; Takahashi, Kyoichi; Silva, Raquel Lima E.; Hylton, Donna; Rudge, John S.; Wiegand, Stanley J.; Campochiaro, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-248</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor (VEGF) plays a central role in the development of retinal neovascularization and diabetic macular edema.  There is also evidence suggesting that VEGF is an important stimulator for choroidal neovascularization.  In this study, we investigated the effect of a specific inhibitor of VEGF, VEGF-TRAPR1R2, in models for these disease processes.  VEGF-TRAPR1R2 is a fusion protein, which combines ligand binding elements taken from the extracellular domains of VEGF receptors 1 and 2 fused to the Fc portion of IgG1.  S.c. injections or a single intra-vitreous injection of VEGF-TRAPR1R2 strongly suppressed choroidal neovascularization in mice with laser-induced rupture of Bruch's membrane.  S.c. injection of VEGF-TRAPR1R2 also significantly inhibited sub-retinal neovascularization in transgenic mice that express VEGF in photo-receptors.  In two models of VEGF-induced breakdown of the blood-retinal barrier (BRB), one in which recombinant VEGF is injected into the vitreous cavity and one in which VEGF expression is induced in the retina in transgenic mice, VEGF-TRAPR1R2 significantly reduced breakdown of the BRB.  These data confirm that VEGF is a crit. stimulus for the development of choroidal neovascularization and indicate that VEGF-TRAPR1R2 may provide a new agent for consideration for treatment of patients with choroidal neovascularization and diabetic macular edema.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkiGqrSuUop7Vg90H21EOLACvtfcHk0lhrytXWIASU9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislOmtbY%253D&md5=aaf2607adcfb94b17a814e89edf881b0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fjcp.10246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.10246%26sid%3Dliteratum%253Aachs%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DSilva%26aufirst%3DR.%2BL.%2B%253BE.%26aulast%3DHylton%26aufirst%3DD.%26aulast%3DRudge%26aufirst%3DJ.%2BS.%26aulast%3DWiegand%26aufirst%3DS.%2BJ.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DVEGF-TRAPR1R2%2520suppresses%2520choroidal%2520neovascularization%2520and%2520VEGF-induced%2520breakdown%2520of%2520the%2520blood%25E2%2588%2592retinal%2520barrier%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2003%26volume%3D195%26spage%3D241%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><div class="note"><p class="first last">Sirna Therapeutics is currently developing an injectable form of SiRNA (Sirna-027) targeting VEGFr.</p></div><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinnen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosnaugh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargeese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhana, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aitchison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A..</span><span> </span><span class="NLM_article-title">Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1</span> <span class="citation_source-journal">Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1038%2Fsj.gt.3302641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFCrt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=225-234&author=J.+Shenauthor=R.+Samulauthor=R.+L.+Silvaauthor=H.+Akiyamaauthor=H.+Liuauthor=Y.+Saishinauthor=S.+F.+Hackettauthor=S.+Zinnenauthor=K.+Kossenauthor=K.+Fosnaughauthor=C.+Vargeeseauthor=A.+Gomezauthor=K.+Bouhanaauthor=R.+Aitchisonauthor=P.+Pavcoauthor=P.+A..+Campochiaro&title=Suppression+of+ocular+neovascularization+with+siRNA+targeting+VEGF+receptor+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Low temperature one-step synthesis of barium titanate: Thermodynamic modeling and experimental synthesis</span></div><div class="casAuthors">Shen, Zhigang; Li, Shigang; Liu, Zhaowen; Zhang, Jianwen; Chen, Jianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Journal of Chemical Engineering</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-233</span>CODEN:
                <span class="NLM_cas:coden">CJCEEB</span>;
        ISSN:<span class="NLM_cas:issn">1004-9541</span>.
    
            (<span class="NLM_cas:orgname">Chemical Industry Press</span>)
        </div><div class="casAbstract">A thermodn. model has been developed to det. the reaction conditions favoring low-temp. direct synthesis of barium titanate (BaTiO3).  The method utilizes std.-state thermodn. data for solid and aq. species and a Debye-Hueckel coeffs. model to represent soln. nonideality.  The method has been used to generate phase stability diagrams that indicate the ranges of pH and reagent concns., for which various species predominate in the system at a given temp.  Also, yield diagrams have been constructed that indicate the concn., pH and temp. conditions for which different yields of cryst. BaTiO3 can be obtained.  The stability and yield diagrams have been used to predict the optimum synthesis conditions (e.g., reagent concns., pH, and temp.).  Subsequently, these predictions have been exptl. verified.  As a result, phase-pure perovskite BaTiO3 has been obtained at temp. ranging from 55 to 85° using BaCl2 and TiCl4 as a source for Ba and Ti, and NaOH as a precipitator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiE6cFMNUEbLVg90H21EOLACvtfcHk0lhrytXWIASU9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFCrt7w%253D&md5=6f269463033ebe1775ecb34ecafff98f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.gt.3302641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.gt.3302641%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DSamul%26aufirst%3DR.%26aulast%3DSilva%26aufirst%3DR.%2BL.%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DHackett%26aufirst%3DS.%2BF.%26aulast%3DZinnen%26aufirst%3DS.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DFosnaugh%26aufirst%3DK.%26aulast%3DVargeese%26aufirst%3DC.%26aulast%3DGomez%26aufirst%3DA.%26aulast%3DBouhana%26aufirst%3DK.%26aulast%3DAitchison%26aufirst%3DR.%26aulast%3DPavco%26aufirst%3DP.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA..%26atitle%3DSuppression%2520of%2520ocular%2520neovascularization%2520with%2520siRNA%2520targeting%2520VEGF%2520receptor%25201%26jtitle%3DGene%2520Ther.%26date%3D2005%26volume%3D13%26spage%3D225%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><div class="note"><p class="first last">Small molecules targeting VEGFr pathway for the treatment of AMD are under development at Pfizer.</p></div><span class="NLM_contrib-group">Beals, C. R.; Day, W. W.; Khalil, D. A.; Klamerus, K. J.; Raber, S. R.; Scassellati-Sorzolini, B.; Zwillich, S. H.</span><span> </span><span class="NLM_article-title">Compositions Comprising Indazole Compound for Sub-Tenon Delivery</span>. WO 2006117666, <span class="NLM_month">April</span><span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=C.+R.+Beals&author=W.+W.+Day&author=D.+A.+Khalil&author=K.+J.+Klamerus&author=S.+R.+Raber&author=B.+Scassellati-Sorzolini&author=S.+H.+Zwillich&title=Compositions+Comprising+Indazole+Compound+for+Sub-Tenon+Delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeals%26aufirst%3DC.%2BR.%26atitle%3DCompositions%2520Comprising%2520Indazole%2520Compound%2520for%2520Sub-Tenon%2520Delivery%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><div class="note"><p class="first last">Orally delivered vatalanib is being evaluated in a phase II clinical trial along with verteporfin in patients with subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration.</p></div><a href="http://www.clinicaltrials.gov/ct/gui/show/NCT00138632" class="extLink">http://www.clinicaltrials.gov/ct/gui/show/NCT00138632</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Orally+delivered+vatalanib+is+being+evaluated+in+a+phase+II+clinical+trial+along+with+verteporfin+in+patients+with+subfoveal+choroidal+neovascularization+%28CNV%29+secondary+to+age-related+macular+degeneration.http%3A%2F%2Fwww.clinicaltrials.gov%2Fct%2Fgui%2Fshow%2FNCT00138632."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><div class="note"><p class="first last">Several devices are in development to deliver drugs to the back of the eye.</p></div><span class="NLM_contrib-group">Sultana, Y</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aqil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, A.</span> <span class="citation_source-journal">Curr. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Several+devices+are+in+development+to+deliver+drugs+to+the+back+of+the+eye.Sultana%2C+Y%3B+Jain%2C+R.%3B+Aqil%2C+M.%3B+Ali%2C+A.Curr.+Drug+Delivery+2006%2C+3%2C+207%E2%80%93217"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSultana%26aufirst%3DY%26aulast%3DJain%26aufirst%3DR.%26aulast%3DAqil%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DA.%26jtitle%3DCurr.%2520Drug%2520Delivery%26date%3D2006%26volume%3D3%26spage%3D207%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">Antismoking compound mecamylamine targeting endothelial nicotinic acetylcholine receptor and pazopanib from GlaxoSmithKline targeting VEGFr are in phase I. <a href="http://clinicaltrials.gov/ct/show/NCT00463320?order=19" class="extLink">http://clinicaltrials.gov/ct/show/NCT00463320?order=19</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><div class="note"><p class="first last">A VEGF trap agent from Regeneron Pharmaceuticals, Inc. and Bayer Health Care AG is in Phase II.</p></div><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hylton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudge, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood−retinal barrier</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1002%2Fjcp.10246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=12652651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislOmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2003&pages=241-248&author=Y.+Saishinauthor=Y.+Saishinauthor=K.+Takahashiauthor=R.+L.+Silvaauthor=D.+Hyltonauthor=J.+S.+Rudgeauthor=S.+J.+Wiegandauthor=P.+A.+Campochiaro&title=VEGF-TRAPR1R2+suppresses+choroidal+neovascularization+and+VEGF-induced+breakdown+of+the+blood%E2%88%92retinal+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier</span></div><div class="casAuthors">Saishin, Yoshitsugu; Saishin, Yumiko; Takahashi, Kyoichi; Silva, Raquel Lima E.; Hylton, Donna; Rudge, John S.; Wiegand, Stanley J.; Campochiaro, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-248</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor (VEGF) plays a central role in the development of retinal neovascularization and diabetic macular edema.  There is also evidence suggesting that VEGF is an important stimulator for choroidal neovascularization.  In this study, we investigated the effect of a specific inhibitor of VEGF, VEGF-TRAPR1R2, in models for these disease processes.  VEGF-TRAPR1R2 is a fusion protein, which combines ligand binding elements taken from the extracellular domains of VEGF receptors 1 and 2 fused to the Fc portion of IgG1.  S.c. injections or a single intra-vitreous injection of VEGF-TRAPR1R2 strongly suppressed choroidal neovascularization in mice with laser-induced rupture of Bruch's membrane.  S.c. injection of VEGF-TRAPR1R2 also significantly inhibited sub-retinal neovascularization in transgenic mice that express VEGF in photo-receptors.  In two models of VEGF-induced breakdown of the blood-retinal barrier (BRB), one in which recombinant VEGF is injected into the vitreous cavity and one in which VEGF expression is induced in the retina in transgenic mice, VEGF-TRAPR1R2 significantly reduced breakdown of the BRB.  These data confirm that VEGF is a crit. stimulus for the development of choroidal neovascularization and indicate that VEGF-TRAPR1R2 may provide a new agent for consideration for treatment of patients with choroidal neovascularization and diabetic macular edema.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkiGqrSuUop7Vg90H21EOLACvtfcHk0ljqyh3ARfIACA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislOmtbY%253D&md5=aaf2607adcfb94b17a814e89edf881b0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjcp.10246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.10246%26sid%3Dliteratum%253Aachs%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DSilva%26aufirst%3DR.%2BL.%26aulast%3DHylton%26aufirst%3DD.%26aulast%3DRudge%26aufirst%3DJ.%2BS.%26aulast%3DWiegand%26aufirst%3DS.%2BJ.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DVEGF-TRAPR1R2%2520suppresses%2520choroidal%2520neovascularization%2520and%2520VEGF-induced%2520breakdown%2520of%2520the%2520blood%25E2%2588%2592retinal%2520barrier%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2003%26volume%3D195%26spage%3D241%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><div class="note"><p class="first last">Othera Pharmaceuticals, Inc. is developing OT-551 targeting NF-κB mediated transcriptional activation for the treatment of AM.</p></div><span class="NLM_contrib-group">Tanito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M. H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. E.</span><span> </span><span class="NLM_article-title">Protective effect of TEMPOL derivatives against light-induced retinal damage in rats</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1900</span><span class="NLM_x">–</span> <span class="NLM_lpage">1905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=1900-1905&author=M.+Tanitoauthor=F.+Liauthor=M.+H+Elliottauthor=M.+Dittmarauthor=R.+E.+Anderson&title=Protective+effect+of+TEMPOL+derivatives+against+light-induced+retinal+damage+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanito%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DElliott%26aufirst%3DM.%2BH%26aulast%3DDittmar%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DR.%2BE.%26atitle%3DProtective%2520effect%2520of%2520TEMPOL%2520derivatives%2520against%2520light-induced%2520retinal%2520damage%2520in%2520rats%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2007%26volume%3D48%26spage%3D1900%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Weis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D.</span><span> </span><span class="NLM_article-title">Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2004&pages=223-229&author=S.+Weisauthor=J.+Cuiauthor=L.+Barnesauthor=D.+Cheresh&title=Endothelial+barrier+disruption+by+VEGF-mediated+Src+activity+potentiates+tumor+cell+extravasation+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeis%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DBarnes%26aufirst%3DL.%26aulast%3DCheresh%26aufirst%3DD.%26atitle%3DEndothelial%2520barrier%2520disruption%2520by%2520VEGF-mediated%2520Src%2520activity%2520potentiates%2520tumor%2520cell%2520extravasation%2520and%2520metastasis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2004%26volume%3D167%26spage%3D223%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Eliceiri, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puente, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupack, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span> </span><span class="NLM_article-title">Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2002&pages=149-159&author=B.+P.+Eliceiriauthor=X.+S.+Puenteauthor=J.+D.+Hoodauthor=D.+G.+Stupackauthor=D.+D.+Schlaepferauthor=X.+Z.+Huangauthor=D.+Sheppardauthor=D.+A.+Cheresh&title=Src-mediated+coupling+of+focal+adhesion+kinase+to+integrin+%CE%B1v%CE%B25+in+vascular+endothelial+growth+factor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEliceiri%26aufirst%3DB.%2BP.%26aulast%3DPuente%26aufirst%3DX.%2BS.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DStupack%26aufirst%3DD.%2BG.%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26aulast%3DHuang%26aufirst%3DX.%2BZ.%26aulast%3DSheppard%26aufirst%3DD.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26atitle%3DSrc-mediated%2520coupling%2520of%2520focal%2520adhesion%2520kinase%2520to%2520integrin%2520%25CE%25B1v%25CE%25B25%2520in%2520vascular%2520endothelial%2520growth%2520factor%2520signaling%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2002%26volume%3D157%26spage%3D149%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Personal communication Martin Friedlander, Department of Cell Biology, Scripps Clinic Torry Pines 10666 North Torrey Pines Road, MS214, The Scripps Research Institute, La Jolla, CA 92037.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Thomas, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugge, J. S.</span><span> </span><span class="NLM_article-title">Cellular functions regulated by Src family kinases</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1146%2Fannurev.cellbio.13.1.513" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=9442882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1997&pages=513-609&author=S.+M.+Thomasauthor=J.+S.+Brugge&title=Cellular+functions+regulated+by+Src+family+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular functions regulated by Src family kinases</span></div><div class="casAuthors">Thomas, Sheila M.; Brugge, Joan S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">513-609</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with many refs.  Src family protein tyrosine kinases are activated following engagement of many different classes of cellular receptors and participate in signaling pathways that control a diverse spectrum of receptor-induced biol. activities.  While several of these kinases have evolved to play distinct roles in specific receptor pathways, there is considerable redundancy in the functions of these kinases, both with respect to the receptor pathways that activate these kinases and the downstream effectors that mediate their biol. activities.  This chapter reviews the evidence implicating Src family kinases in specific receptor pathways and describes the mechanisms leading to their activation, the targets that interact with these kinases, and the biol. events that they regulate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_psatEFVwjbVg90H21EOLACvtfcHk0ljqyh3ARfIACA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSrsQ%253D%253D&md5=4b8d18cc815109e3e0a593b846984aac</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.13.1.513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.13.1.513%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DS.%2BM.%26aulast%3DBrugge%26aufirst%3DJ.%2BS.%26atitle%3DCellular%2520functions%2520regulated%2520by%2520Src%2520family%2520kinases%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D1997%26volume%3D13%26spage%3D513%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Eliceiri, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span> </span><span class="NLM_article-title">Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=915-924&author=B.+P.+Eliceiriauthor=R.+Paulauthor=P.+L.+Schwartzbergauthor=J.+D.+Hoodauthor=J.+Lengauthor=D.+A.+Cheresh&title=Selective+requirement+for+Src+kinases+during+VEGF-induced+angiogenesis+and+vascular+permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEliceiri%26aufirst%3DB.%2BP.%26aulast%3DPaul%26aufirst%3DR.%26aulast%3DSchwartzberg%26aufirst%3DP.%2BL.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DLeng%26aufirst%3DJ.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26atitle%3DSelective%2520requirement%2520for%2520Src%2520kinases%2520during%2520VEGF-induced%2520angiogenesis%2520and%2520vascular%2520permeability%26jtitle%3DMol.%2520Cell%26date%3D1999%26volume%3D4%26spage%3D915%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Noronha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dneprovskaia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gritzen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebansky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPherson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palanki, M. S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Splittgerber, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrasidlo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, N.</span><span> </span><span class="NLM_article-title">Discovery and preliminary structure activity relationship studies of novel benzotriazine based compounds as Src inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5546</span><span class="NLM_x">–</span> <span class="NLM_lpage">5550</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5546-5550&author=G.+Noronhaauthor=K.+Barrettauthor=J.+Caoauthor=E.+Dneprovskaiaauthor=R.+Fineauthor=X.+Gongauthor=C.+Gritzenauthor=J.+Hoodauthor=X.+Kangauthor=B.+Klebanskyauthor=D.+Lohseauthor=C.+C.+Makauthor=A.+McPhersonauthor=M.+S.+S.+Palankiauthor=V.+P.+Pathakauthor=J.+Renickauthor=R.+Sollauthor=U.+Splittgerberauthor=W.+Wrasidloauthor=B.+Zengauthor=N.+Zhao&title=Discovery+and+preliminary+structure+activity+relationship+studies+of+novel+benzotriazine+based+compounds+as+Src+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoronha%26aufirst%3DG.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DDneprovskaia%26aufirst%3DE.%26aulast%3DFine%26aufirst%3DR.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DGritzen%26aufirst%3DC.%26aulast%3DHood%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DX.%26aulast%3DKlebansky%26aufirst%3DB.%26aulast%3DLohse%26aufirst%3DD.%26aulast%3DMak%26aufirst%3DC.%2BC.%26aulast%3DMcPherson%26aufirst%3DA.%26aulast%3DPalanki%26aufirst%3DM.%2BS.%2BS.%26aulast%3DPathak%26aufirst%3DV.%2BP.%26aulast%3DRenick%26aufirst%3DJ.%26aulast%3DSoll%26aufirst%3DR.%26aulast%3DSplittgerber%26aufirst%3DU.%26aulast%3DWrasidlo%26aufirst%3DW.%26aulast%3DZeng%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DN.%26atitle%3DDiscovery%2520and%2520preliminary%2520structure%2520activity%2520relationship%2520studies%2520of%2520novel%2520benzotriazine%2520based%2520compounds%2520as%2520Src%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5546%26epage%3D5550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Noronha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boccia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodhag, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dneprovskaia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gritzen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Key, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebansky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kousba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPherson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palanki, M. S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Splittgerber, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoughton, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu., H.</span><span> </span><span class="NLM_article-title">Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine, a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays.</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">602</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=602-608&author=G.+Noronhaauthor=K.+Barrettauthor=A.+Bocciaauthor=T.+Brodhagauthor=J.+Caoauthor=C.+P.+Chowauthor=E.+Dneprovskaiaauthor=J.+Doukasauthor=R.+Fineauthor=X.+Gongauthor=C.+Gritzenauthor=H.+Guauthor=E.+Hannaauthor=J.+D.+Hoodauthor=S.+Huauthor=X.+Kangauthor=J.+Keyauthor=B.+Klebanskyauthor=A.+Kousbaauthor=G.+Liauthor=D.+Lohseauthor=C.+Makauthor=A.+McPhersonauthor=M.+S.+P.+Palankiauthor=V.+P.+Pathakauthor=J.+Renickauthor=F.+Shiauthor=R.+Sollauthor=U.+Splittgerberauthor=S+Stoughtonauthor=S.+Tangauthor=S.+Yeeauthor=B.+Zengauthor=N.+Zhaoauthor=H.+Zhu.&title=Discovery+of+%5B7-%282%2C6-dichlorophenyl%29-5-methylbenzo%5B1%2C2%2C4%5Dtriazin-3-yl%5D-%5B4-%282-pyrrolidin-1-ylethoxy%29phenyl%5Damine%2C+a+potent%2C+orally+active+Src+kinase+inhibitor+with+anti-tumor+activity+in+preclinical+assays."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoronha%26aufirst%3DG.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBoccia%26aufirst%3DA.%26aulast%3DBrodhag%26aufirst%3DT.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DChow%26aufirst%3DC.%2BP.%26aulast%3DDneprovskaia%26aufirst%3DE.%26aulast%3DDoukas%26aufirst%3DJ.%26aulast%3DFine%26aufirst%3DR.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DGritzen%26aufirst%3DC.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DHanna%26aufirst%3DE.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DX.%26aulast%3DKey%26aufirst%3DJ.%26aulast%3DKlebansky%26aufirst%3DB.%26aulast%3DKousba%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DLohse%26aufirst%3DD.%26aulast%3DMak%26aufirst%3DC.%26aulast%3DMcPherson%26aufirst%3DA.%26aulast%3DPalanki%26aufirst%3DM.%2BS.%2BP.%26aulast%3DPathak%26aufirst%3DV.%2BP.%26aulast%3DRenick%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DF.%26aulast%3DSoll%26aufirst%3DR.%26aulast%3DSplittgerber%26aufirst%3DU.%26aulast%3DStoughton%26aufirst%3DS%26aulast%3DTang%26aufirst%3DS.%26aulast%3DYee%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DZhu.%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520%255B7-%25282%252C6-dichlorophenyl%2529-5-methylbenzo%255B1%252C2%252C4%255Dtriazin-3-yl%255D-%255B4-%25282-pyrrolidin-1-ylethoxy%2529phenyl%255Damine%252C%2520a%2520potent%252C%2520orally%2520active%2520Src%2520kinase%2520inhibitor%2520with%2520anti-tumor%2520activity%2520in%2520preclinical%2520assays.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D602%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Wolf, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, K.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzotriazines, I.</span><span> </span><span class="NLM_article-title">A new series of compounds having antimalarial activity</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">3551</span><span class="NLM_x">–</span> <span class="NLM_lpage">3553</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01642a060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1954&pages=3551-3553&author=F.+J.+Wolfauthor=K.+Pfisterauthor=R.+M.+Wilsonauthor=C.+A.+Robinsonauthor=I.+Benzotriazines&title=A+new+series+of+compounds+having+antimalarial+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja01642a060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01642a060%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DF.%2BJ.%26aulast%3DPfister%26aufirst%3DK.%26aulast%3DWilson%26aufirst%3DR.%2BM.%26aulast%3DRobinson%26aufirst%3DC.%2BA.%26aulast%3DBenzotriazines%26aufirst%3DI.%26atitle%3DA%2520new%2520series%2520of%2520compounds%2520having%2520antimalarial%2520activity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1954%26volume%3D76%26spage%3D3551%26epage%3D3553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Mason, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, G.</span> <span class="citation_source-journal">J. Chem. Soc. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_fpage">911</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1039%2Fj29700000911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADyaE3cXktlGgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mason%2C+J.+C.%3B+Tennant%2C+G.J.+Chem.+Soc.+B+1970%2C+911%E2%80%93916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic N-oxides.  VI.  Synthesis and nuclear magnetic resonance spectra of 3-aminobenzo-1,2-4-triazines and their mono- and di-N-oxides</span></div><div class="casAuthors">Mason, J. C.; Tennant, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society [Section] B:  Physical Organic</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">911-16</span>CODEN:
                <span class="NLM_cas:coden">JCSPAC</span>;
        ISSN:<span class="NLM_cas:issn">0045-6470</span>.
    </div><div class="casAbstract">A series of 3-aminobenzo-1,2,4-triazine derivs. were prepd. and their oxidn. with H2O2 in AcOH studied.  The position of the N-oxide group(s) in the products was established by NMR anal.  Oxidn. of 3-aminobenzo-1,2,4-triazines at room temp. gave almost exclusively the 2-oxide, whereas prolonged oxidn. at 50° gave the 1,4-di-N-oxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXrnjoL5TFF7Vg90H21EOLACvtfcHk0lhwLpEkpvEGkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXktlGgsbg%253D&md5=3e3b6619866eca70f6bb14b77c48271c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2Fj29700000911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fj29700000911%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BC.%26aulast%3DTennant%26aufirst%3DG.%26jtitle%3DJ.%2520Chem.%2520Soc.%2520B%26date%3D1970%26spage%3D911%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kudo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perseghini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, G. C.</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1282</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1002%2Fanie.200503479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFyjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kudo%2C+N.%3B+Perseghini%2C+M.%3B+Fu%2C+G.+C.Angew.+Chem.%2C+Int.+Ed.+2006%2C+45%2C+1282%E2%80%931284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A versatile method for Suzuki cross-coupling reactions of nitrogen heterocycles</span></div><div class="casAuthors">Kudo, Noriaki; Perseghini, Mauro; Fu, Gregory C.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1282-1284</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A wide-ranging study of Suzuki reactions which use nitrogen-contg. heterocycles was described.  This method was highly versatile (a single procedure was used for all substrates, including boronate esters and trifluoroborates), compatible with a variety of unprotected functionalities (e.g., NH2- and OH-substituted substrates), and efficient even with inactivated aryl chlorides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaUyKcanJOLbVg90H21EOLACvtfcHk0lhwLpEkpvEGkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFyjs7Y%253D&md5=efb90d1dc5db87ee2dfc6cda6341c9eb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fanie.200503479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200503479%26sid%3Dliteratum%253Aachs%26aulast%3DKudo%26aufirst%3DN.%26aulast%3DPerseghini%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DG.%2BC.%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D1282%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Tundel, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo052131u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tundel%2C+R.+E.%3B+Anderson%2C+K.+W.%3B+Buchwald%2C+S.+L.J.+Org.+Chem.+2006%2C+71%2C+430%E2%80%93433"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo052131u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052131u%26sid%3Dliteratum%253Aachs%26aulast%3DTundel%26aufirst%3DR.%2BE.%26aulast%3DAnderson%26aufirst%3DK.%2BW.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D430%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stover, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K. A.</span><span> </span><span class="NLM_article-title">Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><div class="note"><p class="first last">PDB entry 1qpe</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=651-66&author=X.+Zhuauthor=J.+L.+Kimauthor=J.+R.+Newcombauthor=P.+E.+Roseauthor=D.+R.+Stoverauthor=L.+M.+Toledoauthor=H.+Zhaoauthor=K.+A.+Morgenstern&title=Structural+analysis+of+the+lymphocyte-specific+kinase+Lck+in+complex+with+non-selective+and+Src+family+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DNewcomb%26aufirst%3DJ.%2BR.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DStover%26aufirst%3DD.%2BR.%26aulast%3DToledo%26aufirst%3DL.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DMorgenstern%26aufirst%3DK.%2BA.%26atitle%3DStructural%2520analysis%2520of%2520the%2520lymphocyte-specific%2520kinase%2520Lck%2520in%2520complex%2520with%2520non-selective%2520and%2520Src%2520family%2520selective%2520kinase%2520inhibitors%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D651%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Breitenlechner, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairies, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honold, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheiblich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koll, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engh, R. A.</span><span> </span><span class="NLM_article-title">Crystal structures of active SRC kinase domain complexes.</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><div class="note"><p class="first last">(PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yom">1yom</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yol">1yol</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yoj">1yoj</a>)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=222-231&author=C.+B.+Breitenlechnerauthor=N.+A.+Kairiesauthor=K.+Honoldauthor=S.+Scheiblichauthor=H.+Kollauthor=E.+Greiterauthor=S.+Kochauthor=W.+Schaferauthor=R.+Huberauthor=R.+A.+Engh&title=Crystal+structures+of+active+SRC+kinase+domain+complexes."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreitenlechner%26aufirst%3DC.%2BB.%26aulast%3DKairies%26aufirst%3DN.%2BA.%26aulast%3DHonold%26aufirst%3DK.%26aulast%3DScheiblich%26aufirst%3DS.%26aulast%3DKoll%26aufirst%3DH.%26aulast%3DGreiter%26aufirst%3DE.%26aulast%3DKoch%26aufirst%3DS.%26aulast%3DSchafer%26aufirst%3DW.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DEngh%26aufirst%3DR.%2BA.%26atitle%3DCrystal%2520structures%2520of%2520active%2520SRC%2520kinase%2520domain%2520complexes.%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D353%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><div class="note"><p class="first last">After we had completed our work in the benzotriazines targeting Src, Abl, and Abl-T315I, a paper from Ariad targeting Src by utilizing the Glu310 in the back of the hydrophobic pocket by making a donor interaction was published:</p></div><span class="NLM_contrib-group">Dalgarno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schravendijk, M. R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNeil, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcal, C.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohacek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1111%2Fj.1747-0285.2005.00316.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=16492148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=After+we+had+completed+our+work+in+the+benzotriazines+targeting+Src%2C+Abl%2C+and+Abl-T315I%2C+a+paper+from+Ariad+targeting+Src+by+utilizing+the+Glu310+in+the+back+of+the+hydrophobic+pocket+by+making+a+donor+interaction+was+published%3ADalgarno%2C+D.%3B+Stehle%2C+T.%3B+Narula%2C+S.%3B+Schelling%2C+P.%3B+Schravendijk%2C+M.+R.+V.%3B+Adams%2C+S.%3B+Andrade%2C+L.%3B+Keats%2C+J.%3B+Ram%2C+M.%3B+Jin%2C+L.%3B+Grossman%2C+T.%3B+MacNeil%2C+I.%3B+Metcal%2C+C.%2C+III%3B+Shakespeare%2C+W.%3B+Wang%2C+Y.%3B+Keenan%2C+T.%3B+Sundaramoorthi%2C+R.%3B+Bohacek%2C+R.%3B+Weigele%2C+M.%3B+Sawyer%2C+TChem.+Biol.+Drug+Des.+2006%2C+67%2C+46"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds</span></div><div class="casAuthors">Dalgarno, David; Stehle, Thilo; Narula, Surinder; Schelling, Pierre; van Schravendijk, Marie Rose; Adams, Susan; Andrade, Lawrence; Keats, Jeff; Ram, Mary; Jin, Lei; Grossman, Trudy; MacNeil, Ian; Metcalf, Chester, III; Shakespeare, William; Wang, Yihan; Keenan, Terry; Sundaramoorthi, Raji; Bohacek, Regine; Weigele, Manfred; Sawyer, Tomi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-57</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The tyrosine kinase pp60src (Src) is the prototypical member of a family of proteins that participate in a broad array of cellular signal transduction processes, including cell growth, differentiation, survival, adhesion, and migration.  Abnormal Src family kinase (SFK) signaling has been linked to several disease states, including osteoporosis and cancer metastases.  Src has thus emerged as a mol. target for the discovery of small-mol. inhibitors that regulate Src kinase activity by binding to the ATP pocket within the catalytic domain.  Here, we present crystal structures of the kinase domain of Src in complex with two purine-based inhibitors: AP23451, a small-mol. inhibitor designed to inhibit Src-dependent bone resorption, and AP23464, a small-mol. inhibitor designed to inhibit the Src-dependent metastatic spread of cancer.  In each case, a trisubstituted purine template core was elaborated using structure-based drug design to yield a potent Src kinase inhibitor.  These structures represent early examples of high affinity purine-based Src family kinase-inhibitor complexes, and they provide a detailed view of the specific protein-ligand interactions that lead to potent inhibition of Src.  In particular, the 3-hydroxyphenethyl N9 substituent of AP23464 forms unique interactions with the protein that are crit. to the picomolar affinity of this compd. for Src.  The comparison of these new structures with two relevant kinase-inhibitor complexes provides a structural basis for the obsd. kinase inhibitory selectivity.  Further comparisons reveal a concerted induced-fit movement between the N- and C-terminal lobes of the kinase that correlates with the affinity of the ligand.  Binding of the most potent inhibitor, AP23464, results in the largest induced-fit movement, which can be directly linked to interactions of the hydrophenethyl N9 substituent with a region at the interface between the two lobes.  A less pronounced induced-fit movement is also obsd. in the Src-AP23451 complex.  These new structures illustrate how the combination of structural, computational, and medicinal chem. can be used to rationalize the process of developing high affinity, selective tyrosine kinase inhibitors as potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqAcWZyLy8JrVg90H21EOLACvtfcHk0lhxDJsGzkauvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7Y%253D&md5=5a89de976e29e65aec0553c84e2e0b92</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00316.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00316.x%26sid%3Dliteratum%253Aachs%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DStehle%26aufirst%3DT.%26aulast%3DNarula%26aufirst%3DS.%26aulast%3DSchelling%26aufirst%3DP.%26aulast%3DSchravendijk%26aufirst%3DM.%2BR.%2BV.%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DAndrade%26aufirst%3DL.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DRam%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DGrossman%26aufirst%3DT.%26aulast%3DMacNeil%26aufirst%3DI.%26aulast%3DMetcal%26aufirst%3DC.%26aulast%3DShakespeare%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKeenan%26aufirst%3DT.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DBohacek%26aufirst%3DR.%26aulast%3DWeigele%26aufirst%3DM.%26aulast%3DSawyer%26aufirst%3DT%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Noronha, G.; Cao, J.; Chow, C.; Dneprovskaia, E.; Hwang, L.; Lohse, D.; Mak, C. C.; McPherson, A.; Fine, R. M.; Kang, X.; Klebansky, B.; Palanki, M. S. S.; Pathak, V. P.; Renick, J.; Soll, R.; Zeng, B.</span> In  <span class="citation_source-book">Frontiers in Drug Design and Discovery</span>; <span class="NLM_contrib-group">Caldwell, G. W.; Atta-ur-Rahman; Player, M. R.; Choudhary, M. I.</span>, Eds.; <span class="NLM_publisher-name">Bentham Science Publishers</span>: <span class="NLM_publisher-loc">Oak Park, IL</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">3</span>, pp <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=121-144&author=G.+Noronha&author=J.+Cao&author=C.+Chow&author=E.+Dneprovskaia&author=L.+Hwang&author=D.+Lohse&author=C.+C.+Mak&author=A.+McPherson&author=R.+M.+Fine&author=X.+Kang&author=B.+Klebansky&author=M.+S.+S.+Palanki&author=V.+P.+Pathak&author=J.+Renick&author=R.+Soll&author=B.+Zengauthor=G.+W.+Caldwell&author=+Atta-ur-Rahman&author=M.+R.+Player&author=M.+I.+Choudhary&title=Frontiers+in+Drug+Design+and+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNoronha%26aufirst%3DG.%26btitle%3DFrontiers%2520in%2520Drug%2520Design%2520and%2520Discovery%26aulast%3DCaldwell%26aufirst%3DG.%2BW.%26pub%3DBentham%2520Science%2520Publishers%26date%3D2007%26volume%3D3%26spage%3D121%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><div class="note"><p class="first last">Compound <b>5</b> was evaluated in YES biochemical assay and found to be a potent inhibitor (<i>K</i><sub>i</sub> = 0.63 nM). The <i>K</i><sub>i</sub> value for compound <b>5</b> in VEGFr2 was 6.79 nM, and in Src it was 9.23 nM.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+5+was+evaluated+in+YES+biochemical+assay+and+found+to+be+a+potent+inhibitor+%28Ki+%3D+0.63+nM%29.+The+Ki+value+for+compound+5+in+VEGFr2+was+6.79+nM%2C+and+in+Src+it+was+9.23+nM."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Saint-Geniez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amore, P. A.</span><span> </span><span class="NLM_article-title">Development and pathology of the hyaloid, choroidal and retinal vasculature</span> <span class="citation_source-journal">Int. J. Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1387%2Fijdb.041895ms" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=15558494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADC%252BD2crosVGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1045-1058&author=M.+Saint-Geniezauthor=P.+A.+D%E2%80%99Amore&title=Development+and+pathology+of+the+hyaloid%2C+choroidal+and+retinal+vasculature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Development and pathology of the hyaloid, choroidal and retinal vasculature</span></div><div class="casAuthors">Saint-Geniez Magali; D'Amore Patricia A</div><div class="citationInfo"><span class="NLM_cas:title">The International journal of developmental biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">1045-58</span>
        ISSN:<span class="NLM_cas:issn">0214-6282</span>.
    </div><div class="casAbstract">During embryogenesis, the development and differentiation of the eye requires the concomitant formation of the neural/glial elements along with a dense vascular network.  The adult neural retina is supported by two distinct vascular systems, the proper retinal vessels and the choroidal vessels.  The two beds differ not only in their pattern of embryonic differentiation, but also in their function in the adult organism.  The retinal vasculature has barrier properties similar to those observed in the brain, whereas the choroidal vessels display a highly fenestrated phenotype.  The hyaloid vasculature is a transient embryonic vascular bed which is complete at birth in mammals and regresses contemporaneously with the formation of the retinal vasculature.  The dependence of the retina on its blood supply makes it highly vulnerable to any vascular changes and indeed ocular diseases, such as proliferative retinopathy, age-related macular degeneration and the hyperplastic primary vitreous, which are associated with abnormalities of the different vascular beds of the eye.  A number of factors have been implicated in developmental and pathological changes in vessel formation and regression, including fibroblast growth factors, platelet-derived endothelial growth factor and vascular endothelial growth factor, among others.  The purpose of this review is to describe and discuss new insights into the mechanisms and molecular cues involved in the development of the normal and pathological vascular systems of the eye.  The characterization of the molecules and cell-cell interactions involved in the formation, stabilization and regression of new vessels has led to the identification of potential control points for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUCQIXDWngcSM8MEzWGjS9fW6udTcc2ebq5N9vGzNzQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crosVGjsA%253D%253D&md5=a805a73906429119f1867ee1f0fce6a0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1387%2Fijdb.041895ms&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1387%252Fijdb.041895ms%26sid%3Dliteratum%253Aachs%26aulast%3DSaint-Geniez%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Amore%26aufirst%3DP.%2BA.%26atitle%3DDevelopment%2520and%2520pathology%2520of%2520the%2520hyaloid%252C%2520choroidal%2520and%2520retinal%2520vasculature%26jtitle%3DInt.%2520J.%2520Dev.%2520Biol.%26date%3D2004%26volume%3D48%26spage%3D1045%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Aguilar, E.; Scheppke, L.; Dorrell, M.; Hood, J.; Dellamary, L.; Yee, S.; Friedlander, M.</span><span> </span><span class="NLM_article-title">Topically Applied Src Kinase/VEGFR Prodrug Reduces Retinal Vascular Permeability</span>. Presented at the <span class="NLM_conf-name">Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)</span>, <span class="NLM_conf-loc">Fort Lauderdale, FL</span>, <span class="NLM_conf-date">April 3 through May 4</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=E.+Aguilar&author=L.+Scheppke&author=M.+Dorrell&author=J.+Hood&author=L.+Dellamary&author=S.+Yee&author=M.+Friedlander&title=Topically+Applied+Src+Kinase%2FVEGFR+Prodrug+Reduces+Retinal+Vascular+Permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DE.%26atitle%3DTopically%2520Applied%2520Src%2520Kinase%252FVEGFR%2520Prodrug%2520Reduces%2520Retinal%2520Vascular%2520Permeability%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Attar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, K, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D. T.</span><span> </span><span class="NLM_article-title">Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1517%2F17425247.2.5.891" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=908-891&author=M.+Attarauthor=J.+Shenauthor=K%2C+J.+Lingauthor=D.+T.+Liu&title=Ophthalmic+drug+delivery+considerations+at+the+cellular+level%3A+drug-metabolising+enzymes+and+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1517%2F17425247.2.5.891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2.5.891%26sid%3Dliteratum%253Aachs%26aulast%3DAttar%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DLing%26aufirst%3DK%252C%2BJ.%26aulast%3DLiu%26aufirst%3DD.%2BT.%26atitle%3DOphthalmic%2520drug%2520delivery%2520considerations%2520at%2520the%2520cellular%2520level%253A%2520drug-metabolising%2520enzymes%2520and%2520transporters%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2005%26volume%3D2%26spage%3D908%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Ahmed Kousba, A.; Yu, J.; Dellamary, L.; White, R.; Hu, S.; Tabak, A.; Cao, J.; Mak, C. C.; Renick, J.; McPherson, A.; Zeng, B.; Pathak, V.; Ibanez, G.; Stoughton, S.; Olafson, T.; Soll, R.; Doukas, J.; Hood, J.; Noronha, G.; Martin., M.</span><span> </span><span class="NLM_article-title">Bioactivation and Ocular Disposition of Topically Applied Prodrug TG100801</span>. Presented at the <span class="NLM_conf-name">8th Scientific Meeting of the Association for Ocular Pharmacology and Therapeutics</span>, <span class="NLM_conf-loc">San Diego, CA</span>, <span class="NLM_conf-date">February 9–11</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=A.+Ahmed+Kousba&author=J.+Yu&author=L.+Dellamary&author=R.+White&author=S.+Hu&author=A.+Tabak&author=J.+Cao&author=C.+C.+Mak&author=J.+Renick&author=A.+McPherson&author=B.+Zeng&author=V.+Pathak&author=G.+Ibanez&author=S.+Stoughton&author=T.+Olafson&author=R.+Soll&author=J.+Doukas&author=J.+Hood&author=G.+Noronha&author=M.+Martin.&title=Bioactivation+and+Ocular+Disposition+of+Topically+Applied+Prodrug+TG100801"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%2BKousba%26aufirst%3DA.%26atitle%3DBioactivation%2520and%2520Ocular%2520Disposition%2520of%2520Topically%2520Applied%2520Prodrug%2520TG100801%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><div class="note"><p class="first last">It is very difficult to accurately dissect sclera and choroid separately in the eyes of mice. Hence, we measured the concentration of the compound from the combined sclera and choroid tissues.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=It+is+very+difficult+to+accurately+dissect+sclera+and+choroid+separately+in+the+eyes+of+mice.+Hence%2C+we+measured+the+concentration+of+the+compound+from+the+combined+sclera+and+choroid+tissues."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><div class="note"><p class="first last">We examined the distribution of radiolabeled compound <b>12</b> in rabbit upon topical instillation in a single eye. The compound was present in most of the removed eye tissues and distributed in various parts of the eye as anticipated. The radiolabeled material was not present in systemic circulation or any other tissues. The bulk of the compound was excreted in the feces. It appears most of the compound was drained through the nasolacrimal drainage system. Manuscript is in preparation.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=We+examined+the+distribution+of+radiolabeled+compound+12+in+rabbit+upon+topical+instillation+in+a+single+eye.+The+compound+was+present+in+most+of+the+removed+eye+tissues+and+distributed+in+various+parts+of+the+eye+as+anticipated.+The+radiolabeled+material+was+not+present+in+systemic+circulation+or+any+other+tissues.+The+bulk+of+the+compound+was+excreted+in+the+feces.+It+appears+most+of+the+compound+was+drained+through+the+nasolacrimal+drainage+system.+Manuscript+is+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Miller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, S. J.</span><span> </span><span class="NLM_article-title">The role of the retinal pigmented epithelium in the involution of subretinal neovascularization</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1644</span><span class="NLM_x">–</span> <span class="NLM_lpage">1652</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=2429937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADyaL2s%252Fjt1OksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1986&pages=1644-1652&author=H.+Millerauthor=B.+Millerauthor=S.+J.+Ryan&title=The+role+of+the+retinal+pigmented+epithelium+in+the+involution+of+subretinal+neovascularization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The role of retinal pigment epithelium in the involution of subretinal neovascularization</span></div><div class="casAuthors">Miller H; Miller B; Ryan S J</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology & visual science</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1644-52</span>
        ISSN:<span class="NLM_cas:issn">0146-0404</span>.
    </div><div class="casAbstract">The extravascular milieu around laser-induced experimental subretinal neovascularization (SRN) was studied during the evolution of the neovascular membrane from its early leaky stage to its late involuted stage.  When the first signs of visible leakage appeared on angiography, newly formed vessels were spread in the subretinal space around the break in Bruch's membrane, fluid was accumulating in the subretinal space, and retinal pigment epithelial (RPE) cells were proliferating in a papillary pattern around the newly formed vessels; the RPE proliferation began with the undamaged cells at the edges of the laser injury.  With further maturation, the RPE continued to envelope the subretinal vessels.  This RPE proliferation was associated with the disappearance of fluid between the enveloped vessels and the sensory retina, and the gradual cessation of fluorescein leakage during angiography.  At the end of the involution process, when the neovascular membrane no longer demonstrated any leakage, the subretinal vessels were found to be tightly enveloped by RPE cells, and no fluid separated them from the sensory retina.  The authors' results suggest that involution of the neovascular membrane with maturation, as demonstrated by the cessation of visible fluorescein leakage, is the result of RPE proliferation that tightly envelopes the newly formed vessels and probably resorbs the previously accumulated subretinal fluid, as well as preventing its further accumulation in the subretinal space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1_M-cDM9zolw2ofyr07jXfW6udTcc2eZMEcX_K2UEhrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s%252Fjt1OksQ%253D%253D&md5=d63f021054201b7e6a8481c0bd172a7c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DH.%26aulast%3DMiller%26aufirst%3DB.%26aulast%3DRyan%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520role%2520of%2520the%2520retinal%2520pigmented%2520epithelium%2520in%2520the%2520involution%2520of%2520subretinal%2520neovascularization%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D1986%26volume%3D27%26spage%3D1644%26epage%3D1652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Dobi, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puliafito, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Destro, M.</span><span> </span><span class="NLM_article-title">A new model of choroidal neovascularization in the rat</span> <span class="citation_source-journal">Arch. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">264</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=2464985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADyaL1M7jtl2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1989&pages=264-269&author=E.+T.+Dobiauthor=C.+A.+Puliafitoauthor=M.+Destro&title=A+new+model+of+choroidal+neovascularization+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A new model of experimental choroidal neovascularization in the rat</span></div><div class="casAuthors">Dobi E T; Puliafito C A; Destro M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of ophthalmology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">264-9</span>
        ISSN:<span class="NLM_cas:issn">0003-9950</span>.
    </div><div class="casAbstract">Choroidal neovascularization in rat eyes was induced by krypton laser photocoagulation.  Lesions were studied weekly by ophthalmoscopy, fundus photography, and fluorescein angiography.  Morphologic correlation was provided by serial sectioning of lesions for light and transmission electron microscopy.  In addition, vascular casts were prepared for scanning electron microscopy.  Choroidal neovascularization occurred in 25 (60%) of 42 lesions, as evidenced by growth of capillaries through breaks in Bruch's membrane.  In addition, 24 (28%) of 86 lesions studied by fluorescein angiography demonstrated leakage.  This study provides the most complete angiographic, histologic, and ultrastructural documentation of experimental choroidal neovascularization in the rat.  This model may be useful for in vivo studies of choroidal angiogenesis and its modulation via drug therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeZXMBev269MvLc4ARHEmzfW6udTcc2eZMEcX_K2UEhrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M7jtl2jsA%253D%253D&md5=c1d0e099d356dff22d15f4ed804ce0f7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobi%26aufirst%3DE.%2BT.%26aulast%3DPuliafito%26aufirst%3DC.%2BA.%26aulast%3DDestro%26aufirst%3DM.%26atitle%3DA%2520new%2520model%2520of%2520choroidal%2520neovascularization%2520in%2520the%2520rat%26jtitle%3DArch.%2520Ophthalmol.%26date%3D1989%26volume%3D107%26spage%3D264%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Soubrane, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delayre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, M.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coscas, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtois, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanny, J.-C.</span><span> </span><span class="NLM_article-title">Basic fibroblast growth factor experimentally induced choroidal angiogenesis in the minipig</span> <span class="citation_source-journal">Curr. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.3109%2F02713689408995776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=7514965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADyaK2c3lt1WjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1994&pages=183-195&author=G.+Soubraneauthor=S.+Y.+Cohenauthor=T.+Delayreauthor=J.+Tassinauthor=M.-P.+Hartmannauthor=G.+J.+Coscasauthor=Y.+Courtoisauthor=J.-C.+Jeanny&title=Basic+fibroblast+growth+factor+experimentally+induced+choroidal+angiogenesis+in+the+minipig"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Basic fibroblast growth factor experimentally induced choroidal angiogenesis in the minipig</span></div><div class="casAuthors">Soubrane G; Cohen S Y; Delayre T; Tassin J; Hartmann M P; Coscas G J; Courtois Y; Jeanny J C</div><div class="citationInfo"><span class="NLM_cas:title">Current eye research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">183-95</span>
        ISSN:<span class="NLM_cas:issn">0271-3683</span>.
    </div><div class="casAbstract">Basic fibroblast growth factor (bFGF), a soluble mitogen, has been isolated and purified from various organs, including the retina.  In vivo angiogenic activity of bFGF has been demonstrated with several assays.  An experimental model of choroidal neovascularization was developed in the mini pig by perfusion of recombinant human bFGF through an osmotic minipump.  Endogenous bFGF and bFGF receptors were localized in the normal pig retina by immunohistochemistry and autoradiography after binding.  The perfusion of exogenous bFGF induced well-organized new vessels along the last 3 mm of the catheter in the suprachoroidal space.  This neovascularization did not penetrate the normal Bruch's membrane.  Vascular cells (identified by von Willebrand factor antibody staining) increased in number and in surface from the proximal part to the end of the intraocular catheter in all bFGF perfused eyes.  In eyes perfused with phosphate buffered saline (controls), but not in the bFGF perfused eyes, an inflammatory response occurred (identified by a macrophage specific antibody).  These results demonstrate that choroidal angiogenesis can be achieved without an inflammatory response by perfusing an excess of bFGF in the suprachoroidal space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIoeyG_snsr-2mnZh2OgS0fW6udTcc2eZMEcX_K2UEhrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c3lt1WjsA%253D%253D&md5=0ef646738fddfa6d12530cbddeabde92</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3109%2F02713689408995776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F02713689408995776%26sid%3Dliteratum%253Aachs%26aulast%3DSoubrane%26aufirst%3DG.%26aulast%3DCohen%26aufirst%3DS.%2BY.%26aulast%3DDelayre%26aufirst%3DT.%26aulast%3DTassin%26aufirst%3DJ.%26aulast%3DHartmann%26aufirst%3DM.-P.%26aulast%3DCoscas%26aufirst%3DG.%2BJ.%26aulast%3DCourtois%26aufirst%3DY.%26aulast%3DJeanny%26aufirst%3DJ.-C.%26atitle%3DBasic%2520fibroblast%2520growth%2520factor%2520experimentally%2520induced%2520choroidal%2520angiogenesis%2520in%2520the%2520minipig%26jtitle%3DCurr.%2520Eye%2520Res.%26date%3D1994%26volume%3D13%26spage%3D183%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, S. J.</span><span> </span><span class="NLM_article-title">A new model of subretinal neovascularization in the rabbit</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2110</span><span class="NLM_x">–</span> <span class="NLM_lpage">2119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=7657549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADyaK2Mzos1Cisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=2110-2119&author=H.+Kimuraauthor=T.+Sakamotoauthor=D.+R.+Hintonauthor=C.+Speeauthor=Y.+Oguraauthor=Y.+Tabataauthor=Y.+Ikadaauthor=S.+J.+Ryan&title=A+new+model+of+subretinal+neovascularization+in+the+rabbit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A new model of subretinal neovascularization in the rabbit</span></div><div class="casAuthors">Kimura H; Sakamoto T; Hinton D R; Spee C; Ogura Y; Tabata Y; Ikada Y; Ryan S J</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology & visual science</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2110-9</span>
        ISSN:<span class="NLM_cas:issn">0146-0404</span>.
    </div><div class="casAbstract">PURPOSE:  To establish a new model of subretinal neovascularization (SRN) in the rabbit by implanting basic fibroblast growth factor (bFGF)-impregnated gelatin microspheres beneath the retina.  METHODS:  Basic fibroblast growth factor-impregnated gelatin microspheres were prepared by forming a polyion complex between gelatin and bFGF.  The microspheres, containing 2.5 micrograms of bFGF, were injected into the subretinal space of rabbit eyes (n = 29).  Control eyes (n = 10) received bFGF-free gelatin microspheres.  Eyes were followed up for 3 days to 8 weeks by ophthalmoscopy, photography, fluorescein angiography, light microscopy, and transmission electron microscopy.  RESULTS:  Twenty of 24 experimental eyes (83%) showed fluorescein leakage from SRN 2 weeks after implantation of the bFGF-impregnated microspheres.  This leakage continued for 2 to 6 more weeks.  In striking contrast, control eyes showed no fluorescein leakage.  Histologic examination revealed SRN in all the experimental eyes but in none of the control eyes.  CONCLUSIONS:  Subretinal implantation of bFGF-impregnated gelatin microspheres induces reproducible SRN in the rabbit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXCqhAcE7ePJQHPYJuLg8TfW6udTcc2eYm3xxt-A72Cbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2Mzos1Cisg%253D%253D&md5=2d949c16f3e6beb6911d4b2b7cc739e7</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DSakamoto%26aufirst%3DT.%26aulast%3DHinton%26aufirst%3DD.%2BR.%26aulast%3DSpee%26aufirst%3DC.%26aulast%3DOgura%26aufirst%3DY.%26aulast%3DTabata%26aufirst%3DY.%26aulast%3DIkada%26aufirst%3DY.%26aulast%3DRyan%26aufirst%3DS.%2BJ.%26atitle%3DA%2520new%2520model%2520of%2520subretinal%2520neovascularization%2520in%2520the%2520rabbit%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D1995%26volume%3D36%26spage%3D2110%26epage%3D2119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lima e Silva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatara, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khu, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauer, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Trans-scleral delivery of polyamine analogs for ocular neovascularization</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1260</span><span class="NLM_x">–</span> <span class="NLM_lpage">1267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50a&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1016%2Fj.exer.2006.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50a&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=16950258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50a&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFGnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2006&pages=1260-1267&author=R.+Lima+e+Silvaauthor=S.+Kachiauthor=H.+Akiyamaauthor=J.+Shenauthor=M.+C.+Hataraauthor=S.+Aslamauthor=Y.+Y.+Gongauthor=N.+H.+Khuauthor=T.+W.+Lauerauthor=S.+F.+Hackettauthor=L.+J.+Martonauthor=P.+A.+Campochiaro&title=Trans-scleral+delivery+of+polyamine+analogs+for+ocular+neovascularization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50aR"><div class="casContent"><span class="casTitleNuber">50a</span><div class="casTitle"><span class="NLM_cas:atitle">Transscleral delivery of polyamine analogs for ocular neovascularization</span></div><div class="casAuthors">Lima e Silva, Raquel; Kachi, Shu; Akiyama, Hideo; Shen, Ji Kui; Hatara, Maria Christina; Aslam, Sadia; Gong, Yuan Yuan; Khu, Naw Htee; Lauer, Thomas W.; Hackett, Sean F.; Marton, Laurence J.; Campochiaro, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1260-1267</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Periocular injections of the polyamine analog CGC-11144 three times a week causes regression of choroidal neovascularization.  This regimen was selected to maximize chances of success for proof of concept, but is not ideal for clin. application.  In this study we explored other regimens for periocular delivery of CGC-11144, and 2 other polyamine analogs, CGC-11047 and CGC-11093.  A single periocular injection of 200 μg of CGC-11144, 2 mg of CGC-11047, or 1.5 mg of CGC-11093 caused significant suppression and regression of laser-induced choroidal neovascularization.  An injection of 2 mg of CGC-11047 or 1.5 mg of CGC-11093 one or two weeks before, but not 3 wk before, rupture of Bruch's membrane also caused significant suppression.  Periocular injection of polyamine analogs also caused strong inhibition of retinal or subretinal neovascularization in mice with oxygen-induced ischemic retinopathy or Rhodopsin promoter/VEGF transgenic mice, resp.  These data suggest that periocular injection of one of 3 different polyamine analogs inhibits retinal or choroidal neovascularization and a single injection provides inhibitory activity for at least 2 to 3 wk, which could provide the basis for a feasible treatment regimen for clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0OdSe4SZZZ7Vg90H21EOLACvtfcHk0lgnabCUHOh6zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFGnsbo%253D&md5=ab37c7a51f7bbe06f5a7bbfb3b85a3cc</span></div><a href="/servlet/linkout?suffix=cit50a&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2006.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2006.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DLima%2Be%2BSilva%26aufirst%3DR.%26aulast%3DKachi%26aufirst%3DS.%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DHatara%26aufirst%3DM.%2BC.%26aulast%3DAslam%26aufirst%3DS.%26aulast%3DGong%26aufirst%3DY.%2BY.%26aulast%3DKhu%26aufirst%3DN.%2BH.%26aulast%3DLauer%26aufirst%3DT.%2BW.%26aulast%3DHackett%26aufirst%3DS.%2BF.%26aulast%3DMarton%26aufirst%3DL.%2BJ.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DTrans-scleral%2520delivery%2520of%2520polyamine%2520analogs%2520for%2520ocular%2520neovascularization%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2006%26volume%3D83%26spage%3D1260%26epage%3D1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit50b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Umeda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vossmeyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stragies, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1820</span><span class="NLM_x">–</span> <span class="NLM_lpage">1828</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=1820-1828&author=N.+Umedaauthor=S.+Kachiauthor=H.+Akiyamaauthor=G.+Zahnauthor=D.+Vossmeyerauthor=R.+Stragiesauthor=P.+A.+Campochiaro&title=Suppression+and+regression+of+choroidal+neovascularization+by+systemic+administration+of+an+alpha5beta1+integrin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUmeda%26aufirst%3DN.%26aulast%3DKachi%26aufirst%3DS.%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DZahn%26aufirst%3DG.%26aulast%3DVossmeyer%26aufirst%3DD.%26aulast%3DStragies%26aufirst%3DR.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DSuppression%2520and%2520regression%2520of%2520choroidal%2520neovascularization%2520by%2520systemic%2520administration%2520of%2520an%2520alpha5beta1%2520integrin%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D69%26spage%3D1820%26epage%3D1828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit50c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Nambu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularization</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3650</span><span class="NLM_x">–</span> <span class="NLM_lpage">3655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50c&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1167%2Fiovs.02-0985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50c&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=12882819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50c&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADC%252BD3szltV2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=3650-3655&author=H.+Nambuauthor=R.+Nambuauthor=M.+Meliaauthor=P.+A.+Campochiaro&title=Combretastatin+A-4+phosphate+suppresses+development+and+induces+regression+of+choroidal+neovascularization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50cR"><div class="casContent"><span class="casTitleNuber">50c</span><div class="casTitle"><span class="NLM_cas:atitle">Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularization</span></div><div class="casAuthors">Nambu Hiroyuki; Nambu Rie; Melia Michele; Campochiaro Peter A</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology & visual science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3650-5</span>
        ISSN:<span class="NLM_cas:issn">0146-0404</span>.
    </div><div class="casAbstract">PURPOSE:  Combretastatin A-4 (CA-4) is a naturally occurring agent that binds tubulin and causes necrosis and shrinkage of tumors by damaging their blood vessels.  In this study the effect of a CA-4 prodrug, combretastatin A-4-phosphate (CA-4-P), was tested in two models of ocular neovascularization.  METHODS:  The effect of CA-4-P was quantitatively assessed in transgenic mice with overexpression of vascular endothelial growth factor in the retina (rho/VEGF mice) and mice with choroidal neovascularization (CNV) due to laser-induced rupture of Bruch's membrane.  RESULTS:  In rho/VEGF mice, daily intraperitoneal injections of 4.0 mg/kg CA-4-P starting at postnatal day (P)7, the time of onset of transgene expression, resulted in a significant reduction in the number of neovascular lesions and total area of neovascularization per retina at P21, compared with vehicle-injected mice.  In mice with laser-induced rupture of Bruch's membrane, daily intraperitoneal injections of 75 or 100 mg/kg CA-4-P resulted in a significant reduction in the area of CNV at rupture sites compared with vehicle-injected mice.  In mice with established CNV, daily intraperitoneal injections of 100 mg/kg CA-4-P for 1 week resulted in a significant reduction in CNV area at rupture sites compared with the baseline area before treatment or the area of CNV in vehicle-treated mice.  CONCLUSIONS:  These data indicate that CA-4-P suppresses the development of VEGF-induced neovascularization in the retina and both blocks development and promotes regression of CNV.  Therefore, CA-4-P shows potential for both prevention and treatment of ocular neovascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQH74-mFuwyNaNc3HjJRoFAfW6udTcc2eYm3xxt-A72Cbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szltV2rtg%253D%253D&md5=36be9072a6e9c8307039d7412a26330f</span></div><a href="/servlet/linkout?suffix=cit50c&amp;dbid=16384&amp;doi=10.1167%2Fiovs.02-0985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.02-0985%26sid%3Dliteratum%253Aachs%26aulast%3DNambu%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DR.%26aulast%3DMelia%26aufirst%3DM.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DCombretastatin%2520A-4%2520phosphate%2520suppresses%2520development%2520and%2520induces%2520regression%2520of%2520choroidal%2520neovascularization%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2003%26volume%3D44%26spage%3D3650%26epage%3D3655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit50d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melia, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bingaman, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Topical nepafenac inhibits ocular neovascularization</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50d&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1167%2Fiovs.02-0346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50d&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=12506103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50d&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADC%252BD38jktFOmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=409-415&author=K.+Takahashiauthor=Y.+Saishinauthor=Y.+Saishinauthor=K.+Moriauthor=A.+Andoauthor=S.+Yamamotoauthor=Y.+Oshimaauthor=H.+Nambuauthor=M.+B.+Meliaauthor=D.+P.+Bingamanauthor=P.+A.+Campochiaro&title=Topical+nepafenac+inhibits+ocular+neovascularization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50dR"><div class="casContent"><span class="casTitleNuber">50d</span><div class="casTitle"><span class="NLM_cas:atitle">Topical nepafenac inhibits ocular neovascularization</span></div><div class="casAuthors">Takahashi Kyoichi; Saishin Yoshitsugu; Saishin Yumiko; Mori Keisuke; Ando Akira; Yamamoto Satoru; Oshima Yuji; Nambu Hiroyuki; Melia Michele B; Bingaman David P; Campochiaro Peter A</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology & visual science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">409-15</span>
        ISSN:<span class="NLM_cas:issn">0146-0404</span>.
    </div><div class="casAbstract">PURPOSE:  Topical nepafenac readily penetrates the cornea and is metabolized to amfenac, a potent cyclooxygenase (COX)-1 and COX-2 inhibitor.  In this study, we tested the effect of topical nepafenac in three murine models of ocular neovascularization (NV).  METHODS:  A masked trial was performed to compare the topical effects of vehicle with one of several concentrations of nepafenac (0.01%, 0.03%, 0.1%, or 0.5%), 0.1% diclofenac, or 0.5% ketorolac tromethamine in mice with oxygen-induced ischemic retinopathy, mice with choroidal NV (CNV) due to laser-induced rupture of Bruch's membrane, or transgenic mice with increased expression of vascular endothelial growth factor (VEGF) in photoreceptors (rho/VEGF transgenic mice).  RESULTS:  Mice treated with 0.1% or 0.5% nepafenac had significantly less CNV and significant less ischemia-induced retinal NV than did vehicle-treated mice.  Nepafenac also blunted the increase in VEGF mRNA in the retina induced by ischemia.  In rho/VEGF transgenic mice, nepafenac failed to inhibit neovascularization.  In additional studies, compared with vehicle-treated mice, mice treated with 0.1% or 0.03% nepafenac had significantly less CNV, whereas eyes treated with 0.1% diclofenac showed no significant difference.  Mice treated with 0.5% ketorolac tromethamine for 14 days had high mortality, but when evaluated after 7 days of treatment showed no difference from mice treated with vehicle for 7 days.  CONCLUSIONS:  Topical nepafenac inhibits CNV and ischemia-induced retinal neovascularization by decreasing production of VEGF.  The absence of effect in rho/VEGF transgenic mice is consistent with this mechanism.  Topical nepafenac may provide an effective new treatment for ocular neovascularization.  The excellent corneal penetration of nepafenac certainly plays an important role in this effect.  It is possible that other antiangiogenic agents are also amenable to topical application after formulations are identified that maximize their corneal penetration.  Because of the many advantages of the topical route of delivery, this is a possible topic for exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBZdWOugH4ZD0SWnHPWbmmfW6udTcc2ea-63_D1BSkPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jktFOmtQ%253D%253D&md5=ef3bd727f479e3d1b785578c93676a30</span></div><a href="/servlet/linkout?suffix=cit50d&amp;dbid=16384&amp;doi=10.1167%2Fiovs.02-0346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.02-0346%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DS.%26aulast%3DOshima%26aufirst%3DY.%26aulast%3DNambu%26aufirst%3DH.%26aulast%3DMelia%26aufirst%3DM.%2BB.%26aulast%3DBingaman%26aufirst%3DD.%2BP.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DTopical%2520nepafenac%2520inhibits%2520ocular%2520neovascularization%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2003%26volume%3D44%26spage%3D409%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><div class="note"><p class="first last">Private communication from Professor Martin Friedlander. Manuscript is in preparation.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Private+communication+from+Professor+Martin+Friedlander.+Manuscript+is+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Calalb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polte, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, S.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=1996&pages=662-668&author=M.+Calalbauthor=X.+Zhangauthor=T.+Polteauthor=S.+Hanks&title=Focal+adhesion+kinase+tyrosine-861+is+a+major+site+of+phosphorylation+by+Src"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalalb%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPolte%26aufirst%3DT.%26aulast%3DHanks%26aufirst%3DS.%26atitle%3DFocal%2520adhesion%2520kinase%2520tyrosine-861%2520is%2520a%2520major%2520site%2520of%2520phosphorylation%2520by%2520Src%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1996%26volume%3D228%26spage%3D662%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Lim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahk, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, E.</span><span> </span><span class="NLM_article-title">Phosphorylation of focal adhesion kinase at tyrosine 861 is crucial for ras transformation of fibroblasts</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">29060</span><span class="NLM_x">–</span> <span class="NLM_lpage">29065</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=29060-29065&author=Y.+Limauthor=I.+Hanauthor=J.+Jeonauthor=H.+Parkauthor=Y.+Bahkauthor=E.+Oh&title=Phosphorylation+of+focal+adhesion+kinase+at+tyrosine+861+is+crucial+for+ras+transformation+of+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DI.%26aulast%3DJeon%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DBahk%26aufirst%3DY.%26aulast%3DOh%26aufirst%3DE.%26atitle%3DPhosphorylation%2520of%2520focal%2520adhesion%2520kinase%2520at%2520tyrosine%2520861%2520is%2520crucial%2520for%2520ras%2520transformation%2520of%2520fibroblasts%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D29060%26epage%3D29065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Eliceiri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D.</span><span> </span><span class="NLM_article-title">Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=915-924&author=B.+Eliceiriauthor=R.+Paulauthor=P.+Schwartzbergauthor=J.+D.+Hoodauthor=J.+Lengauthor=D.+Cheresh&title=Selective+requirement+for+Src+kinases+during+VEGF-induced+angiogenesis+and+vascular+permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEliceiri%26aufirst%3DB.%26aulast%3DPaul%26aufirst%3DR.%26aulast%3DSchwartzberg%26aufirst%3DP.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DLeng%26aufirst%3DJ.%26aulast%3DCheresh%26aufirst%3DD.%26atitle%3DSelective%2520requirement%2520for%2520Src%2520kinases%2520during%2520VEGF-induced%2520angiogenesis%2520and%2520vascular%2520permeability%26jtitle%3DMol.%2520Cell%26date%3D1999%26volume%3D4%26spage%3D915%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Abu-Ghazaleh, R.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabir, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zachary, I.</span><span> </span><span class="NLM_article-title">Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2001&pages=255-264&author=R.%3B+Abu-Ghazalehauthor=J.+Kabirauthor=H.%3B+Jiaauthor=M.+Loboauthor=I.+Zachary&title=Src+mediates+stimulation+by+vascular+endothelial+growth+factor+of+the+phosphorylation+of+focal+adhesion+kinase+at+tyrosine+861%2C+and+migration+and+anti-apoptosis+in+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbu-Ghazaleh%26aufirst%3DR.%253B%26aulast%3DKabir%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DH.%253B%26aulast%3DLobo%26aufirst%3DM.%26aulast%3DZachary%26aufirst%3DI.%26atitle%3DSrc%2520mediates%2520stimulation%2520by%2520vascular%2520endothelial%2520growth%2520factor%2520of%2520the%2520phosphorylation%2520of%2520focal%2520adhesion%2520kinase%2520at%2520tyrosine%2520861%252C%2520and%2520migration%2520and%2520anti-apoptosis%2520in%2520endothelial%2520cells%26jtitle%3DBiochem.%2520J.%26date%3D2001%26volume%3D360%26spage%3D255%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Eliceiri, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puente, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupack, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span> </span><span class="NLM_article-title">Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2002&pages=149-160&author=B.+P.+Eliceiriauthor=X.+S.+Puenteauthor=J.+D.+Hoodauthor=D.+G.+Stupackauthor=D.+D.+Schlaepferauthor=X.+Z.+Huangauthor=D.+Sheppardauthor=D.+A.+Cheresh&title=Src-mediated+coupling+of+focal+adhesion+kinase+to+integrin+alpha%28v%29beta5+in+vascular+endothelial+growth+factor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEliceiri%26aufirst%3DB.%2BP.%26aulast%3DPuente%26aufirst%3DX.%2BS.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DStupack%26aufirst%3DD.%2BG.%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26aulast%3DHuang%26aufirst%3DX.%2BZ.%26aulast%3DSheppard%26aufirst%3DD.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26atitle%3DSrc-mediated%2520coupling%2520of%2520focal%2520adhesion%2520kinase%2520to%2520integrin%2520alpha%2528v%2529beta5%2520in%2520vascular%2520endothelial%2520growth%2520factor%2520signaling%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2002%26volume%3D157%26spage%3D149%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><a href="http://www.clinicaltrials.gov/ct/show/NCT00509548?order=1" class="extLink">http://www.clinicaltrials.gov/ct/show/NCT00509548?order=1</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.clinicaltrials.gov%2Fct%2Fshow%2FNCT00509548%3Forder%3D1."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Doukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umeda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellamary, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racanelli-Layton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noronha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema.</span> <span class="citation_source-journal">J. Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span> <span class="NLM_fpage"></span><div class="note"><p class="first last">accepted for publication</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2008&author=J.+Doukasauthor=S.+Maheshauthor=N.+Umedaauthor=S.+Kachiauthor=H.+Akiyamaauthor=K.+Yokoiauthor=J.+Caoauthor=Z.+Chenauthor=L.+Dellamaryauthor=B.+Tamauthor=A.+Racanelli-Laytonauthor=J.+Hoodauthor=M.+Martinauthor=G.+Noronhaauthor=R.+Sollauthor=P.+A.+Campochiaro&title=Topical+administration+of+a+multi-targeted+kinase+inhibitor+suppresses+choroidal+neovascularization+and+retinal+edema."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoukas%26aufirst%3DJ.%26aulast%3DMahesh%26aufirst%3DS.%26aulast%3DUmeda%26aufirst%3DN.%26aulast%3DKachi%26aufirst%3DS.%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DYokoi%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDellamary%26aufirst%3DL.%26aulast%3DTam%26aufirst%3DB.%26aulast%3DRacanelli-Layton%26aufirst%3DA.%26aulast%3DHood%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DNoronha%26aufirst%3DG.%26aulast%3DSoll%26aufirst%3DR.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DTopical%2520administration%2520of%2520a%2520multi-targeted%2520kinase%2520inhibitor%2520suppresses%2520choroidal%2520neovascularization%2520and%2520retinal%2520edema.%26jtitle%3DJ.%2520Cell%2520Physiol.%26date%3D2008%26volume%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Verbeke, G.; Molenberghs, G.</span>.  <span class="citation_source-book">Linear Mixed Models for Longitudinal Data</span>; <span class="NLM_publisher-name">Springer-Verlag Inc.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=93-120&author=G.+Verbeke&author=G.+Molenberghs&title=Linear+Mixed+Models+for+Longitudinal+Data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVerbeke%26aufirst%3DG.%26btitle%3DLinear%2520Mixed%2520Models%2520for%2520Longitudinal%2520Data%26pub%3DSpringer-Verlag%2520Inc%26date%3D2000%26spage%3D93%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':[],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':[],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50a','cit50b','cit50c','cit50d'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 29 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kuei-Ju Cheng, Chien-Ming Hsieh, Kunal Nepali, <span class="NLM_string-name hlFld-ContribAuthor">Jing-Ping Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10533-10593. <a href="https://doi.org/10.1021/acs.jmedchem.9b01033" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01033%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOcular%252BDisease%252BTherapeutics%25253A%252BDesign%252Band%252BDelivery%252Bof%252BDrugs%252Bfor%252BDiseases%252Bof%252Bthe%252BEye%26aulast%3DCheng%26aufirst%3DKuei-Ju%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D28062019%26date%3D02062020%26volume%3D63%26issue%3D19%26spage%3D10533%26epage%3D10593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Myunghoe Heo, Bit Lee, Kamakshi Sishtla, Xiang Fei, Sanha Lee, Soojun Park, Yue Yuan, Seul Lee, Sangil Kwon, Jungeun Lee, Sanghee Kim, Timothy W. Corson, <span class="NLM_string-name hlFld-ContribAuthor">Seung-Yong Seo</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis of Homoisoflavanones by Asymmetric Transfer Hydrogenation and Their Biological Evaluation for Antiangiogenic Activity. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (16)
                                     , 9995-10011. <a href="https://doi.org/10.1021/acs.joc.9b01134" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01134%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEnantioselective%252BSynthesis%252Bof%252BHomoisoflavanones%252Bby%252BAsymmetric%252BTransfer%252BHydrogenation%252Band%252BTheir%252BBiological%252BEvaluation%252Bfor%252BAntiangiogenic%252BActivity%26aulast%3DHeo%26aufirst%3DMyunghoe%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24042019%26date%3D05082019%26volume%3D84%26issue%3D16%26spage%3D9995%26epage%3D10011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher M.  Adams</span>, <span class="hlFld-ContribAuthor ">Karen  Anderson</span>, <span class="hlFld-ContribAuthor ">Gerald  Artman, III</span>, <span class="hlFld-ContribAuthor ">Jean-Claude  Bizec</span>, <span class="hlFld-ContribAuthor ">Rosemarie  Cepeda</span>, <span class="hlFld-ContribAuthor ">Jason  Elliott</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Fassbender</span>, <span class="hlFld-ContribAuthor ">Malay  Ghosh</span>, <span class="hlFld-ContribAuthor ">Shawn  Hanks</span>, <span class="hlFld-ContribAuthor ">Leo A.  Hardegger</span>, <span class="hlFld-ContribAuthor ">Vinayak P.  Hosagrahara</span>, <span class="hlFld-ContribAuthor ">Bruce  Jaffee</span>, <span class="hlFld-ContribAuthor ">Keith  Jendza</span>, <span class="hlFld-ContribAuthor ">Nan  Ji</span>, <span class="hlFld-ContribAuthor ">Leland  Johnson</span>, <span class="hlFld-ContribAuthor ">Wendy  Lee</span>, <span class="hlFld-ContribAuthor ">Donglei  Liu</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Debby  Long</span>, <span class="hlFld-ContribAuthor ">Fupeng  Ma</span>, <span class="hlFld-ContribAuthor ">Nello  Mainolfi</span>, <span class="hlFld-ContribAuthor ">Erik L.  Meredith</span>, <span class="hlFld-ContribAuthor ">Karl  Miranda</span>, <span class="hlFld-ContribAuthor ">Yao  Peng</span>, <span class="hlFld-ContribAuthor ">Stephen  Poor</span>, <span class="hlFld-ContribAuthor ">James  Powers</span>, <span class="hlFld-ContribAuthor ">Yubin  Qiu</span>, <span class="hlFld-ContribAuthor ">Chang  Rao</span>, <span class="hlFld-ContribAuthor ">Siyuan  Shen</span>, <span class="hlFld-ContribAuthor ">Jeremy M.  Sivak</span>, <span class="hlFld-ContribAuthor ">Catherine  Solovay</span>, <span class="hlFld-ContribAuthor ">Peter  Tarsa</span>, <span class="hlFld-ContribAuthor ">Amber  Woolfenden</span>, <span class="hlFld-ContribAuthor ">Chun  Zhang</span>, and <span class="hlFld-ContribAuthor ">Yiqin  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (4)
                                     , 1622-1635. <a href="https://doi.org/10.1021/acs.jmedchem.7b01731" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01731%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BN-%2525281-Methyl-5-%252528trifluoromethyl%252529-1H-pyrazol-3-yl%252529-5-%252528%2525286-%252B%252528%252528methylamino%252529methyl%252529pyrimidin-4-yl%252529oxy%252529-1H-indole-1-carboxamide%252B%252528Acrizanib%252529%25252C%252Ba%252BVEGFR-2%252BInhibitor%252BSpecifically%252BDesigned%252Bfor%252BTopical%252BOcular%252BDelivery%25252C%252Bas%252Ba%252BTherapy%252Bfor%252BNeovascular%252BAge-Related%252BMacular%252BDegeneration%26aulast%3DAdams%26aufirst%3DChristopher%2BM.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D28112017%26date%3D05022018%26date%3D22022018%26volume%3D61%26issue%3D4%26spage%3D1622%26epage%3D1635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula  Ruiz-Castillo</span> and <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>  . </span><span class="cited-content_cbyCitation_article-title">Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (19)
                                     , 12564-12649. <a href="https://doi.org/10.1021/acs.chemrev.6b00512" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00512%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DApplications%252Bof%252BPalladium-Catalyzed%252BC%2525E2%252580%252593N%252BCross-Coupling%252BReactions%26aulast%3DRuiz-Castillo%26aufirst%3DPaula%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03082016%26date%3D30092016%26date%3D12102016%26volume%3D116%26issue%3D19%26spage%3D12564%26epage%3D12649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Halesha D.  Basavarajappa</span>, <span class="hlFld-ContribAuthor ">Bit  Lee</span>, <span class="hlFld-ContribAuthor ">Hyungjun  Lee</span>, <span class="hlFld-ContribAuthor ">Rania S.  Sulaiman</span>, <span class="hlFld-ContribAuthor ">Hongchan  An</span>, <span class="hlFld-ContribAuthor ">Carlos  Magaña</span>, <span class="hlFld-ContribAuthor ">Mehdi  Shadmand</span>, <span class="hlFld-ContribAuthor ">Alexandra  Vayl</span>, <span class="hlFld-ContribAuthor ">Gangaraju  Rajashekhar</span>, <span class="hlFld-ContribAuthor ">Eun-Yeong  Kim</span>, <span class="hlFld-ContribAuthor ">Young-Ger  Suh</span>, <span class="hlFld-ContribAuthor ">Kiho  Lee</span>, <span class="hlFld-ContribAuthor ">Seung-Yong  Seo</span>, and <span class="hlFld-ContribAuthor ">Timothy W.  Corson</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (12)
                                     , 5015-5027. <a href="https://doi.org/10.1021/acs.jmedchem.5b00449" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00449%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BHomoisoflavonoids%252Bfor%252BRetinal%252BNeovascularization%26aulast%3DBasavarajappa%26aufirst%3DHalesha%2BD.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D11032015%26date%3D16062015%26date%3D25062015%26date%3D02062015%26volume%3D58%26issue%3D12%26spage%3D5015%26epage%3D5027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincent  Gasparik</span>, <span class="hlFld-ContribAuthor ">François  Daubeuf</span>, <span class="hlFld-ContribAuthor ">Muriel  Hachet-Haas</span>, <span class="hlFld-ContribAuthor ">François  Rohmer</span>, <span class="hlFld-ContribAuthor ">Patrick  Gizzi</span>, <span class="hlFld-ContribAuthor ">Jacques  Haiech</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Galzi</span>, <span class="hlFld-ContribAuthor ">Marcel  Hibert</span>, <span class="hlFld-ContribAuthor ">Dominique  Bonnet</span>, and <span class="hlFld-ContribAuthor ">Nelly  Frossard</span>  . </span><span class="cited-content_cbyCitation_article-title">Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (1)
                                     , 10-14. <a href="https://doi.org/10.1021/ml200017d" title="DOI URL">https://doi.org/10.1021/ml200017d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml200017d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml200017d%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DProdrugs%252Bof%252Ba%252BCXC%252BChemokine-12%252B%252528CXCL12%252529%252BNeutraligand%252BPrevent%252BInflammatory%252BReactions%252Bin%252Ban%252BAsthma%252BModel%252Bin%252BVivo%26aulast%3DGasparik%26aufirst%3DVincent%26date%3D2012%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D21042011%26date%3D09122011%26date%3D16122011%26date%3D12012012%26date%3D09122011%26volume%3D3%26issue%3D1%26spage%3D10%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lifeng  Ding</span>, <span class="hlFld-ContribAuthor ">Chongyan  Chen</span>, <span class="hlFld-ContribAuthor ">Qiang  Li</span>, <span class="hlFld-ContribAuthor ">Jinxia  Yuan</span>, <span class="hlFld-ContribAuthor ">Hongdao  Li</span>, <span class="hlFld-ContribAuthor ">Yanfeng  Xue</span>, <span class="hlFld-ContribAuthor ">Hongmei  Dong</span>, <span class="hlFld-ContribAuthor ">Baoyi  Li</span>, <span class="hlFld-ContribAuthor ">Yulan  Niu</span>. </span><span class="cited-content_cbyCitation_article-title">Process and theoretical research on electroplating Cu–Sn alloys of low Sn. </span><span class="cited-content_cbyCitation_journal-name">Journal of Applied Electrochemistry</span><span> <strong>2021,</strong> <em>51 </em>
                                    (9)
                                     , 1287-1299. <a href="https://doi.org/10.1007/s10800-021-01584-8" title="DOI URL">https://doi.org/10.1007/s10800-021-01584-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10800-021-01584-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10800-021-01584-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Applied%2520Electrochemistry%26atitle%3DProcess%252Band%252Btheoretical%252Bresearch%252Bon%252Belectroplating%252BCu%2525E2%252580%252593Sn%252Balloys%252Bof%252Blow%252BSn%26aulast%3DDing%26aufirst%3DLifeng%26date%3D2021%26date%3D2021%26volume%3D51%26issue%3D9%26spage%3D1287%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José Antonio  Encinar</span>, <span class="hlFld-ContribAuthor ">Javier A.  Menendez</span>. </span><span class="cited-content_cbyCitation_article-title">Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2’-O-Methylation of Viral RNA. </span><span class="cited-content_cbyCitation_journal-name">Viruses</span><span> <strong>2020,</strong> <em>12 </em>
                                    (5)
                                     , 525. <a href="https://doi.org/10.3390/v12050525" title="DOI URL">https://doi.org/10.3390/v12050525</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/v12050525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fv12050525%26sid%3Dliteratum%253Aachs%26jtitle%3DViruses%26atitle%3DPotential%252BDrugs%252BTargeting%252BEarly%252BInnate%252BImmune%252BEvasion%252Bof%252BSARS-Coronavirus%252B2%252Bvia%252B2%2525E2%252580%252599-O-Methylation%252Bof%252BViral%252BRNA%26aulast%3DEncinar%26aufirst%3DJos%25C3%25A9%2BAntonio%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D5%26spage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Cheng</span>, <span class="hlFld-ContribAuthor ">Lifeng  Ding</span>, <span class="hlFld-ContribAuthor ">Qiang  Li</span>, <span class="hlFld-ContribAuthor ">Chongyan  Chen</span>, <span class="hlFld-ContribAuthor ">Ruonan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiangpeng  Kong</span>, <span class="hlFld-ContribAuthor ">Zhengwei  Song</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Zhao</span>, <span class="hlFld-ContribAuthor ">Yulan  Niu</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of hydroxyl-containing additives on the codeposition of Cu–Zn–Sn alloys. </span><span class="cited-content_cbyCitation_journal-name">Journal of Applied Electrochemistry</span><span> <strong>2020,</strong> <em>50 </em>
                                    (4)
                                     , 475-488. <a href="https://doi.org/10.1007/s10800-020-01405-4" title="DOI URL">https://doi.org/10.1007/s10800-020-01405-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10800-020-01405-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10800-020-01405-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Applied%2520Electrochemistry%26atitle%3DEffect%252Bof%252Bhydroxyl-containing%252Badditives%252Bon%252Bthe%252Bcodeposition%252Bof%252BCu%2525E2%252580%252593Zn%2525E2%252580%252593Sn%252Balloys%26aulast%3DCheng%26aufirst%3DJun%26date%3D2020%26date%3D2020%26volume%3D50%26issue%3D4%26spage%3D475%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parveen  Bansal</span>, <span class="hlFld-ContribAuthor ">Malika  Arora</span>. </span><span class="cited-content_cbyCitation_article-title">Small Interfering RNAs and RNA Therapeutics in Cardiovascular Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 369-381. <a href="https://doi.org/10.1007/978-981-15-1671-9_23" title="DOI URL">https://doi.org/10.1007/978-981-15-1671-9_23</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-15-1671-9_23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-15-1671-9_23%26sid%3Dliteratum%253Aachs%26atitle%3DSmall%252BInterfering%252BRNAs%252Band%252BRNA%252BTherapeutics%252Bin%252BCardiovascular%252BDiseases%26aulast%3DBansal%26aufirst%3DParveen%26date%3D2020%26date%3D2020%26spage%3D369%26epage%3D381%26pub%3DSpringer%2520Singapore%26atitle%3DNon-coding%252BRNAs%252Bin%252BCardiovascular%252BDiseases%26aulast%3DXiao%26aufirst%3DJunjie%26date%3D2020%26volume%3D1229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Raggi</span>, <span class="hlFld-ContribAuthor ">Karim  Fiaccadori</span>, <span class="hlFld-ContribAuthor ">Mirella  Pastore</span>, <span class="hlFld-ContribAuthor ">Margherita  Correnti</span>, <span class="hlFld-ContribAuthor ">Benedetta  Piombanti</span>, <span class="hlFld-ContribAuthor ">Elisa  Forti</span>, <span class="hlFld-ContribAuthor ">Nadia  Navari</span>, <span class="hlFld-ContribAuthor ">Giovanni  Abbadessa</span>, <span class="hlFld-ContribAuthor ">Terence  Hall</span>, <span class="hlFld-ContribAuthor ">Annarita  Destro</span>, <span class="hlFld-ContribAuthor ">Luca  Di Tommaso</span>, <span class="hlFld-ContribAuthor ">Massimo  Roncalli</span>, <span class="hlFld-ContribAuthor ">Fanyin  Meng</span>, <span class="hlFld-ContribAuthor ">Shannon  Glaser</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Rovida</span>, <span class="hlFld-ContribAuthor ">Caterina  Peraldo-Neia</span>, <span class="hlFld-ContribAuthor ">Paula  Olaizola</span>, <span class="hlFld-ContribAuthor ">Jesus M.  Banales</span>, <span class="hlFld-ContribAuthor ">Alessio  Gerussi</span>, <span class="hlFld-ContribAuthor ">Alessandra  Elvevi</span>, <span class="hlFld-ContribAuthor ">Michele  Droz dit Busset</span>, <span class="hlFld-ContribAuthor ">Sherrie  Bhoori</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Mazzaferro</span>, <span class="hlFld-ContribAuthor ">Gianfranco  Alpini</span>, <span class="hlFld-ContribAuthor ">Fabio  Marra</span>, <span class="hlFld-ContribAuthor ">Pietro  Invernizzi</span>. </span><span class="cited-content_cbyCitation_article-title">Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma. </span><span class="cited-content_cbyCitation_journal-name">The American Journal of Pathology</span><span> <strong>2019,</strong> <em>189 </em>
                                    (10)
                                     , 2090-2101. <a href="https://doi.org/10.1016/j.ajpath.2019.06.007" title="DOI URL">https://doi.org/10.1016/j.ajpath.2019.06.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ajpath.2019.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ajpath.2019.06.007%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520American%2520Journal%2520of%2520Pathology%26atitle%3DAntitumor%252BActivity%252Bof%252Ba%252BNovel%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252BInhibitor%252Bfor%252BIntrahepatic%252BCholangiocarcinoma%26aulast%3DRaggi%26aufirst%3DChiara%26date%3D2019%26volume%3D189%26issue%3D10%26spage%3D2090%26epage%3D2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nazia  Ikram</span>, <span class="hlFld-ContribAuthor ">Muhammad Usman  Mirza</span>, <span class="hlFld-ContribAuthor ">Michiel  Vanmeert</span>, <span class="hlFld-ContribAuthor ">Matheus  Froeyen</span>, <span class="hlFld-ContribAuthor ">Outi M. H.  Salo-Ahen</span>, <span class="hlFld-ContribAuthor ">Muhammad  Tahir</span>, <span class="hlFld-ContribAuthor ">Aamer  Qazi</span>, <span class="hlFld-ContribAuthor ">Sarfraz  Ahmad</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Oncogenic Kinases: An In Vitro Validated Computational Approach Identified Potential Multi-Target Anticancer Compounds. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2019,</strong> <em>9 </em>
                                    (4)
                                     , 124. <a href="https://doi.org/10.3390/biom9040124" title="DOI URL">https://doi.org/10.3390/biom9040124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom9040124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom9040124%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DInhibition%252Bof%252BOncogenic%252BKinases%25253A%252BAn%252BIn%252BVitro%252BValidated%252BComputational%252BApproach%252BIdentified%252BPotential%252BMulti-Target%252BAnticancer%252BCompounds%26aulast%3DIkram%26aufirst%3DNazia%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D4%26spage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandrasekaran  Ramakrishnan</span>, <span class="hlFld-ContribAuthor ">Anthony  Mary Thangakani</span>, <span class="hlFld-ContribAuthor ">Devadasan  Velmurugan</span>, <span class="hlFld-ContribAuthor ">Dhanabalan  Anantha Krishnan</span>, <span class="hlFld-ContribAuthor ">Masakazu  Sekijima</span>, <span class="hlFld-ContribAuthor ">Yutaka  Akiyama</span>, <span class="hlFld-ContribAuthor ">M. Michael  Gromiha</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of type I and type II inhibitors of c-Yes kinase using
              in silico
              and experimental techniques. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2018,</strong> <em>36 </em>
                                    (6)
                                     , 1566-1576. <a href="https://doi.org/10.1080/07391102.2017.1329098" title="DOI URL">https://doi.org/10.1080/07391102.2017.1329098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2017.1329098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2017.1329098%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIdentification%252Bof%252Btype%252BI%252Band%252Btype%252BII%252Binhibitors%252Bof%252Bc-Yes%252Bkinase%252Busing%252Bin%252Bsilico%252Band%252Bexperimental%252Btechniques%26aulast%3DRamakrishnan%26aufirst%3DChandrasekaran%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D6%26spage%3D1566%26epage%3D1576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sepehr  Feizi</span>, <span class="hlFld-ContribAuthor ">Amir A.  Azari</span>, <span class="hlFld-ContribAuthor ">Sharareh  Safapour</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic approaches for corneal neovascularization. </span><span class="cited-content_cbyCitation_journal-name">Eye and Vision</span><span> <strong>2017,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40662-017-0094-6" title="DOI URL">https://doi.org/10.1186/s40662-017-0094-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40662-017-0094-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40662-017-0094-6%26sid%3Dliteratum%253Aachs%26jtitle%3DEye%2520and%2520Vision%26atitle%3DTherapeutic%252Bapproaches%252Bfor%252Bcorneal%252Bneovascularization%26aulast%3DFeizi%26aufirst%3DSepehr%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pranjal  Taskar</span>, <span class="hlFld-ContribAuthor ">Akshaya  Tatke</span>, <span class="hlFld-ContribAuthor ">Soumyajit  Majumdar</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the use of prodrugs for drug delivery to the eye. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Delivery</span><span> <strong>2017,</strong> <em>14 </em>
                                    (1)
                                     , 49-63. <a href="https://doi.org/10.1080/17425247.2016.1208649" title="DOI URL">https://doi.org/10.1080/17425247.2016.1208649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17425247.2016.1208649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17425247.2016.1208649%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Delivery%26atitle%3DAdvances%252Bin%252Bthe%252Buse%252Bof%252Bprodrugs%252Bfor%252Bdrug%252Bdelivery%252Bto%252Bthe%252Beye%26aulast%3DTaskar%26aufirst%3DPranjal%26date%3D2017%26date%3D2016%26volume%3D14%26issue%3D1%26spage%3D49%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amany M.  Ghanim</span>, <span class="hlFld-ContribAuthor ">David W.  Knight</span>, <span class="hlFld-ContribAuthor ">Nermine A.  Osman</span>, <span class="hlFld-ContribAuthor ">Hanan A.  Abdel-Fattah</span>, <span class="hlFld-ContribAuthor ">Azza M.  Kadry</span>. </span><span class="cited-content_cbyCitation_article-title">New methods for the selective alkylation of 3-thioxo-1,2,4-triazin-5-ones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (21)
                                     , 2215-2218. <a href="https://doi.org/10.1016/j.tetlet.2016.03.065" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.03.065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.03.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.03.065%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DNew%252Bmethods%252Bfor%252Bthe%252Bselective%252Balkylation%252Bof%252B3-thioxo-1%25252C2%25252C4-triazin-5-ones%26aulast%3DGhanim%26aufirst%3DAmany%2BM.%26date%3D2016%26volume%3D57%26issue%3D21%26spage%3D2215%26epage%3D2218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atul  Kumar</span>, <span class="hlFld-ContribAuthor ">S. N.  Mohanraj</span>, <span class="hlFld-ContribAuthor ">Kavitha  Duraipandi</span>, <span class="hlFld-ContribAuthor ">Anuradha V.  Pai</span>. </span><span class="cited-content_cbyCitation_article-title">Antiangiogenic Agents and Photodynamic Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 245-268. <a href="https://doi.org/10.1007/978-3-319-25498-2_9" title="DOI URL">https://doi.org/10.1007/978-3-319-25498-2_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-25498-2_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-25498-2_9%26sid%3Dliteratum%253Aachs%26atitle%3DAntiangiogenic%252BAgents%252Band%252BPhotodynamic%252BTherapy%26aulast%3DKumar%26aufirst%3DAtul%26date%3D2016%26date%3D2016%26spage%3D245%26epage%3D268%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPharmacology%252Bof%252BOcular%252BTherapeutics%26aulast%3DVelpandian%26aufirst%3DThirumurthy%26date%3D2016%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew C.T.  Fyfe</span>. </span><span class="cited-content_cbyCitation_article-title">Non-systemic Intestine-Targeted Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 1-44. <a href="https://doi.org/10.1016/bs.pmch.2015.10.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2015.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2015.10.001%26sid%3Dliteratum%253Aachs%26atitle%3DNon-systemic%252BIntestine-Targeted%252BDrugs%26aulast%3DFyfe%26aufirst%3DMatthew%2BC.T.%26date%3D2016%26spage%3D1%26epage%3D44%26pub%3DElsevier%26date%3D2016%26volume%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anton M.  Kolomeyer</span>, <span class="hlFld-ContribAuthor ">Marco A.  Zarbin</span>. </span><span class="cited-content_cbyCitation_article-title">Trophic factors in the pathogenesis and therapy for retinal degenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">Survey of Ophthalmology</span><span> <strong>2014,</strong> <em>59 </em>
                                    (2)
                                     , 134-165. <a href="https://doi.org/10.1016/j.survophthal.2013.09.004" title="DOI URL">https://doi.org/10.1016/j.survophthal.2013.09.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.survophthal.2013.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.survophthal.2013.09.004%26sid%3Dliteratum%253Aachs%26jtitle%3DSurvey%2520of%2520Ophthalmology%26atitle%3DTrophic%252Bfactors%252Bin%252Bthe%252Bpathogenesis%252Band%252Btherapy%252Bfor%252Bretinal%252Bdegenerative%252Bdiseases%26aulast%3DKolomeyer%26aufirst%3DAnton%2BM.%26date%3D2014%26volume%3D59%26issue%3D2%26spage%3D134%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.  Ramakrishnan</span>, <span class="hlFld-ContribAuthor ">A. M.  Thangakani</span>, <span class="hlFld-ContribAuthor ">D.  Velmurugan</span>, <span class="hlFld-ContribAuthor ">M. Michael  Gromiha</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel c-Yes Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 494-500. <a href="https://doi.org/10.1007/978-3-319-09330-7_57" title="DOI URL">https://doi.org/10.1007/978-3-319-09330-7_57</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-09330-7_57&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-09330-7_57%26sid%3Dliteratum%253Aachs%26atitle%3DIdentification%252Bof%252BNovel%252Bc-Yes%252BKinase%252BInhibitors%26aulast%3DRamakrishnan%26aufirst%3DC.%26date%3D2014%26spage%3D494%26epage%3D500%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DIntelligent%252BComputing%252Bin%252BBioinformatics%26aulast%3DHuang%26aufirst%3DDe-Shuang%26date%3D2014%26volume%3D8590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muneto  Mogi</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Adams</span>, <span class="hlFld-ContribAuthor ">Nan  Ji</span>, <span class="hlFld-ContribAuthor ">Nello  Mainolfi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in Small-Molecule Agents Against Age-Related Macular Degeneration. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 353-369. <a href="https://doi.org/10.1016/B978-0-12-417150-3.00022-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-417150-3.00022-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417150-3.00022-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417150-3.00022-3%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BProgress%252Bin%252BSmall-Molecule%252BAgents%252BAgainst%252BAge-Related%252BMacular%252BDegeneration%26aulast%3DMogi%26aufirst%3DMuneto%26date%3D2013%26spage%3D353%26epage%3D369%26pub%3DElsevier%26date%3D2013%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kang  Zhang</span>, <span class="hlFld-ContribAuthor ">Liangfang  Zhang</span>, <span class="hlFld-ContribAuthor ">Robert N.  Weinreb</span>. </span><span class="cited-content_cbyCitation_article-title">Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2012,</strong> <em>11 </em>
                                    (7)
                                     , 541-559. <a href="https://doi.org/10.1038/nrd3745" title="DOI URL">https://doi.org/10.1038/nrd3745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd3745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd3745%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DOphthalmic%252Bdrug%252Bdiscovery%25253A%252Bnovel%252Btargets%252Band%252Bmechanisms%252Bfor%252Bretinal%252Bdiseases%252Band%252Bglaucoma%26aulast%3DZhang%26aufirst%3DKang%26date%3D2012%26date%3D2012%26volume%3D11%26issue%3D7%26spage%3D541%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Surekha  Maddula</span>, <span class="hlFld-ContribAuthor ">Don K.  Davis</span>, <span class="hlFld-ContribAuthor ">Soumya  Maddula</span>, <span class="hlFld-ContribAuthor ">Michael K.  Burrow</span>, <span class="hlFld-ContribAuthor ">Balamurali K.  Ambati</span>. </span><span class="cited-content_cbyCitation_article-title">Horizons in Therapy for Corneal Angiogenesis. </span><span class="cited-content_cbyCitation_journal-name">Ophthalmology</span><span> <strong>2011,</strong> <em>118 </em>
                                    (3)
                                     , 591-599. <a href="https://doi.org/10.1016/j.ophtha.2011.01.041" title="DOI URL">https://doi.org/10.1016/j.ophtha.2011.01.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ophtha.2011.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ophtha.2011.01.041%26sid%3Dliteratum%253Aachs%26jtitle%3DOphthalmology%26atitle%3DHorizons%252Bin%252BTherapy%252Bfor%252BCorneal%252BAngiogenesis%26aulast%3DMaddula%26aufirst%3DSurekha%26date%3D2011%26volume%3D118%26issue%3D3%26spage%3D591%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Gadek</span>, <span class="hlFld-ContribAuthor ">Dennis  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Topical Drug Delivery to the Back of the Eye. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 111-124. <a href="https://doi.org/10.1007/978-1-4419-9920-7_5" title="DOI URL">https://doi.org/10.1007/978-1-4419-9920-7_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4419-9920-7_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4419-9920-7_5%26sid%3Dliteratum%253Aachs%26atitle%3DTopical%252BDrug%252BDelivery%252Bto%252Bthe%252BBack%252Bof%252Bthe%252BEye%26aulast%3DGadek%26aufirst%3DThomas%26date%3D2011%26date%3D2011%26spage%3D111%26epage%3D124%26pub%3DSpringer%2520US%26atitle%3DDrug%252BProduct%252BDevelopment%252Bfor%252Bthe%252BBack%252Bof%252Bthe%252BEye%26aulast%3DKompella%26aufirst%3DUday%2BB.%26date%3D2011%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adriana  Albini</span>, <span class="hlFld-ContribAuthor ">Stefano  Indraccolo</span>, <span class="hlFld-ContribAuthor ">Douglas M.  Noonan</span>, <span class="hlFld-ContribAuthor ">Ulrich  Pfeffer</span>. </span><span class="cited-content_cbyCitation_article-title">Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs. </span><span class="cited-content_cbyCitation_journal-name">Clinical & Experimental Metastasis</span><span> <strong>2010,</strong> <em>27 </em>
                                    (6)
                                     , 419-439. <a href="https://doi.org/10.1007/s10585-010-9312-5" title="DOI URL">https://doi.org/10.1007/s10585-010-9312-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10585-010-9312-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10585-010-9312-5%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520%2526%2520Experimental%2520Metastasis%26atitle%3DFunctional%252Bgenomics%252Bof%252Bendothelial%252Bcells%252Btreated%252Bwith%252Banti-angiogenic%252Bor%252Bangiopreventive%252Bdrugs%26aulast%3DAlbini%26aufirst%3DAdriana%26date%3D2010%26date%3D2010%26volume%3D27%26issue%3D6%26spage%3D419%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Klimko Peter  Gerard</span>. </span><span class="cited-content_cbyCitation_article-title">Ophthalmic Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 569-618. <a href="https://doi.org/10.1002/0471266949.bmc199" title="DOI URL">https://doi.org/10.1002/0471266949.bmc199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc199%26sid%3Dliteratum%253Aachs%26atitle%3DOphthalmic%252BAgents%26aulast%3DGerard%26aufirst%3DKlimko%2BPeter%26date%3D2010%26date%3D2010%26spage%3D569%26epage%3D618%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott E.  Denmark</span>, <span class="hlFld-ContribAuthor ">Russell C.  Smith</span>, <span class="hlFld-ContribAuthor ">Wen-Tau T.  Chang</span>, <span class="hlFld-ContribAuthor ">Joseck M.  Muhuhi</span>. </span><span class="cited-content_cbyCitation_article-title">Cross-Coupling Reactions of Aromatic and Heteroaromatic Silanolates with Aromatic and Heteroaromatic Halides. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2009,</strong> <em>131 </em>
                                    (8)
                                     , 3104-3118. <a href="https://doi.org/10.1021/ja8091449" title="DOI URL">https://doi.org/10.1021/ja8091449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja8091449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja8091449%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DCross-Coupling%252BReactions%252Bof%252BAromatic%252Band%252BHeteroaromatic%252BSilanolates%252Bwith%252BAromatic%252Band%252BHeteroaromatic%252BHalides%26aulast%3DDenmark%26aufirst%3DScott%2BE.%26date%3D2009%26date%3D2009%26volume%3D131%26issue%3D8%26spage%3D3104%26epage%3D3118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moorthy SS  Palanki</span>, <span class="hlFld-ContribAuthor ">Jianguo  Cao</span>, <span class="hlFld-ContribAuthor ">Chun P  Chow</span>, <span class="hlFld-ContribAuthor ">Elena  Dneprovskaia</span>, <span class="hlFld-ContribAuthor ">Chi Ching  Mak</span>, <span class="hlFld-ContribAuthor ">Andrew  McPherson</span>, <span class="hlFld-ContribAuthor ">Ved P  Pathak</span>, <span class="hlFld-ContribAuthor ">Joel  Renick</span>, <span class="hlFld-ContribAuthor ">Richard  Soll</span>, <span class="hlFld-ContribAuthor ">Binqi  Zeng</span>, <span class="hlFld-ContribAuthor ">Glenn  Noronha</span>. </span><span class="cited-content_cbyCitation_article-title">Development of novel benzotriazines for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2009,</strong> <em>4 </em>
                                    (1)
                                     , 33-49. <a href="https://doi.org/10.1517/17460440802580536" title="DOI URL">https://doi.org/10.1517/17460440802580536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460440802580536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460440802580536%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DDevelopment%252Bof%252Bnovel%252Bbenzotriazines%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DPalanki%26aufirst%3DMoorthy%2BSS%26date%3D2009%26date%3D2008%26volume%3D4%26issue%3D1%26spage%3D33%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M  Slevin</span>, <span class="hlFld-ContribAuthor ">P  Kumar</span>, <span class="hlFld-ContribAuthor ">Quiyu  Wang</span>, <span class="hlFld-ContribAuthor ">S  Kumar</span>, <span class="hlFld-ContribAuthor ">J  Gaffney</span>, <span class="hlFld-ContribAuthor ">M  Grau-Olivares</span>, <span class="hlFld-ContribAuthor ">J  Krupinski</span>. </span><span class="cited-content_cbyCitation_article-title">New VEGF antagonists as possible therapeutic agents in vascular disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2008,</strong> <em>17 </em>
                                    (9)
                                     , 1301-1314. <a href="https://doi.org/10.1517/13543784.17.9.1301" title="DOI URL">https://doi.org/10.1517/13543784.17.9.1301</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.17.9.1301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.17.9.1301%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DNew%252BVEGF%252Bantagonists%252Bas%252Bpossible%252Btherapeutic%252Bagents%252Bin%252Bvascular%252Bdisease%26aulast%3DSlevin%26aufirst%3DM%26date%3D2008%26date%3D2008%26volume%3D17%26issue%3D9%26spage%3D1301%26epage%3D1314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/medium/jm-2007-011276_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011276&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/medium/jm-2007-011276_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0001.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011276&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) NH<sub>2</sub>CN, pyridine HCl, 100 °C, 12 h; (ii) 30% aqueous NaOH, 100 °C, 2 h; (b) 10% Raney nickel, H<sub>2</sub>, EtOH, room temp, 12 h; (c) R<sup>1</sup>B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME/EtOH/H<sub>2</sub>O, reflux, 12 h; (d) Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, reflux, 12 h; (e) BBr<sub>3</sub>, DCM, 0 °C to room temp; (f) Pd(OAc)<sub>2</sub>, Xantphos, K<sup>+</sup><i>t</i>-BuO<sup>−</sup>, dioxane, reflux, 12 h.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/medium/jm-2007-011276_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0002.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011276&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) RCl, Et<sub>3</sub>N, DCM, room temp; (b) (i) POCl<sub>3</sub>, Et<sub>3</sub>N, DCM, room temp; (ii) NaHCO<sub>3</sub>, room temp; (c) (i) <i>tert</i>-butoxycarbonylaminoacetic acid, EDCI, DMAP, DMF, room temp; (ii) 5% TFA/DCM, room temp; (d) 4-(morpholin-4-ylmethyl)benzoic acid, EDCI, DMAP, DMF, room temp.</p></p></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/medium/jm-2007-011276_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Compound <b>2</b> at the ATP pocket of Src. The Glu310 from αC-helix is in proximity to the 7-phenyl ring. (B) Compound <b>2</b> at the ATP pocket of VEGFr2. The Glu885 from the αC-helix is in proximity to the 7-phenyl ring. (C) Compound <b>5</b> at the ATP pocket of Src. (D) Compound <b>5</b> at the ATP pocket of VEGFr2. The molecular surface is colored according to the hydrophobicity of the surrounding residues; blue is hydrophilic, and red is hydrophobic. The hydroxyl group of <b>5</b> acts as hydrogen bond donor and interacts with Glu310 in Src (C). The binding orientation of <b>5</b> in the VEGFr pocket is very similar to that of <b>5</b> in Src (D). There are two hydrogen bond interactions between the benzotriazine ring and Cys919 that serves as the hinge. The hydroxyl group on <b>5</b> acts as hydrogen bond donor and interacts with Glu885.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011276&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/medium/jm-2007-011276_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Topical administration of <b>12</b> inhibits laser-induced choroidal neovascularization: (A) Representative image of rupture site treated with 0.61% w/v of <b>12</b>;<b></b> (B) representative image of rupture site treated with 1.83% w/v of <b>12</b>; (C) representative image of rupture site treated with vehicle; (D) representative image of rupture site untreated; (E) choroidal neovascularization area vs treatment with different concentrations of <b>12</b> and controls. Topical administration of <b>12</b> reduced laser-induced choroidal neovascularization: 23 eyes/group; (∗) <i>p</i> = 0.0001, 0.61% <b>12</b> vs no treatment; (†) <i>p</i> = 0.0427, 0.61% <b>12</b> vs vehicle; (∗∗) <i>p</i> = 0.0063, 1.83% <b>12</b> vs no treatment. The data were analyzed by linear mixed model with the Dunnett method used to adjust for multiple comparisons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7011276/production/images/large/jm-2007-011276_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7011276&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61100" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61100" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 59 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">De Jong, P. T.</span><span> </span><span class="NLM_article-title">Age-related macular degeneration</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1474</span><span class="NLM_x">–</span> <span class="NLM_lpage">1485</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1056%2FNEJMra062326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=17021323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGgtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1474-1485&author=P.+T.+De+Jong&title=Age-related+macular+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: Age-related macular degeneration</span></div><div class="casAuthors">de Jong, Paulus T. V. M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1474-1485</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  SINCE 1874, WHEN IT WAS FIRST DESCRIBED IN THE MEDICAL LITERATURE AS "sym. central choroidoretinal disease occurring in senile persons," age-related macular degeneration has also been referred to as senile, or diski-form, macular degeneration, among many other terms.  About 25 years ago, the term "age-related maculopathy" was coined and its end stage was acknowledged as age-related macular degeneration.  In this review, the author use the commonly accepted age-related macular degeneration, although the author have reservations about its appropriateness.  Topics discussed include: the outer retina and adjacent tissues; the retinal-pigment epithelium; Phagocytosis by RPE cells; Bruch's membrane; Ruysch's complex; genetics; smoking; light-induced toxic effects; and converging risk factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8AFwko1o2qbVg90H21EOLACvtfcHk0lh8NEarFjw7Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGgtrjM&md5=498f520dd9e50616700812f7e648a9fd</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJMra062326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra062326%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BJong%26aufirst%3DP.%2BT.%26atitle%3DAge-related%2520macular%2520degeneration%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1474%26epage%3D1485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Rattner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathans, J.</span><span> </span><span class="NLM_article-title">Macular degeneration: recent advances and therapeutic opportunities</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">860</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1038%2Fnrn2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=17033682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFShtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=860-872&author=A.+Rattnerauthor=J.+Nathans&title=Macular+degeneration%3A+recent+advances+and+therapeutic+opportunities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Macular degeneration: recent advances and therapeutic opportunities</span></div><div class="casAuthors">Rattner, Amir; Nathans, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">860-872</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The central retina mediates high acuity vision, and its progressive dysfunction due to macular degeneration is the leading cause of visual disability among adults in industrialized societies.  A summary of recent progress in understanding the pathophysiol. of macular degeneration is given, and the implications of this new knowledge for treatment and prevention are discussed.  The past decade has witnessed remarkable advances in this field, including the development of new, noninvasive retinal imaging technologies, the development of animal models for macular disease, and the isolation of many of the genes responsible for both early- and late-onset macular diseases.  These advances have set the stage for the development of effective mechanism-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq03vnpUksgkbVg90H21EOLACvtfcHk0lh8NEarFjw7Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFShtrnL&md5=c818a393a17d8926426b8a14cac34594</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrn2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2007%26sid%3Dliteratum%253Aachs%26aulast%3DRattner%26aufirst%3DA.%26aulast%3DNathans%26aufirst%3DJ.%26atitle%3DMacular%2520degeneration%253A%2520recent%2520advances%2520and%2520therapeutic%2520opportunities%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D860%26epage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Shweiki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshet, E.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1992&pages=843-845&author=D.+Shweikiauthor=A.+Itinauthor=D.+Sofferauthor=E.+Keshet&title=Vascular+endothelial+growth+factor+induced+by+hypoxia+may+mediate+hypoxia-initiated+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShweiki%26aufirst%3DD.%26aulast%3DItin%26aufirst%3DA.%26aulast%3DSoffer%26aufirst%3DD.%26aulast%3DKeshet%26aufirst%3DE.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520induced%2520by%2520hypoxia%2520may%2520mediate%2520hypoxia-initiated%2520angiogenesis%26jtitle%3DNature%26date%3D1992%26volume%3D359%26spage%3D843%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Forsythe, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koos, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenza, G. L.</span><span> </span><span class="NLM_article-title">**Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4604</span><span class="NLM_x">–</span> <span class="NLM_lpage">4613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=8756616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADyaK28XltFKjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=4604-4613&author=J.+A.+Forsytheauthor=B.+H.+Jiangauthor=N.+V.+Iyerauthor=A.+Fatonauthor=S.+W.+Leungauthor=R.+D.+Koosauthor=G.+L.+Semenza&title=**Activation+of+vascular+endothelial+growth+factor+gene+transcription+by+hypoxia-inducible+factor+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1</span></div><div class="casAuthors">Forsythe, Jo A.; Jiang, Bing-Hua; Iyer, Narayan V.; Agani, Faton; Leung, Sandra W.; Koos, Robert D.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4604-4613</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Expression of vascular endothelial growth factor (VEGF) is induced in cells exposed to hypoxia or ischemia.  Neovascularization stimulated by VEGF occurs in severals important clin. contexts, including myocardial ischemia, retinal disease, and tumor growth.  Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric basic helix-loop-helix protein that activates transcription of the human erythropoietin gene in hypoxic cells.  Here we demonstrate the involvement of HIF-1 in the activation of VEGF transcription.  VEGF 5'-flanking sequences mediated transcriptional activation of reporter gene expression in hypoxic Hep3B cells.  A 47-bp sequence located 985 to 939 bp 5' to the VEGF transcription initiation site mediated hypoxia-inducible reporter gene expression directed by a simian virus 40 promoter element that was otherwise minimally responsive to hypoxia.  When reporters contg. VEGF sequences, in the context of the native VEGF or heterologous simian virus 40 promoter, were cotransfected with expression vectors encoding HIF-1α and HIF-1β (ARNT [aryl hydrocarbon receptor nuclear translocator]), reporter gene transcription was much greater in both hypoxic and nonhypoxic cells than in cells transfected with the reporter alone.  A HIF-1 binding site was demonstrated in the 47-bp hypoxia response element, and a 3-bp substitution eliminated the ability of the element to bind HIF-1 and to activate transcription in response to hypoxia and/or recombinant HIF-1.  Cotransfection of cells with an expression vector encoding a dominant neg. form of HIF-1α inhibited the activation of reporter transcription in hypoxic cells in a dose-dependent manner.  VEGF mRNA was not induced by hypoxia in mutant cells that do not express the HIF-1β (ARNT) subunit.  These findings implicate HIF-1 in the activation of VEGF transcription in hypoxic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWR5k0flrm27Vg90H21EOLACvtfcHk0lgyAHRuub_clw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltFKjsrc%253D&md5=d699f194fc5edae7b2b6a5ce97359808</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForsythe%26aufirst%3DJ.%2BA.%26aulast%3DJiang%26aufirst%3DB.%2BH.%26aulast%3DIyer%26aufirst%3DN.%2BV.%26aulast%3DFaton%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DS.%2BW.%26aulast%3DKoos%26aufirst%3DR.%2BD.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3D%252A%252AActivation%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520gene%2520transcription%2520by%2520hypoxia-inducible%2520factor%25201%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D4604%26epage%3D4613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Aiello, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigg, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keyt, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jampel, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquale, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieme, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, G. L.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">1480</span><span class="NLM_x">–</span> <span class="NLM_lpage">1487</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1056%2FNEJM199412013312203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=7526212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADyaK2M%252FlvFamsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1994&pages=1480-1487&author=L.+P.+Aielloauthor=R.+L.+Averyauthor=P.+G.+Arriggauthor=B.+A.+Keytauthor=H.+D.+Jampelauthor=S.+T.+Shahauthor=L.+R.+Pasqualeauthor=H.+Thiemeauthor=M.+A.+Iwamotoauthor=J.+E.+Parkauthor=H.+V.+Nguyenauthor=L.+M.+Aielloauthor=N.+Ferraraauthor=G.+L.+King&title=Vascular+endothelial+growth+factor+in+ocular+fluid+of+patients+with+diabetic+retinopathy+and+other+retinal+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders</span></div><div class="casAuthors">Aiello L P; Avery R L; Arrigg P G; Keyt B A; Jampel H D; Shah S T; Pasquale L R; Thieme H; Iwamoto M A; Park J E</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1480-7</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Retinal ischemia induces intraocular neovascularization, which often leads to glaucoma, vitreous hemorrhage, and retinal detachment, presumably by stimulating the release of angiogenic molecules.  Vascular endothelial growth factor (VEGF) is an endothelial-cell-specific angiogenic factor whose production is increased by hypoxia.  METHODS:  We measured the concentration of VEGF in 210 specimens of ocular fluid obtained from 164 patients undergoing intraocular surgery, using both radioimmuno-assays and radioreceptor assays.  Vitreous proliferative potential was measured with in vitro assays of the growth of retinal endothelial cells and with VEGF-neutralizing antibody.  RESULTS:  VEGF was detected in 69 of 136 ocular-fluid samples from patients with diabetic retinopathy, 29 of 38 samples from patients with neovascularization of the iris, and 3 of 4 samples from patients with ischemic occlusion of the central retinal vein, as compared with 2 of 31 samples from patients with no neovascular disorders (P < 0.001, P < 0.001, and P = 0.006, respectively).  The mean (+/- SD) VEGF concentration in 70 samples of ocular fluid from patients with active proliferative diabetic retinopathy (3.6 +/- 6.3 ng per milliliter) was higher than that in 25 samples from patients with nonproliferative diabetic retinopathy (0.1 +/- 0.1 ng per milliliter, P = 0.008), 41 samples from patients with quiescent proliferative diabetic retinopathy (0.2 +/- 0.6 ng per milliliter, P < 0.001), or 31 samples from nondiabetic patients (0.1 +/- 0.2 ng per milliliter, P = 0.003).  Concentrations of VEGF in vitreous fluid (8.8 +/- 9.9 ng per milliliter) were higher than those in aqueous fluid (5.6 +/- 8.6 ng per milliliter, P = 0.033) in all 10 pairs of samples obtained simultaneously from the same patient; VEGF concentrations in vitreous fluid declined after successful laser photocoagulation.  VEGF stimulated the growth of retinal endothelial cells in vitro, as did vitreous fluid containing measurable VEGF.  Stimulation was inhibited by VEGF-neutralizing antibodies.  CONCLUSIONS:  Our data suggest that VEGF plays a major part in mediating active intraocular neovascularization in patients with ischemic retinal diseases, such as diabetic retinopathy and retinal-vein occlusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuQPc8Cq5uLhWfpMXQLRstfW6udTcc2ebXkJUBve5CJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FlvFamsA%253D%253D&md5=0711104bb524c018047b810c879aa08e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJM199412013312203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199412013312203%26sid%3Dliteratum%253Aachs%26aulast%3DAiello%26aufirst%3DL.%2BP.%26aulast%3DAvery%26aufirst%3DR.%2BL.%26aulast%3DArrigg%26aufirst%3DP.%2BG.%26aulast%3DKeyt%26aufirst%3DB.%2BA.%26aulast%3DJampel%26aufirst%3DH.%2BD.%26aulast%3DShah%26aufirst%3DS.%2BT.%26aulast%3DPasquale%26aufirst%3DL.%2BR.%26aulast%3DThieme%26aufirst%3DH.%26aulast%3DIwamoto%26aufirst%3DM.%2BA.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BV.%26aulast%3DAiello%26aufirst%3DL.%2BM.%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DKing%26aufirst%3DG.%2BL.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520in%2520ocular%2520fluid%2520of%2520patients%2520with%2520diabetic%2520retinopathy%2520and%2520other%2520retinal%2520disorders%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1994%26volume%3D331%26spage%3D1480%26epage%3D1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pe’er, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shweiki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnessin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshet, E.</span><span> </span><span class="NLM_article-title">Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1995&pages=638-645&author=J.+Pe%E2%80%99erauthor=D.+Shweikiauthor=A.+Itinauthor=I.+Hemoauthor=H.+Gnessinauthor=E.+Keshet&title=Hypoxia-induced+expression+of+vascular+endothelial+growth+factor+by+retinal+cells+is+a+common+factor+in+neovascularizing+ocular+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPe%25E2%2580%2599er%26aufirst%3DJ.%26aulast%3DShweiki%26aufirst%3DD.%26aulast%3DItin%26aufirst%3DA.%26aulast%3DHemo%26aufirst%3DI.%26aulast%3DGnessin%26aufirst%3DH.%26aulast%3DKeshet%26aufirst%3DE.%26atitle%3DHypoxia-induced%2520expression%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520by%2520retinal%2520cells%2520is%2520a%2520common%2520factor%2520in%2520neovascularizing%2520ocular%2520diseases%26jtitle%3DLab.%2520Invest.%26date%3D1995%26volume%3D72%26spage%3D638%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Wand, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendahl, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiroz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S. S.</span><span> </span><span class="NLM_article-title">AAV-mediated expression of vascular endothelial growth factor induces choroidal neovasculariaztion in rat</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1167%2Fiovs.02-0281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=12556414" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=781-790&author=F.+Wandauthor=K.+G.+Rendahlauthor=W.+C.+Manningauthor=D.+Quirozauthor=M.+Coyneauthor=S.+S.+Miller&title=AAV-mediated+expression+of+vascular+endothelial+growth+factor+induces+choroidal+neovasculariaztion+in+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1167%2Fiovs.02-0281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.02-0281%26sid%3Dliteratum%253Aachs%26aulast%3DWand%26aufirst%3DF.%26aulast%3DRendahl%26aufirst%3DK.%2BG.%26aulast%3DManning%26aufirst%3DW.%2BC.%26aulast%3DQuiroz%26aufirst%3DD.%26aulast%3DCoyne%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DS.%2BS.%26atitle%3DAAV-mediated%2520expression%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520induces%2520choroidal%2520neovasculariaztion%2520in%2520rat%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2003%26volume%3D44%26spage%3D781%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Reich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosnot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolentino, M. J.</span><span> </span><span class="NLM_article-title">Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model</span> <span class="citation_source-journal">Mol. Vision</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=12789138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1yhtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=210-216&author=S.+J.+Reichauthor=J.+Fosnotauthor=A.+Kurokiauthor=W.+Tangauthor=X.+Yangauthor=A.+M.+Maguireauthor=J.+Bennettauthor=M.+J.+Tolentino&title=Small+interfering+RNA+%28siRNA%29+targeting+VEGF+effectively+inhibits+ocular+neovascularization+in+a+mouse+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocularneovascularization in a mouse model</span></div><div class="casAuthors">Reich, Samuel J.; Fosnot, Joshua; Kuroki, Akiko; Tang, Waixing; Yang, Xiangyang; Maguire, Albert M.; Bennett, Jean; Tolentino, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Vision</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">210-216</span>CODEN:
                <span class="NLM_cas:coden">MVEPFB</span>;
        ISSN:<span class="NLM_cas:issn">1090-0535</span>.
    
            (<span class="NLM_cas:orgname">Molecular Vision</span>)
        </div><div class="casAbstract">The purpose of this study was to demonstrate the feasibility of RNA interference mediated by siRNA in retinal cells in vitro and in the murine retina in vivo.  SiRNAs specific for enhanced green fluorescent protein (EGFP) and murine and human vascular endothelial growth factor (VEGF) were designed.  In vitro studies in human cell lines entailed modulation of endogenous VEGF levels through chem. induced hypoxia.  Effects of siRNA treatment on these levels were measured by ELISA.  In vivo studies evaluating effects of siRNA on levels of EGFP and VEGF were performed by co-injecting recombinant viruses carrying EGFP or hVEGF cDNAs along with the appropriate siRNAs subretinally in mice.  Addnl. studies aimed at blocking prodn. of endogenous mVEGF were performed using laser-induced choroidal neovascularization (CNV) in mice.  Effects of in vivo treatments were evaluated ophthalmoscopically. Retinal/choroidal flat mounts were evaluated after perfusion with dextran-fluorescein.  Alternatively, retinas were evaluated in histol. sections or VEGF levels were measured in intact eyes using ELISA.  Successful delivery of siRNA to the subretinal space was confirmed by observing significantly reduced levels of EGFP in eyes treated with Ad.CMV.EGFP plus EGFP-directed siRNA.  SiRNAs directed against hVEGF effectively and specifically inhibit hypoxia-induced VEGF levels in human cell lines and after adenoviral induced hVEGF transgene expression in vivo.  In addn., subretinal delivery of siRNA directed against murine Vegf significantly inhibited CNV after laser photocoagulation.  Conclusions: Delivery of siRNA can be used in vitro and in vivo to target specific RNAs and to reduce the levels of the specific protein product in the targeted cells.  This work suggests that RNA interference has potential for application to studies of retinal biol. and for the treatment of a variety of retinal diseases,including those involving abnormal blood vessel growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE7ARwnY-FW7Vg90H21EOLACvtfcHk0lgyAHRuub_clw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1yhtb4%253D&md5=56e41fe856c0a61d32a1df66878c0258</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DS.%2BJ.%26aulast%3DFosnot%26aufirst%3DJ.%26aulast%3DKuroki%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DMaguire%26aufirst%3DA.%2BM.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DTolentino%26aufirst%3DM.%2BJ.%26atitle%3DSmall%2520interfering%2520RNA%2520%2528siRNA%2529%2520targeting%2520VEGF%2520effectively%2520inhibits%2520ocular%2520neovascularization%2520in%2520a%2520mouse%2520model%26jtitle%3DMol.%2520Vision%26date%3D2003%26volume%3D9%26spage%3D210%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Bainbridge, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagherzadeh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selwood, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zachary, I.</span><span> </span><span class="NLM_article-title">A peptide encoded by exon 6 of VEGF (EG3306) inhibits VEGF-induced angiogenesis in vitro and ischaemic retinal neovascularisation <i>in vivo</i></span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=793-799&author=J.+W.+Bainbridgeauthor=H.+Jiaauthor=A.+Bagherzadehauthor=D.+Selwoodauthor=R.+R.+Aliauthor=I.+Zachary&title=A+peptide+encoded+by+exon+6+of+VEGF+%28EG3306%29+inhibits+VEGF-induced+angiogenesis+in+vitro+and+ischaemic+retinal+neovascularisation+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBainbridge%26aufirst%3DJ.%2BW.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DBagherzadeh%26aufirst%3DA.%26aulast%3DSelwood%26aufirst%3DD.%26aulast%3DAli%26aufirst%3DR.%2BR.%26aulast%3DZachary%26aufirst%3DI.%26atitle%3DA%2520peptide%2520encoded%2520by%2520exon%25206%2520of%2520VEGF%2520%2528EG3306%2529%2520inhibits%2520VEGF-induced%2520angiogenesis%2520in%2520vitro%2520and%2520ischaemic%2520retinal%2520neovascularisation%2520in%2520vivo%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D302%26spage%3D793%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Aiello, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. E.</span><span> </span><span class="NLM_article-title">Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">10457</span><span class="NLM_x">–</span> <span class="NLM_lpage">10461</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=10457-10461&author=L.+P.+Aielloauthor=E.+A.+Pierceauthor=E.+D.+Foleyauthor=H.+Takagiauthor=H.+Chenauthor=L.+Riddleauthor=N.+Ferraraauthor=G.+L.+Kingauthor=L.+E.+Smith&title=Suppression+of+retinal+neovascularization+in+vivo+by+inhibition+of+vascular+endothelial+growth+factor+%28VEGF%29+using+soluble+VEGF-receptor+chimeric+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAiello%26aufirst%3DL.%2BP.%26aulast%3DPierce%26aufirst%3DE.%2BA.%26aulast%3DFoley%26aufirst%3DE.%2BD.%26aulast%3DTakagi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DRiddle%26aufirst%3DL.%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DKing%26aufirst%3DG.%2BL.%26aulast%3DSmith%26aufirst%3DL.%2BE.%26atitle%3DSuppression%2520of%2520retinal%2520neovascularization%2520in%2520vivo%2520by%2520inhibition%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520%2528VEGF%2529%2520using%2520soluble%2520VEGF-receptor%2520chimeric%2520proteins%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D10457%26epage%3D10461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damico, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shams, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R.</span><span> </span><span class="NLM_article-title">Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration</span> <span class="citation_source-journal">Retina</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1097%2F01.iae.0000242842.14624.e7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=17031284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADC%252BD28rpvFyisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=859-870&author=N.+Ferraraauthor=L.+Damicoauthor=N.+Shamsauthor=H.+Lowmanauthor=R.+Kim&title=Development+of+ranibizumab%2C+an+anti-vascular+endothelial+growth+factor+antigen+binding+fragment%2C+as+therapy+for+neovascular+age-related+macular+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration</span></div><div class="casAuthors">Ferrara Napoleone; Damico Lisa; Shams Naveed; Lowman Henry; Kim Robert</div><div class="citationInfo"><span class="NLM_cas:title">Retina (Philadelphia, Pa.)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">859-70</span>
        ISSN:<span class="NLM_cas:issn">0275-004X</span>.
    </div><div class="casAbstract">BACKGROUND:  Angiogenesis is a key aspect of the wet form of age-related neovascular (AMD), the leading cause of blindness in the elderly population.  Substantial evidence indicated that vascular endothelial growth factor (VEGF)-A is a major mediator of angiogenesis and vascular leakage in wet AMD.  VEGF-A is the prototype member of a gene family that includes also PlGF, VEGF-B, VEGF-C, VEGF-D and the orf virus-encoded VEGF-E.  Several isoforms of VEGF-A can be generated due to alternative mRNA splicing.  Various VEGF inhibitors have been clinically developed.  Among these, ranibizumab is a high affinity recombinant Fab that neutralizes all isoforms of VEGF-A.  The article briefly reviews the biology of VEGF and then focuses on the path that led to clinical development of ranibizumab.  RESULTS:  The safety and efficacy of ranibizumab in the treatment of neovascular AMD have been evaluated in two large phase III, multicenter, randomized, double-masked, controlled pivotal trials in different neovascular AMD patient populations.  Combined, the trial results indicate that ranibizumab results not only in a slowing down of vision loss but also in a significant proportion of patients experiencing a clinically meaningful vision gain.  The visual acuity benefit over control was observed regardless of CNV lesion type.  Furthermore, the benefit was associated with a low rate of serious adverse events.  CONCLUSIONS:  Ranibizumab represents a novel therapy that, for the first time, appears to have the potential to enable many AMD patients to obtain a meaningful and sustained gain of vision.  On June 30 2006, ranibizumab was approved by the US Food and Drug Administration for the treatment of wet AMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQc5sTUAVP5StHxxy173TfNfW6udTcc2eau6kjWQR6OpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rpvFyisQ%253D%253D&md5=9a134ad45e80dbd723a66f48b8811500</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1097%2F01.iae.0000242842.14624.e7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.iae.0000242842.14624.e7%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DDamico%26aufirst%3DL.%26aulast%3DShams%26aufirst%3DN.%26aulast%3DLowman%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DR.%26atitle%3DDevelopment%2520of%2520ranibizumab%252C%2520an%2520anti-vascular%2520endothelial%2520growth%2520factor%2520antigen%2520binding%2520fragment%252C%2520as%2520therapy%2520for%2520neovascular%2520age-related%2520macular%2520degeneration%26jtitle%3DRetina%26date%3D2006%26volume%3D26%26spage%3D859%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Rosenfeld, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heier, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. Y.</span><span> </span><span class="NLM_article-title">Ranibizumab for neovascular age-related macular degeneration</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1056%2FNEJMoa054481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=17021318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGgtr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1419-1431&author=P.+J.+Rosenfeldauthor=D.+M.+Brownauthor=J.+S.+Heierauthor=D.+S.+Boyerauthor=P.+K.+Kaiserauthor=C.+Y.+Chungauthor=R.+Y.+Kim&title=Ranibizumab+for+neovascular+age-related+macular+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Ranibizumab for neovascular age-related macular degeneration</span></div><div class="casAuthors">Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaiser, Peter K.; Chung, Carol Y.; Kim, Robert Y.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1419-1431</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Ranibizumab - a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A - has been evaluated for the treatment of neovascular age-related macular degeneration.  METHODS: In this multicenter, 2-yr, double-blind, sham-controlled study, we randomly assigned patients with age-related macular degeneration with either minimally classic or occult (with no classic lesions) choroidal neovascularization to receive 24 monthly intravitreal injections of ranibizumab (either 0.3 mg or 0.5 mg) or sham injections.  The primary end point was the proportion of patients losing fewer than 15 letters from baseline visual acuity at 12 mo.  RESULTS: We enrolled 716 patients in the study.  At 12 mo, 94.5% of the group given 0.3 mg of ranibizumab and 94.6% of those given 0.5 mg lost fewer than 15 letters, as compared with 62.2% of patients receiving sham injections (P < 0.001 for both comparisons).  Visual acuity improved by 15 or more letters in 24.8% of the 0.3-mg group and 33.8% of the 0.5-mg group, as compared with 5.0% of the sham-injection group (P < 0.001 for both doses).  Mean increases in visual acuity were 6.5 letters in the 0.3-mg group and 7.2 letters in the 0.5-mg group, as compared with a decrease of 10.4 letters in the sham-injection group (P < 0.001 for both comparisons).  The benefit in visual acuity was maintained at 24 mo.  During 24 mo, presumed endophthalmitis was identified in five patients (1.0%) and serious uveitis in six patients (1.3%) given ranibizumab.  CONCLUSIONS: Intravitreal administration of ranibizumab for 2 years prevented vision loss and improved mean visual acuity, with low rates of serious adverse events, in patients with minimally classic or occult (with no classic lesions) choroidal neovascularization secondary to age-related macular degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXzgb9csG98rVg90H21EOLACvtfcHk0lhFQ_X7GJGUrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGgtr3M&md5=810a3aa65cbc439b42c31e4fe23045b2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa054481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa054481%26sid%3Dliteratum%253Aachs%26aulast%3DRosenfeld%26aufirst%3DP.%2BJ.%26aulast%3DBrown%26aufirst%3DD.%2BM.%26aulast%3DHeier%26aufirst%3DJ.%2BS.%26aulast%3DBoyer%26aufirst%3DD.%2BS.%26aulast%3DKaiser%26aufirst%3DP.%2BK.%26aulast%3DChung%26aufirst%3DC.%2BY.%26aulast%3DKim%26aufirst%3DR.%2BY.%26atitle%3DRanibizumab%2520for%2520neovascular%2520age-related%2520macular%2520degeneration%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1419%26epage%3D1431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Brown, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michels, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soubrane, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heier, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span> </span><span class="NLM_article-title">Ranibizumab versus verteporfin for neovascular age-related macular degeneration</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1432</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1056%2FNEJMoa062655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=17021319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGgtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1432-1444&author=D.+M.+Brownauthor=P.+K.+Kaiserauthor=M.+Michelsauthor=G.+Soubraneauthor=E.+S.+Heierauthor=R.+Y.+Kimauthor=J.+P.+Syauthor=S.+Schneider&title=Ranibizumab+versus+verteporfin+for+neovascular+age-related+macular+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Ranibizumab versus verteporfin for neovascular age-related macular degeneration</span></div><div class="casAuthors">Brown, David M.; Kaiser, Peter K.; Michels, Mark; Soubrane, Gisele; Heier, Effrey S.; Kim, Robert Y.; Sy, Judy P.; Schneider, Susan</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1432-1444</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: We compared ranibizumab - a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A - with photodynamic therapy with verteporfin in the treatment of predominantly classic neovascular age-related macular degeneration.  METHODS: During the first year of this 2-yr, multicenter, double-blind study, we randomly assigned patients in a 1:1:1 ratio to receive monthly intravitreal injections of ranibizumab (0.3 mg or 0.5 mg) plus sham verteporfin therapy or monthly sham injections plus active verteporfin therapy.  The primary end point was the proportion of patients losing fewer than 15 letters from baseline visual acuity at 12 mo.  RESULTS: Of the 423 patients enrolled, 94.3% of those given 0.3 mg of ranibizumab and 96.4% of those given 0.5 mg lost fewer than 15 letters, as compared with 64.3% of those in the verteporfin group (P < 0.001 for each comparison).  Visual acuity i.m.- proved by 15 letters or more in 35.7% of the 0.3-mg group and 40.3% of the 0.5-mg group, as compared with 5.6% of the verteporfin group (P < 0.001 for each comparison).  Mean visual acuity increased by 8.5 letters in the 0.3-mg group and 11.3 letters in the 0.5-mg group, as compared with a decrease of 9.5 letters in the verteporfin group (P < 0.001 for each comparison).  Among 140 patients treated with 0.5 mg of ranibizumab, presumed endophthalmitis occurred in 2 patients (1.4%) and serious uveitis in 1 (0.7%).  CONCLUSIONS: Ranibizumab was superior to verteporfin as intravitreal treatment of predominantly classic neovascular age-related macular degeneration, with low rates of serious ocular adverse events.  Treatment improved visual acuity on av. at 1 yr.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu19lFQmxb77Vg90H21EOLACvtfcHk0li8n4cN2BrRtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGgtrrI&md5=1acef0cfe4198d3aac6f7bffb048307b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa062655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa062655%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BM.%26aulast%3DKaiser%26aufirst%3DP.%2BK.%26aulast%3DMichels%26aufirst%3DM.%26aulast%3DSoubrane%26aufirst%3DG.%26aulast%3DHeier%26aufirst%3DE.%2BS.%26aulast%3DKim%26aufirst%3DR.%2BY.%26aulast%3DSy%26aufirst%3DJ.%2BP.%26aulast%3DSchneider%26aufirst%3DS.%26atitle%3DRanibizumab%2520versus%2520verteporfin%2520for%2520neovascular%2520age-related%2520macular%2520degeneration%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1432%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Nguyen, Q. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatlipinar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinlan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer-Galler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor is a critical stimulus for diabetic macular edema</span> <span class="citation_source-journal">Am. J. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1016%2Fj.ajo.2006.06.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=17046701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12msLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2006&pages=961-969&author=Q.+D.+Nguyenauthor=S.+Tatlipinarauthor=S.+M.+Shahauthor=J.+A.+Hallerauthor=E.+Quinlanauthor=J.+Sungauthor=I.+Zimmer-Gallerauthor=D.+V.+Doauthor=P.+A.+Campochiaro&title=Vascular+endothelial+growth+factor+is+a+critical+stimulus+for+diabetic+macular+edema"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema</span></div><div class="casAuthors">Nguyen, Quan Dong; Tatlipinar, Sinan; Shah, Syed Mahmood; Haller, Julia A.; Quinlan, Edward; Sung, Jennifer; Zimmer-Galler, Ingrid; Do, Diana V.; Campochiaro, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Ophthalmology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">961-969</span>CODEN:
                <span class="NLM_cas:coden">AJOPAA</span>;
        ISSN:<span class="NLM_cas:issn">0002-9394</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Purpose: The role of vascular endothelial growth factor (VEGF) in diabetic macular edema (DME) was tested with ranibizumab, a specific antagonist of VEGF.  Design: A nonrandomized clin. trial.  Methods: Ten patients with chronic DME received intraocular injections of 0.5 mg of ranibizumab at baseline and at one, two, four, and six months.  The primary outcome was change in foveal thickness between baseline and seven months, and the secondary outcome measures were changes from baseline in visual acuity and macular vol.  Results: Mean values at baseline were 503 μm for foveal thickness, 9.22 mm3 for macular vol., and 28.1 letters (20/80) read on an Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity chart.  At seven months (one month after the fifth injection), the mean foveal thickness was 257 μm, which was a redn. of 246 μm (85% of the excess foveal thickness present at baseline; P = .005 by Wilcoxon signed-rank test for likelihood that this change is due to ranibizumab rather than chance).  The macular vol. was 7.47 mm3, which was a redn. of 1.75 mm3 (77% of the excess macular vol. at baseline; P = .009).  Mean visual acuity was 40.4 letters (20/40), which was an improvement of 12.3 letters (P = .005).  The injections were well-tolerated with no ocular or systemic adverse events.  Conclusion: Intraocular injections of ranibizumab significantly reduced foveal thickness and improved visual acuity in 10 patients with DME, which demonstrated that VEGF is an important therapeutic target for DME.  A randomized, controlled, double-masked trial is needed to test whether intraocular injections of ranibizumab provide long-term benefit to patients with DME.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraQ4X1zj_2PLVg90H21EOLACvtfcHk0li8n4cN2BrRtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12msLfE&md5=1eaf14ff1ca9d7b98f917d48f841c1f7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ajo.2006.06.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajo.2006.06.068%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DQ.%2BD.%26aulast%3DTatlipinar%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DS.%2BM.%26aulast%3DHaller%26aufirst%3DJ.%2BA.%26aulast%3DQuinlan%26aufirst%3DE.%26aulast%3DSung%26aufirst%3DJ.%26aulast%3DZimmer-Galler%26aufirst%3DI.%26aulast%3DDo%26aufirst%3DD.%2BV.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520is%2520a%2520critical%2520stimulus%2520for%2520diabetic%2520macular%2520edema%26jtitle%3DAm.%2520J.%2520Ophthalmol.%26date%3D2006%26volume%3D142%26spage%3D961%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Fernando, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, H. I.</span><span> </span><span class="NLM_article-title">Targeted therapy of colorectal cancer: clinical experience with bevacizumab</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=1-18&author=N.+H.+Fernandoauthor=H.+I.+Hurwitz&title=Targeted+therapy+of+colorectal+cancer%3A+clinical+experience+with+bevacizumab"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernando%26aufirst%3DN.%2BH.%26aulast%3DHurwitz%26aufirst%3DH.%2BI.%26atitle%3DTargeted%2520therapy%2520of%2520colorectal%2520cancer%253A%2520clinical%2520experience%2520with%2520bevacizumab%26jtitle%3DOncologist%26date%3D2004%26volume%3D1%26spage%3D1%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, R. L. ;E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hylton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudge, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood−retinal barrier</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1002%2Fjcp.10246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=12652651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislOmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2003&pages=241-248&author=Y.+Saishinauthor=Y.+Saishinauthor=K.+Takahashiauthor=R.+L.+%3BE.+Silvaauthor=D.+Hyltonauthor=J.+S.+Rudgeauthor=S.+J.+Wiegandauthor=P.+A.+Campochiaro&title=VEGF-TRAPR1R2+suppresses+choroidal+neovascularization+and+VEGF-induced+breakdown+of+the+blood%E2%88%92retinal+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier</span></div><div class="casAuthors">Saishin, Yoshitsugu; Saishin, Yumiko; Takahashi, Kyoichi; Silva, Raquel Lima E.; Hylton, Donna; Rudge, John S.; Wiegand, Stanley J.; Campochiaro, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-248</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor (VEGF) plays a central role in the development of retinal neovascularization and diabetic macular edema.  There is also evidence suggesting that VEGF is an important stimulator for choroidal neovascularization.  In this study, we investigated the effect of a specific inhibitor of VEGF, VEGF-TRAPR1R2, in models for these disease processes.  VEGF-TRAPR1R2 is a fusion protein, which combines ligand binding elements taken from the extracellular domains of VEGF receptors 1 and 2 fused to the Fc portion of IgG1.  S.c. injections or a single intra-vitreous injection of VEGF-TRAPR1R2 strongly suppressed choroidal neovascularization in mice with laser-induced rupture of Bruch's membrane.  S.c. injection of VEGF-TRAPR1R2 also significantly inhibited sub-retinal neovascularization in transgenic mice that express VEGF in photo-receptors.  In two models of VEGF-induced breakdown of the blood-retinal barrier (BRB), one in which recombinant VEGF is injected into the vitreous cavity and one in which VEGF expression is induced in the retina in transgenic mice, VEGF-TRAPR1R2 significantly reduced breakdown of the BRB.  These data confirm that VEGF is a crit. stimulus for the development of choroidal neovascularization and indicate that VEGF-TRAPR1R2 may provide a new agent for consideration for treatment of patients with choroidal neovascularization and diabetic macular edema.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkiGqrSuUop7Vg90H21EOLACvtfcHk0li8n4cN2BrRtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislOmtbY%253D&md5=aaf2607adcfb94b17a814e89edf881b0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fjcp.10246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.10246%26sid%3Dliteratum%253Aachs%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DSilva%26aufirst%3DR.%2BL.%2B%253BE.%26aulast%3DHylton%26aufirst%3DD.%26aulast%3DRudge%26aufirst%3DJ.%2BS.%26aulast%3DWiegand%26aufirst%3DS.%2BJ.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DVEGF-TRAPR1R2%2520suppresses%2520choroidal%2520neovascularization%2520and%2520VEGF-induced%2520breakdown%2520of%2520the%2520blood%25E2%2588%2592retinal%2520barrier%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2003%26volume%3D195%26spage%3D241%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><div class="note"><p class="first last">Sirna Therapeutics is currently developing an injectable form of SiRNA (Sirna-027) targeting VEGFr.</p></div><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinnen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosnaugh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargeese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhana, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aitchison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A..</span><span> </span><span class="NLM_article-title">Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1</span> <span class="citation_source-journal">Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1038%2Fsj.gt.3302641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFCrt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=225-234&author=J.+Shenauthor=R.+Samulauthor=R.+L.+Silvaauthor=H.+Akiyamaauthor=H.+Liuauthor=Y.+Saishinauthor=S.+F.+Hackettauthor=S.+Zinnenauthor=K.+Kossenauthor=K.+Fosnaughauthor=C.+Vargeeseauthor=A.+Gomezauthor=K.+Bouhanaauthor=R.+Aitchisonauthor=P.+Pavcoauthor=P.+A..+Campochiaro&title=Suppression+of+ocular+neovascularization+with+siRNA+targeting+VEGF+receptor+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Low temperature one-step synthesis of barium titanate: Thermodynamic modeling and experimental synthesis</span></div><div class="casAuthors">Shen, Zhigang; Li, Shigang; Liu, Zhaowen; Zhang, Jianwen; Chen, Jianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Journal of Chemical Engineering</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-233</span>CODEN:
                <span class="NLM_cas:coden">CJCEEB</span>;
        ISSN:<span class="NLM_cas:issn">1004-9541</span>.
    
            (<span class="NLM_cas:orgname">Chemical Industry Press</span>)
        </div><div class="casAbstract">A thermodn. model has been developed to det. the reaction conditions favoring low-temp. direct synthesis of barium titanate (BaTiO3).  The method utilizes std.-state thermodn. data for solid and aq. species and a Debye-Hueckel coeffs. model to represent soln. nonideality.  The method has been used to generate phase stability diagrams that indicate the ranges of pH and reagent concns., for which various species predominate in the system at a given temp.  Also, yield diagrams have been constructed that indicate the concn., pH and temp. conditions for which different yields of cryst. BaTiO3 can be obtained.  The stability and yield diagrams have been used to predict the optimum synthesis conditions (e.g., reagent concns., pH, and temp.).  Subsequently, these predictions have been exptl. verified.  As a result, phase-pure perovskite BaTiO3 has been obtained at temp. ranging from 55 to 85° using BaCl2 and TiCl4 as a source for Ba and Ti, and NaOH as a precipitator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiE6cFMNUEbLVg90H21EOLACvtfcHk0ljvU9YDPW2SLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFCrt7w%253D&md5=6f269463033ebe1775ecb34ecafff98f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.gt.3302641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.gt.3302641%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DSamul%26aufirst%3DR.%26aulast%3DSilva%26aufirst%3DR.%2BL.%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DHackett%26aufirst%3DS.%2BF.%26aulast%3DZinnen%26aufirst%3DS.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DFosnaugh%26aufirst%3DK.%26aulast%3DVargeese%26aufirst%3DC.%26aulast%3DGomez%26aufirst%3DA.%26aulast%3DBouhana%26aufirst%3DK.%26aulast%3DAitchison%26aufirst%3DR.%26aulast%3DPavco%26aufirst%3DP.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA..%26atitle%3DSuppression%2520of%2520ocular%2520neovascularization%2520with%2520siRNA%2520targeting%2520VEGF%2520receptor%25201%26jtitle%3DGene%2520Ther.%26date%3D2005%26volume%3D13%26spage%3D225%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><div class="note"><p class="first last">Small molecules targeting VEGFr pathway for the treatment of AMD are under development at Pfizer.</p></div><span class="NLM_contrib-group">Beals, C. R.; Day, W. W.; Khalil, D. A.; Klamerus, K. J.; Raber, S. R.; Scassellati-Sorzolini, B.; Zwillich, S. H.</span><span> </span><span class="NLM_article-title">Compositions Comprising Indazole Compound for Sub-Tenon Delivery</span>. WO 2006117666, <span class="NLM_month">April</span><span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=C.+R.+Beals&author=W.+W.+Day&author=D.+A.+Khalil&author=K.+J.+Klamerus&author=S.+R.+Raber&author=B.+Scassellati-Sorzolini&author=S.+H.+Zwillich&title=Compositions+Comprising+Indazole+Compound+for+Sub-Tenon+Delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeals%26aufirst%3DC.%2BR.%26atitle%3DCompositions%2520Comprising%2520Indazole%2520Compound%2520for%2520Sub-Tenon%2520Delivery%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><div class="note"><p class="first last">Orally delivered vatalanib is being evaluated in a phase II clinical trial along with verteporfin in patients with subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration.</p></div><a href="http://www.clinicaltrials.gov/ct/gui/show/NCT00138632" class="extLink">http://www.clinicaltrials.gov/ct/gui/show/NCT00138632</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Orally+delivered+vatalanib+is+being+evaluated+in+a+phase+II+clinical+trial+along+with+verteporfin+in+patients+with+subfoveal+choroidal+neovascularization+%28CNV%29+secondary+to+age-related+macular+degeneration.http%3A%2F%2Fwww.clinicaltrials.gov%2Fct%2Fgui%2Fshow%2FNCT00138632."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><div class="note"><p class="first last">Several devices are in development to deliver drugs to the back of the eye.</p></div><span class="NLM_contrib-group">Sultana, Y</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aqil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, A.</span> <span class="citation_source-journal">Curr. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Several+devices+are+in+development+to+deliver+drugs+to+the+back+of+the+eye.Sultana%2C+Y%3B+Jain%2C+R.%3B+Aqil%2C+M.%3B+Ali%2C+A.Curr.+Drug+Delivery+2006%2C+3%2C+207%E2%80%93217"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSultana%26aufirst%3DY%26aulast%3DJain%26aufirst%3DR.%26aulast%3DAqil%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DA.%26jtitle%3DCurr.%2520Drug%2520Delivery%26date%3D2006%26volume%3D3%26spage%3D207%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">Antismoking compound mecamylamine targeting endothelial nicotinic acetylcholine receptor and pazopanib from GlaxoSmithKline targeting VEGFr are in phase I. <a href="http://clinicaltrials.gov/ct/show/NCT00463320?order=19" class="extLink">http://clinicaltrials.gov/ct/show/NCT00463320?order=19</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><div class="note"><p class="first last">A VEGF trap agent from Regeneron Pharmaceuticals, Inc. and Bayer Health Care AG is in Phase II.</p></div><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hylton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudge, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood−retinal barrier</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1002%2Fjcp.10246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=12652651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislOmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2003&pages=241-248&author=Y.+Saishinauthor=Y.+Saishinauthor=K.+Takahashiauthor=R.+L.+Silvaauthor=D.+Hyltonauthor=J.+S.+Rudgeauthor=S.+J.+Wiegandauthor=P.+A.+Campochiaro&title=VEGF-TRAPR1R2+suppresses+choroidal+neovascularization+and+VEGF-induced+breakdown+of+the+blood%E2%88%92retinal+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier</span></div><div class="casAuthors">Saishin, Yoshitsugu; Saishin, Yumiko; Takahashi, Kyoichi; Silva, Raquel Lima E.; Hylton, Donna; Rudge, John S.; Wiegand, Stanley J.; Campochiaro, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-248</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor (VEGF) plays a central role in the development of retinal neovascularization and diabetic macular edema.  There is also evidence suggesting that VEGF is an important stimulator for choroidal neovascularization.  In this study, we investigated the effect of a specific inhibitor of VEGF, VEGF-TRAPR1R2, in models for these disease processes.  VEGF-TRAPR1R2 is a fusion protein, which combines ligand binding elements taken from the extracellular domains of VEGF receptors 1 and 2 fused to the Fc portion of IgG1.  S.c. injections or a single intra-vitreous injection of VEGF-TRAPR1R2 strongly suppressed choroidal neovascularization in mice with laser-induced rupture of Bruch's membrane.  S.c. injection of VEGF-TRAPR1R2 also significantly inhibited sub-retinal neovascularization in transgenic mice that express VEGF in photo-receptors.  In two models of VEGF-induced breakdown of the blood-retinal barrier (BRB), one in which recombinant VEGF is injected into the vitreous cavity and one in which VEGF expression is induced in the retina in transgenic mice, VEGF-TRAPR1R2 significantly reduced breakdown of the BRB.  These data confirm that VEGF is a crit. stimulus for the development of choroidal neovascularization and indicate that VEGF-TRAPR1R2 may provide a new agent for consideration for treatment of patients with choroidal neovascularization and diabetic macular edema.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkiGqrSuUop7Vg90H21EOLACvtfcHk0lhWFhM5u7WvUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislOmtbY%253D&md5=aaf2607adcfb94b17a814e89edf881b0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjcp.10246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.10246%26sid%3Dliteratum%253Aachs%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DSilva%26aufirst%3DR.%2BL.%26aulast%3DHylton%26aufirst%3DD.%26aulast%3DRudge%26aufirst%3DJ.%2BS.%26aulast%3DWiegand%26aufirst%3DS.%2BJ.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DVEGF-TRAPR1R2%2520suppresses%2520choroidal%2520neovascularization%2520and%2520VEGF-induced%2520breakdown%2520of%2520the%2520blood%25E2%2588%2592retinal%2520barrier%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2003%26volume%3D195%26spage%3D241%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><div class="note"><p class="first last">Othera Pharmaceuticals, Inc. is developing OT-551 targeting NF-κB mediated transcriptional activation for the treatment of AM.</p></div><span class="NLM_contrib-group">Tanito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M. H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. E.</span><span> </span><span class="NLM_article-title">Protective effect of TEMPOL derivatives against light-induced retinal damage in rats</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1900</span><span class="NLM_x">–</span> <span class="NLM_lpage">1905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=1900-1905&author=M.+Tanitoauthor=F.+Liauthor=M.+H+Elliottauthor=M.+Dittmarauthor=R.+E.+Anderson&title=Protective+effect+of+TEMPOL+derivatives+against+light-induced+retinal+damage+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanito%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DElliott%26aufirst%3DM.%2BH%26aulast%3DDittmar%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DR.%2BE.%26atitle%3DProtective%2520effect%2520of%2520TEMPOL%2520derivatives%2520against%2520light-induced%2520retinal%2520damage%2520in%2520rats%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2007%26volume%3D48%26spage%3D1900%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Weis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D.</span><span> </span><span class="NLM_article-title">Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2004&pages=223-229&author=S.+Weisauthor=J.+Cuiauthor=L.+Barnesauthor=D.+Cheresh&title=Endothelial+barrier+disruption+by+VEGF-mediated+Src+activity+potentiates+tumor+cell+extravasation+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeis%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DBarnes%26aufirst%3DL.%26aulast%3DCheresh%26aufirst%3DD.%26atitle%3DEndothelial%2520barrier%2520disruption%2520by%2520VEGF-mediated%2520Src%2520activity%2520potentiates%2520tumor%2520cell%2520extravasation%2520and%2520metastasis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2004%26volume%3D167%26spage%3D223%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Eliceiri, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puente, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupack, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span> </span><span class="NLM_article-title">Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2002&pages=149-159&author=B.+P.+Eliceiriauthor=X.+S.+Puenteauthor=J.+D.+Hoodauthor=D.+G.+Stupackauthor=D.+D.+Schlaepferauthor=X.+Z.+Huangauthor=D.+Sheppardauthor=D.+A.+Cheresh&title=Src-mediated+coupling+of+focal+adhesion+kinase+to+integrin+%CE%B1v%CE%B25+in+vascular+endothelial+growth+factor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEliceiri%26aufirst%3DB.%2BP.%26aulast%3DPuente%26aufirst%3DX.%2BS.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DStupack%26aufirst%3DD.%2BG.%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26aulast%3DHuang%26aufirst%3DX.%2BZ.%26aulast%3DSheppard%26aufirst%3DD.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26atitle%3DSrc-mediated%2520coupling%2520of%2520focal%2520adhesion%2520kinase%2520to%2520integrin%2520%25CE%25B1v%25CE%25B25%2520in%2520vascular%2520endothelial%2520growth%2520factor%2520signaling%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2002%26volume%3D157%26spage%3D149%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Personal communication Martin Friedlander, Department of Cell Biology, Scripps Clinic Torry Pines 10666 North Torrey Pines Road, MS214, The Scripps Research Institute, La Jolla, CA 92037.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Thomas, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugge, J. S.</span><span> </span><span class="NLM_article-title">Cellular functions regulated by Src family kinases</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1146%2Fannurev.cellbio.13.1.513" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=9442882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1997&pages=513-609&author=S.+M.+Thomasauthor=J.+S.+Brugge&title=Cellular+functions+regulated+by+Src+family+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular functions regulated by Src family kinases</span></div><div class="casAuthors">Thomas, Sheila M.; Brugge, Joan S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">513-609</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with many refs.  Src family protein tyrosine kinases are activated following engagement of many different classes of cellular receptors and participate in signaling pathways that control a diverse spectrum of receptor-induced biol. activities.  While several of these kinases have evolved to play distinct roles in specific receptor pathways, there is considerable redundancy in the functions of these kinases, both with respect to the receptor pathways that activate these kinases and the downstream effectors that mediate their biol. activities.  This chapter reviews the evidence implicating Src family kinases in specific receptor pathways and describes the mechanisms leading to their activation, the targets that interact with these kinases, and the biol. events that they regulate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_psatEFVwjbVg90H21EOLACvtfcHk0lhWFhM5u7WvUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSrsQ%253D%253D&md5=4b8d18cc815109e3e0a593b846984aac</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.13.1.513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.13.1.513%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DS.%2BM.%26aulast%3DBrugge%26aufirst%3DJ.%2BS.%26atitle%3DCellular%2520functions%2520regulated%2520by%2520Src%2520family%2520kinases%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D1997%26volume%3D13%26spage%3D513%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Eliceiri, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span> </span><span class="NLM_article-title">Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=915-924&author=B.+P.+Eliceiriauthor=R.+Paulauthor=P.+L.+Schwartzbergauthor=J.+D.+Hoodauthor=J.+Lengauthor=D.+A.+Cheresh&title=Selective+requirement+for+Src+kinases+during+VEGF-induced+angiogenesis+and+vascular+permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEliceiri%26aufirst%3DB.%2BP.%26aulast%3DPaul%26aufirst%3DR.%26aulast%3DSchwartzberg%26aufirst%3DP.%2BL.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DLeng%26aufirst%3DJ.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26atitle%3DSelective%2520requirement%2520for%2520Src%2520kinases%2520during%2520VEGF-induced%2520angiogenesis%2520and%2520vascular%2520permeability%26jtitle%3DMol.%2520Cell%26date%3D1999%26volume%3D4%26spage%3D915%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Noronha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dneprovskaia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gritzen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebansky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPherson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palanki, M. S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Splittgerber, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrasidlo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, N.</span><span> </span><span class="NLM_article-title">Discovery and preliminary structure activity relationship studies of novel benzotriazine based compounds as Src inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5546</span><span class="NLM_x">–</span> <span class="NLM_lpage">5550</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5546-5550&author=G.+Noronhaauthor=K.+Barrettauthor=J.+Caoauthor=E.+Dneprovskaiaauthor=R.+Fineauthor=X.+Gongauthor=C.+Gritzenauthor=J.+Hoodauthor=X.+Kangauthor=B.+Klebanskyauthor=D.+Lohseauthor=C.+C.+Makauthor=A.+McPhersonauthor=M.+S.+S.+Palankiauthor=V.+P.+Pathakauthor=J.+Renickauthor=R.+Sollauthor=U.+Splittgerberauthor=W.+Wrasidloauthor=B.+Zengauthor=N.+Zhao&title=Discovery+and+preliminary+structure+activity+relationship+studies+of+novel+benzotriazine+based+compounds+as+Src+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoronha%26aufirst%3DG.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DDneprovskaia%26aufirst%3DE.%26aulast%3DFine%26aufirst%3DR.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DGritzen%26aufirst%3DC.%26aulast%3DHood%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DX.%26aulast%3DKlebansky%26aufirst%3DB.%26aulast%3DLohse%26aufirst%3DD.%26aulast%3DMak%26aufirst%3DC.%2BC.%26aulast%3DMcPherson%26aufirst%3DA.%26aulast%3DPalanki%26aufirst%3DM.%2BS.%2BS.%26aulast%3DPathak%26aufirst%3DV.%2BP.%26aulast%3DRenick%26aufirst%3DJ.%26aulast%3DSoll%26aufirst%3DR.%26aulast%3DSplittgerber%26aufirst%3DU.%26aulast%3DWrasidlo%26aufirst%3DW.%26aulast%3DZeng%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DN.%26atitle%3DDiscovery%2520and%2520preliminary%2520structure%2520activity%2520relationship%2520studies%2520of%2520novel%2520benzotriazine%2520based%2520compounds%2520as%2520Src%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5546%26epage%3D5550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Noronha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boccia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodhag, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dneprovskaia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gritzen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Key, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebansky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kousba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPherson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palanki, M. S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Splittgerber, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoughton, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu., H.</span><span> </span><span class="NLM_article-title">Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine, a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays.</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">602</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=602-608&author=G.+Noronhaauthor=K.+Barrettauthor=A.+Bocciaauthor=T.+Brodhagauthor=J.+Caoauthor=C.+P.+Chowauthor=E.+Dneprovskaiaauthor=J.+Doukasauthor=R.+Fineauthor=X.+Gongauthor=C.+Gritzenauthor=H.+Guauthor=E.+Hannaauthor=J.+D.+Hoodauthor=S.+Huauthor=X.+Kangauthor=J.+Keyauthor=B.+Klebanskyauthor=A.+Kousbaauthor=G.+Liauthor=D.+Lohseauthor=C.+Makauthor=A.+McPhersonauthor=M.+S.+P.+Palankiauthor=V.+P.+Pathakauthor=J.+Renickauthor=F.+Shiauthor=R.+Sollauthor=U.+Splittgerberauthor=S+Stoughtonauthor=S.+Tangauthor=S.+Yeeauthor=B.+Zengauthor=N.+Zhaoauthor=H.+Zhu.&title=Discovery+of+%5B7-%282%2C6-dichlorophenyl%29-5-methylbenzo%5B1%2C2%2C4%5Dtriazin-3-yl%5D-%5B4-%282-pyrrolidin-1-ylethoxy%29phenyl%5Damine%2C+a+potent%2C+orally+active+Src+kinase+inhibitor+with+anti-tumor+activity+in+preclinical+assays."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoronha%26aufirst%3DG.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBoccia%26aufirst%3DA.%26aulast%3DBrodhag%26aufirst%3DT.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DChow%26aufirst%3DC.%2BP.%26aulast%3DDneprovskaia%26aufirst%3DE.%26aulast%3DDoukas%26aufirst%3DJ.%26aulast%3DFine%26aufirst%3DR.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DGritzen%26aufirst%3DC.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DHanna%26aufirst%3DE.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DX.%26aulast%3DKey%26aufirst%3DJ.%26aulast%3DKlebansky%26aufirst%3DB.%26aulast%3DKousba%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DLohse%26aufirst%3DD.%26aulast%3DMak%26aufirst%3DC.%26aulast%3DMcPherson%26aufirst%3DA.%26aulast%3DPalanki%26aufirst%3DM.%2BS.%2BP.%26aulast%3DPathak%26aufirst%3DV.%2BP.%26aulast%3DRenick%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DF.%26aulast%3DSoll%26aufirst%3DR.%26aulast%3DSplittgerber%26aufirst%3DU.%26aulast%3DStoughton%26aufirst%3DS%26aulast%3DTang%26aufirst%3DS.%26aulast%3DYee%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DZhu.%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520%255B7-%25282%252C6-dichlorophenyl%2529-5-methylbenzo%255B1%252C2%252C4%255Dtriazin-3-yl%255D-%255B4-%25282-pyrrolidin-1-ylethoxy%2529phenyl%255Damine%252C%2520a%2520potent%252C%2520orally%2520active%2520Src%2520kinase%2520inhibitor%2520with%2520anti-tumor%2520activity%2520in%2520preclinical%2520assays.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D602%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Wolf, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, K.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzotriazines, I.</span><span> </span><span class="NLM_article-title">A new series of compounds having antimalarial activity</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">3551</span><span class="NLM_x">–</span> <span class="NLM_lpage">3553</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01642a060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1954&pages=3551-3553&author=F.+J.+Wolfauthor=K.+Pfisterauthor=R.+M.+Wilsonauthor=C.+A.+Robinsonauthor=I.+Benzotriazines&title=A+new+series+of+compounds+having+antimalarial+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja01642a060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01642a060%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DF.%2BJ.%26aulast%3DPfister%26aufirst%3DK.%26aulast%3DWilson%26aufirst%3DR.%2BM.%26aulast%3DRobinson%26aufirst%3DC.%2BA.%26aulast%3DBenzotriazines%26aufirst%3DI.%26atitle%3DA%2520new%2520series%2520of%2520compounds%2520having%2520antimalarial%2520activity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1954%26volume%3D76%26spage%3D3551%26epage%3D3553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Mason, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, G.</span> <span class="citation_source-journal">J. Chem. Soc. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_fpage">911</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1039%2Fj29700000911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADyaE3cXktlGgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mason%2C+J.+C.%3B+Tennant%2C+G.J.+Chem.+Soc.+B+1970%2C+911%E2%80%93916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic N-oxides.  VI.  Synthesis and nuclear magnetic resonance spectra of 3-aminobenzo-1,2-4-triazines and their mono- and di-N-oxides</span></div><div class="casAuthors">Mason, J. C.; Tennant, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society [Section] B:  Physical Organic</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">911-16</span>CODEN:
                <span class="NLM_cas:coden">JCSPAC</span>;
        ISSN:<span class="NLM_cas:issn">0045-6470</span>.
    </div><div class="casAbstract">A series of 3-aminobenzo-1,2,4-triazine derivs. were prepd. and their oxidn. with H2O2 in AcOH studied.  The position of the N-oxide group(s) in the products was established by NMR anal.  Oxidn. of 3-aminobenzo-1,2,4-triazines at room temp. gave almost exclusively the 2-oxide, whereas prolonged oxidn. at 50° gave the 1,4-di-N-oxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXrnjoL5TFF7Vg90H21EOLACvtfcHk0liyPjby4ldgyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXktlGgsbg%253D&md5=3e3b6619866eca70f6bb14b77c48271c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2Fj29700000911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fj29700000911%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BC.%26aulast%3DTennant%26aufirst%3DG.%26jtitle%3DJ.%2520Chem.%2520Soc.%2520B%26date%3D1970%26spage%3D911%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kudo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perseghini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, G. C.</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1282</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1002%2Fanie.200503479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFyjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kudo%2C+N.%3B+Perseghini%2C+M.%3B+Fu%2C+G.+C.Angew.+Chem.%2C+Int.+Ed.+2006%2C+45%2C+1282%E2%80%931284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A versatile method for Suzuki cross-coupling reactions of nitrogen heterocycles</span></div><div class="casAuthors">Kudo, Noriaki; Perseghini, Mauro; Fu, Gregory C.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1282-1284</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A wide-ranging study of Suzuki reactions which use nitrogen-contg. heterocycles was described.  This method was highly versatile (a single procedure was used for all substrates, including boronate esters and trifluoroborates), compatible with a variety of unprotected functionalities (e.g., NH2- and OH-substituted substrates), and efficient even with inactivated aryl chlorides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaUyKcanJOLbVg90H21EOLACvtfcHk0liyPjby4ldgyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFyjs7Y%253D&md5=efb90d1dc5db87ee2dfc6cda6341c9eb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fanie.200503479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200503479%26sid%3Dliteratum%253Aachs%26aulast%3DKudo%26aufirst%3DN.%26aulast%3DPerseghini%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DG.%2BC.%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D1282%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Tundel, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo052131u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tundel%2C+R.+E.%3B+Anderson%2C+K.+W.%3B+Buchwald%2C+S.+L.J.+Org.+Chem.+2006%2C+71%2C+430%E2%80%93433"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo052131u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052131u%26sid%3Dliteratum%253Aachs%26aulast%3DTundel%26aufirst%3DR.%2BE.%26aulast%3DAnderson%26aufirst%3DK.%2BW.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D430%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stover, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K. A.</span><span> </span><span class="NLM_article-title">Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><div class="note"><p class="first last">PDB entry 1qpe</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=651-66&author=X.+Zhuauthor=J.+L.+Kimauthor=J.+R.+Newcombauthor=P.+E.+Roseauthor=D.+R.+Stoverauthor=L.+M.+Toledoauthor=H.+Zhaoauthor=K.+A.+Morgenstern&title=Structural+analysis+of+the+lymphocyte-specific+kinase+Lck+in+complex+with+non-selective+and+Src+family+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DNewcomb%26aufirst%3DJ.%2BR.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DStover%26aufirst%3DD.%2BR.%26aulast%3DToledo%26aufirst%3DL.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DMorgenstern%26aufirst%3DK.%2BA.%26atitle%3DStructural%2520analysis%2520of%2520the%2520lymphocyte-specific%2520kinase%2520Lck%2520in%2520complex%2520with%2520non-selective%2520and%2520Src%2520family%2520selective%2520kinase%2520inhibitors%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D651%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Breitenlechner, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairies, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honold, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheiblich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koll, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engh, R. A.</span><span> </span><span class="NLM_article-title">Crystal structures of active SRC kinase domain complexes.</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><div class="note"><p class="first last">(PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yom">1yom</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yol">1yol</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yoj">1yoj</a>)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=222-231&author=C.+B.+Breitenlechnerauthor=N.+A.+Kairiesauthor=K.+Honoldauthor=S.+Scheiblichauthor=H.+Kollauthor=E.+Greiterauthor=S.+Kochauthor=W.+Schaferauthor=R.+Huberauthor=R.+A.+Engh&title=Crystal+structures+of+active+SRC+kinase+domain+complexes."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreitenlechner%26aufirst%3DC.%2BB.%26aulast%3DKairies%26aufirst%3DN.%2BA.%26aulast%3DHonold%26aufirst%3DK.%26aulast%3DScheiblich%26aufirst%3DS.%26aulast%3DKoll%26aufirst%3DH.%26aulast%3DGreiter%26aufirst%3DE.%26aulast%3DKoch%26aufirst%3DS.%26aulast%3DSchafer%26aufirst%3DW.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DEngh%26aufirst%3DR.%2BA.%26atitle%3DCrystal%2520structures%2520of%2520active%2520SRC%2520kinase%2520domain%2520complexes.%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D353%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><div class="note"><p class="first last">After we had completed our work in the benzotriazines targeting Src, Abl, and Abl-T315I, a paper from Ariad targeting Src by utilizing the Glu310 in the back of the hydrophobic pocket by making a donor interaction was published:</p></div><span class="NLM_contrib-group">Dalgarno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schravendijk, M. R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNeil, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcal, C.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohacek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1111%2Fj.1747-0285.2005.00316.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=16492148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=After+we+had+completed+our+work+in+the+benzotriazines+targeting+Src%2C+Abl%2C+and+Abl-T315I%2C+a+paper+from+Ariad+targeting+Src+by+utilizing+the+Glu310+in+the+back+of+the+hydrophobic+pocket+by+making+a+donor+interaction+was+published%3ADalgarno%2C+D.%3B+Stehle%2C+T.%3B+Narula%2C+S.%3B+Schelling%2C+P.%3B+Schravendijk%2C+M.+R.+V.%3B+Adams%2C+S.%3B+Andrade%2C+L.%3B+Keats%2C+J.%3B+Ram%2C+M.%3B+Jin%2C+L.%3B+Grossman%2C+T.%3B+MacNeil%2C+I.%3B+Metcal%2C+C.%2C+III%3B+Shakespeare%2C+W.%3B+Wang%2C+Y.%3B+Keenan%2C+T.%3B+Sundaramoorthi%2C+R.%3B+Bohacek%2C+R.%3B+Weigele%2C+M.%3B+Sawyer%2C+TChem.+Biol.+Drug+Des.+2006%2C+67%2C+46"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds</span></div><div class="casAuthors">Dalgarno, David; Stehle, Thilo; Narula, Surinder; Schelling, Pierre; van Schravendijk, Marie Rose; Adams, Susan; Andrade, Lawrence; Keats, Jeff; Ram, Mary; Jin, Lei; Grossman, Trudy; MacNeil, Ian; Metcalf, Chester, III; Shakespeare, William; Wang, Yihan; Keenan, Terry; Sundaramoorthi, Raji; Bohacek, Regine; Weigele, Manfred; Sawyer, Tomi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-57</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The tyrosine kinase pp60src (Src) is the prototypical member of a family of proteins that participate in a broad array of cellular signal transduction processes, including cell growth, differentiation, survival, adhesion, and migration.  Abnormal Src family kinase (SFK) signaling has been linked to several disease states, including osteoporosis and cancer metastases.  Src has thus emerged as a mol. target for the discovery of small-mol. inhibitors that regulate Src kinase activity by binding to the ATP pocket within the catalytic domain.  Here, we present crystal structures of the kinase domain of Src in complex with two purine-based inhibitors: AP23451, a small-mol. inhibitor designed to inhibit Src-dependent bone resorption, and AP23464, a small-mol. inhibitor designed to inhibit the Src-dependent metastatic spread of cancer.  In each case, a trisubstituted purine template core was elaborated using structure-based drug design to yield a potent Src kinase inhibitor.  These structures represent early examples of high affinity purine-based Src family kinase-inhibitor complexes, and they provide a detailed view of the specific protein-ligand interactions that lead to potent inhibition of Src.  In particular, the 3-hydroxyphenethyl N9 substituent of AP23464 forms unique interactions with the protein that are crit. to the picomolar affinity of this compd. for Src.  The comparison of these new structures with two relevant kinase-inhibitor complexes provides a structural basis for the obsd. kinase inhibitory selectivity.  Further comparisons reveal a concerted induced-fit movement between the N- and C-terminal lobes of the kinase that correlates with the affinity of the ligand.  Binding of the most potent inhibitor, AP23464, results in the largest induced-fit movement, which can be directly linked to interactions of the hydrophenethyl N9 substituent with a region at the interface between the two lobes.  A less pronounced induced-fit movement is also obsd. in the Src-AP23451 complex.  These new structures illustrate how the combination of structural, computational, and medicinal chem. can be used to rationalize the process of developing high affinity, selective tyrosine kinase inhibitors as potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqAcWZyLy8JrVg90H21EOLACvtfcHk0liyPjby4ldgyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7Y%253D&md5=5a89de976e29e65aec0553c84e2e0b92</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00316.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00316.x%26sid%3Dliteratum%253Aachs%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DStehle%26aufirst%3DT.%26aulast%3DNarula%26aufirst%3DS.%26aulast%3DSchelling%26aufirst%3DP.%26aulast%3DSchravendijk%26aufirst%3DM.%2BR.%2BV.%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DAndrade%26aufirst%3DL.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DRam%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DGrossman%26aufirst%3DT.%26aulast%3DMacNeil%26aufirst%3DI.%26aulast%3DMetcal%26aufirst%3DC.%26aulast%3DShakespeare%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKeenan%26aufirst%3DT.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DBohacek%26aufirst%3DR.%26aulast%3DWeigele%26aufirst%3DM.%26aulast%3DSawyer%26aufirst%3DT%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Noronha, G.; Cao, J.; Chow, C.; Dneprovskaia, E.; Hwang, L.; Lohse, D.; Mak, C. C.; McPherson, A.; Fine, R. M.; Kang, X.; Klebansky, B.; Palanki, M. S. S.; Pathak, V. P.; Renick, J.; Soll, R.; Zeng, B.</span> In  <span class="citation_source-book">Frontiers in Drug Design and Discovery</span>; <span class="NLM_contrib-group">Caldwell, G. W.; Atta-ur-Rahman; Player, M. R.; Choudhary, M. I.</span>, Eds.; <span class="NLM_publisher-name">Bentham Science Publishers</span>: <span class="NLM_publisher-loc">Oak Park, IL</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">3</span>, pp <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=121-144&author=G.+Noronha&author=J.+Cao&author=C.+Chow&author=E.+Dneprovskaia&author=L.+Hwang&author=D.+Lohse&author=C.+C.+Mak&author=A.+McPherson&author=R.+M.+Fine&author=X.+Kang&author=B.+Klebansky&author=M.+S.+S.+Palanki&author=V.+P.+Pathak&author=J.+Renick&author=R.+Soll&author=B.+Zengauthor=G.+W.+Caldwell&author=+Atta-ur-Rahman&author=M.+R.+Player&author=M.+I.+Choudhary&title=Frontiers+in+Drug+Design+and+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNoronha%26aufirst%3DG.%26btitle%3DFrontiers%2520in%2520Drug%2520Design%2520and%2520Discovery%26aulast%3DCaldwell%26aufirst%3DG.%2BW.%26pub%3DBentham%2520Science%2520Publishers%26date%3D2007%26volume%3D3%26spage%3D121%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><div class="note"><p class="first last">Compound <b>5</b> was evaluated in YES biochemical assay and found to be a potent inhibitor (<i>K</i><sub>i</sub> = 0.63 nM). The <i>K</i><sub>i</sub> value for compound <b>5</b> in VEGFr2 was 6.79 nM, and in Src it was 9.23 nM.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+5+was+evaluated+in+YES+biochemical+assay+and+found+to+be+a+potent+inhibitor+%28Ki+%3D+0.63+nM%29.+The+Ki+value+for+compound+5+in+VEGFr2+was+6.79+nM%2C+and+in+Src+it+was+9.23+nM."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Saint-Geniez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amore, P. A.</span><span> </span><span class="NLM_article-title">Development and pathology of the hyaloid, choroidal and retinal vasculature</span> <span class="citation_source-journal">Int. J. Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1387%2Fijdb.041895ms" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=15558494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADC%252BD2crosVGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1045-1058&author=M.+Saint-Geniezauthor=P.+A.+D%E2%80%99Amore&title=Development+and+pathology+of+the+hyaloid%2C+choroidal+and+retinal+vasculature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Development and pathology of the hyaloid, choroidal and retinal vasculature</span></div><div class="casAuthors">Saint-Geniez Magali; D'Amore Patricia A</div><div class="citationInfo"><span class="NLM_cas:title">The International journal of developmental biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">1045-58</span>
        ISSN:<span class="NLM_cas:issn">0214-6282</span>.
    </div><div class="casAbstract">During embryogenesis, the development and differentiation of the eye requires the concomitant formation of the neural/glial elements along with a dense vascular network.  The adult neural retina is supported by two distinct vascular systems, the proper retinal vessels and the choroidal vessels.  The two beds differ not only in their pattern of embryonic differentiation, but also in their function in the adult organism.  The retinal vasculature has barrier properties similar to those observed in the brain, whereas the choroidal vessels display a highly fenestrated phenotype.  The hyaloid vasculature is a transient embryonic vascular bed which is complete at birth in mammals and regresses contemporaneously with the formation of the retinal vasculature.  The dependence of the retina on its blood supply makes it highly vulnerable to any vascular changes and indeed ocular diseases, such as proliferative retinopathy, age-related macular degeneration and the hyperplastic primary vitreous, which are associated with abnormalities of the different vascular beds of the eye.  A number of factors have been implicated in developmental and pathological changes in vessel formation and regression, including fibroblast growth factors, platelet-derived endothelial growth factor and vascular endothelial growth factor, among others.  The purpose of this review is to describe and discuss new insights into the mechanisms and molecular cues involved in the development of the normal and pathological vascular systems of the eye.  The characterization of the molecules and cell-cell interactions involved in the formation, stabilization and regression of new vessels has led to the identification of potential control points for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUCQIXDWngcSM8MEzWGjS9fW6udTcc2ebiM2iNPJY5vbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crosVGjsA%253D%253D&md5=a805a73906429119f1867ee1f0fce6a0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1387%2Fijdb.041895ms&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1387%252Fijdb.041895ms%26sid%3Dliteratum%253Aachs%26aulast%3DSaint-Geniez%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Amore%26aufirst%3DP.%2BA.%26atitle%3DDevelopment%2520and%2520pathology%2520of%2520the%2520hyaloid%252C%2520choroidal%2520and%2520retinal%2520vasculature%26jtitle%3DInt.%2520J.%2520Dev.%2520Biol.%26date%3D2004%26volume%3D48%26spage%3D1045%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Aguilar, E.; Scheppke, L.; Dorrell, M.; Hood, J.; Dellamary, L.; Yee, S.; Friedlander, M.</span><span> </span><span class="NLM_article-title">Topically Applied Src Kinase/VEGFR Prodrug Reduces Retinal Vascular Permeability</span>. Presented at the <span class="NLM_conf-name">Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)</span>, <span class="NLM_conf-loc">Fort Lauderdale, FL</span>, <span class="NLM_conf-date">April 3 through May 4</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=E.+Aguilar&author=L.+Scheppke&author=M.+Dorrell&author=J.+Hood&author=L.+Dellamary&author=S.+Yee&author=M.+Friedlander&title=Topically+Applied+Src+Kinase%2FVEGFR+Prodrug+Reduces+Retinal+Vascular+Permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DE.%26atitle%3DTopically%2520Applied%2520Src%2520Kinase%252FVEGFR%2520Prodrug%2520Reduces%2520Retinal%2520Vascular%2520Permeability%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Attar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, K, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D. T.</span><span> </span><span class="NLM_article-title">Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1517%2F17425247.2.5.891" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=908-891&author=M.+Attarauthor=J.+Shenauthor=K%2C+J.+Lingauthor=D.+T.+Liu&title=Ophthalmic+drug+delivery+considerations+at+the+cellular+level%3A+drug-metabolising+enzymes+and+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1517%2F17425247.2.5.891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2.5.891%26sid%3Dliteratum%253Aachs%26aulast%3DAttar%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DLing%26aufirst%3DK%252C%2BJ.%26aulast%3DLiu%26aufirst%3DD.%2BT.%26atitle%3DOphthalmic%2520drug%2520delivery%2520considerations%2520at%2520the%2520cellular%2520level%253A%2520drug-metabolising%2520enzymes%2520and%2520transporters%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2005%26volume%3D2%26spage%3D908%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Ahmed Kousba, A.; Yu, J.; Dellamary, L.; White, R.; Hu, S.; Tabak, A.; Cao, J.; Mak, C. C.; Renick, J.; McPherson, A.; Zeng, B.; Pathak, V.; Ibanez, G.; Stoughton, S.; Olafson, T.; Soll, R.; Doukas, J.; Hood, J.; Noronha, G.; Martin., M.</span><span> </span><span class="NLM_article-title">Bioactivation and Ocular Disposition of Topically Applied Prodrug TG100801</span>. Presented at the <span class="NLM_conf-name">8th Scientific Meeting of the Association for Ocular Pharmacology and Therapeutics</span>, <span class="NLM_conf-loc">San Diego, CA</span>, <span class="NLM_conf-date">February 9–11</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=A.+Ahmed+Kousba&author=J.+Yu&author=L.+Dellamary&author=R.+White&author=S.+Hu&author=A.+Tabak&author=J.+Cao&author=C.+C.+Mak&author=J.+Renick&author=A.+McPherson&author=B.+Zeng&author=V.+Pathak&author=G.+Ibanez&author=S.+Stoughton&author=T.+Olafson&author=R.+Soll&author=J.+Doukas&author=J.+Hood&author=G.+Noronha&author=M.+Martin.&title=Bioactivation+and+Ocular+Disposition+of+Topically+Applied+Prodrug+TG100801"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%2BKousba%26aufirst%3DA.%26atitle%3DBioactivation%2520and%2520Ocular%2520Disposition%2520of%2520Topically%2520Applied%2520Prodrug%2520TG100801%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><div class="note"><p class="first last">It is very difficult to accurately dissect sclera and choroid separately in the eyes of mice. Hence, we measured the concentration of the compound from the combined sclera and choroid tissues.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=It+is+very+difficult+to+accurately+dissect+sclera+and+choroid+separately+in+the+eyes+of+mice.+Hence%2C+we+measured+the+concentration+of+the+compound+from+the+combined+sclera+and+choroid+tissues."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><div class="note"><p class="first last">We examined the distribution of radiolabeled compound <b>12</b> in rabbit upon topical instillation in a single eye. The compound was present in most of the removed eye tissues and distributed in various parts of the eye as anticipated. The radiolabeled material was not present in systemic circulation or any other tissues. The bulk of the compound was excreted in the feces. It appears most of the compound was drained through the nasolacrimal drainage system. Manuscript is in preparation.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=We+examined+the+distribution+of+radiolabeled+compound+12+in+rabbit+upon+topical+instillation+in+a+single+eye.+The+compound+was+present+in+most+of+the+removed+eye+tissues+and+distributed+in+various+parts+of+the+eye+as+anticipated.+The+radiolabeled+material+was+not+present+in+systemic+circulation+or+any+other+tissues.+The+bulk+of+the+compound+was+excreted+in+the+feces.+It+appears+most+of+the+compound+was+drained+through+the+nasolacrimal+drainage+system.+Manuscript+is+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Miller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, S. J.</span><span> </span><span class="NLM_article-title">The role of the retinal pigmented epithelium in the involution of subretinal neovascularization</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1644</span><span class="NLM_x">–</span> <span class="NLM_lpage">1652</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=2429937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADyaL2s%252Fjt1OksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1986&pages=1644-1652&author=H.+Millerauthor=B.+Millerauthor=S.+J.+Ryan&title=The+role+of+the+retinal+pigmented+epithelium+in+the+involution+of+subretinal+neovascularization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The role of retinal pigment epithelium in the involution of subretinal neovascularization</span></div><div class="casAuthors">Miller H; Miller B; Ryan S J</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology & visual science</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1644-52</span>
        ISSN:<span class="NLM_cas:issn">0146-0404</span>.
    </div><div class="casAbstract">The extravascular milieu around laser-induced experimental subretinal neovascularization (SRN) was studied during the evolution of the neovascular membrane from its early leaky stage to its late involuted stage.  When the first signs of visible leakage appeared on angiography, newly formed vessels were spread in the subretinal space around the break in Bruch's membrane, fluid was accumulating in the subretinal space, and retinal pigment epithelial (RPE) cells were proliferating in a papillary pattern around the newly formed vessels; the RPE proliferation began with the undamaged cells at the edges of the laser injury.  With further maturation, the RPE continued to envelope the subretinal vessels.  This RPE proliferation was associated with the disappearance of fluid between the enveloped vessels and the sensory retina, and the gradual cessation of fluorescein leakage during angiography.  At the end of the involution process, when the neovascular membrane no longer demonstrated any leakage, the subretinal vessels were found to be tightly enveloped by RPE cells, and no fluid separated them from the sensory retina.  The authors' results suggest that involution of the neovascular membrane with maturation, as demonstrated by the cessation of visible fluorescein leakage, is the result of RPE proliferation that tightly envelopes the newly formed vessels and probably resorbs the previously accumulated subretinal fluid, as well as preventing its further accumulation in the subretinal space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1_M-cDM9zolw2ofyr07jXfW6udTcc2eZvXk0r6a_UCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s%252Fjt1OksQ%253D%253D&md5=d63f021054201b7e6a8481c0bd172a7c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DH.%26aulast%3DMiller%26aufirst%3DB.%26aulast%3DRyan%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520role%2520of%2520the%2520retinal%2520pigmented%2520epithelium%2520in%2520the%2520involution%2520of%2520subretinal%2520neovascularization%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D1986%26volume%3D27%26spage%3D1644%26epage%3D1652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Dobi, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puliafito, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Destro, M.</span><span> </span><span class="NLM_article-title">A new model of choroidal neovascularization in the rat</span> <span class="citation_source-journal">Arch. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">264</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=2464985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADyaL1M7jtl2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1989&pages=264-269&author=E.+T.+Dobiauthor=C.+A.+Puliafitoauthor=M.+Destro&title=A+new+model+of+choroidal+neovascularization+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A new model of experimental choroidal neovascularization in the rat</span></div><div class="casAuthors">Dobi E T; Puliafito C A; Destro M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of ophthalmology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">264-9</span>
        ISSN:<span class="NLM_cas:issn">0003-9950</span>.
    </div><div class="casAbstract">Choroidal neovascularization in rat eyes was induced by krypton laser photocoagulation.  Lesions were studied weekly by ophthalmoscopy, fundus photography, and fluorescein angiography.  Morphologic correlation was provided by serial sectioning of lesions for light and transmission electron microscopy.  In addition, vascular casts were prepared for scanning electron microscopy.  Choroidal neovascularization occurred in 25 (60%) of 42 lesions, as evidenced by growth of capillaries through breaks in Bruch's membrane.  In addition, 24 (28%) of 86 lesions studied by fluorescein angiography demonstrated leakage.  This study provides the most complete angiographic, histologic, and ultrastructural documentation of experimental choroidal neovascularization in the rat.  This model may be useful for in vivo studies of choroidal angiogenesis and its modulation via drug therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeZXMBev269MvLc4ARHEmzfW6udTcc2eZvXk0r6a_UCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M7jtl2jsA%253D%253D&md5=c1d0e099d356dff22d15f4ed804ce0f7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobi%26aufirst%3DE.%2BT.%26aulast%3DPuliafito%26aufirst%3DC.%2BA.%26aulast%3DDestro%26aufirst%3DM.%26atitle%3DA%2520new%2520model%2520of%2520choroidal%2520neovascularization%2520in%2520the%2520rat%26jtitle%3DArch.%2520Ophthalmol.%26date%3D1989%26volume%3D107%26spage%3D264%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Soubrane, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delayre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, M.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coscas, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtois, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanny, J.-C.</span><span> </span><span class="NLM_article-title">Basic fibroblast growth factor experimentally induced choroidal angiogenesis in the minipig</span> <span class="citation_source-journal">Curr. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.3109%2F02713689408995776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=7514965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADyaK2c3lt1WjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1994&pages=183-195&author=G.+Soubraneauthor=S.+Y.+Cohenauthor=T.+Delayreauthor=J.+Tassinauthor=M.-P.+Hartmannauthor=G.+J.+Coscasauthor=Y.+Courtoisauthor=J.-C.+Jeanny&title=Basic+fibroblast+growth+factor+experimentally+induced+choroidal+angiogenesis+in+the+minipig"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Basic fibroblast growth factor experimentally induced choroidal angiogenesis in the minipig</span></div><div class="casAuthors">Soubrane G; Cohen S Y; Delayre T; Tassin J; Hartmann M P; Coscas G J; Courtois Y; Jeanny J C</div><div class="citationInfo"><span class="NLM_cas:title">Current eye research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">183-95</span>
        ISSN:<span class="NLM_cas:issn">0271-3683</span>.
    </div><div class="casAbstract">Basic fibroblast growth factor (bFGF), a soluble mitogen, has been isolated and purified from various organs, including the retina.  In vivo angiogenic activity of bFGF has been demonstrated with several assays.  An experimental model of choroidal neovascularization was developed in the mini pig by perfusion of recombinant human bFGF through an osmotic minipump.  Endogenous bFGF and bFGF receptors were localized in the normal pig retina by immunohistochemistry and autoradiography after binding.  The perfusion of exogenous bFGF induced well-organized new vessels along the last 3 mm of the catheter in the suprachoroidal space.  This neovascularization did not penetrate the normal Bruch's membrane.  Vascular cells (identified by von Willebrand factor antibody staining) increased in number and in surface from the proximal part to the end of the intraocular catheter in all bFGF perfused eyes.  In eyes perfused with phosphate buffered saline (controls), but not in the bFGF perfused eyes, an inflammatory response occurred (identified by a macrophage specific antibody).  These results demonstrate that choroidal angiogenesis can be achieved without an inflammatory response by perfusing an excess of bFGF in the suprachoroidal space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIoeyG_snsr-2mnZh2OgS0fW6udTcc2eZvXk0r6a_UCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c3lt1WjsA%253D%253D&md5=0ef646738fddfa6d12530cbddeabde92</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3109%2F02713689408995776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F02713689408995776%26sid%3Dliteratum%253Aachs%26aulast%3DSoubrane%26aufirst%3DG.%26aulast%3DCohen%26aufirst%3DS.%2BY.%26aulast%3DDelayre%26aufirst%3DT.%26aulast%3DTassin%26aufirst%3DJ.%26aulast%3DHartmann%26aufirst%3DM.-P.%26aulast%3DCoscas%26aufirst%3DG.%2BJ.%26aulast%3DCourtois%26aufirst%3DY.%26aulast%3DJeanny%26aufirst%3DJ.-C.%26atitle%3DBasic%2520fibroblast%2520growth%2520factor%2520experimentally%2520induced%2520choroidal%2520angiogenesis%2520in%2520the%2520minipig%26jtitle%3DCurr.%2520Eye%2520Res.%26date%3D1994%26volume%3D13%26spage%3D183%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, S. J.</span><span> </span><span class="NLM_article-title">A new model of subretinal neovascularization in the rabbit</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2110</span><span class="NLM_x">–</span> <span class="NLM_lpage">2119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=7657549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADyaK2Mzos1Cisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=2110-2119&author=H.+Kimuraauthor=T.+Sakamotoauthor=D.+R.+Hintonauthor=C.+Speeauthor=Y.+Oguraauthor=Y.+Tabataauthor=Y.+Ikadaauthor=S.+J.+Ryan&title=A+new+model+of+subretinal+neovascularization+in+the+rabbit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A new model of subretinal neovascularization in the rabbit</span></div><div class="casAuthors">Kimura H; Sakamoto T; Hinton D R; Spee C; Ogura Y; Tabata Y; Ikada Y; Ryan S J</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology & visual science</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2110-9</span>
        ISSN:<span class="NLM_cas:issn">0146-0404</span>.
    </div><div class="casAbstract">PURPOSE:  To establish a new model of subretinal neovascularization (SRN) in the rabbit by implanting basic fibroblast growth factor (bFGF)-impregnated gelatin microspheres beneath the retina.  METHODS:  Basic fibroblast growth factor-impregnated gelatin microspheres were prepared by forming a polyion complex between gelatin and bFGF.  The microspheres, containing 2.5 micrograms of bFGF, were injected into the subretinal space of rabbit eyes (n = 29).  Control eyes (n = 10) received bFGF-free gelatin microspheres.  Eyes were followed up for 3 days to 8 weeks by ophthalmoscopy, photography, fluorescein angiography, light microscopy, and transmission electron microscopy.  RESULTS:  Twenty of 24 experimental eyes (83%) showed fluorescein leakage from SRN 2 weeks after implantation of the bFGF-impregnated microspheres.  This leakage continued for 2 to 6 more weeks.  In striking contrast, control eyes showed no fluorescein leakage.  Histologic examination revealed SRN in all the experimental eyes but in none of the control eyes.  CONCLUSIONS:  Subretinal implantation of bFGF-impregnated gelatin microspheres induces reproducible SRN in the rabbit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXCqhAcE7ePJQHPYJuLg8TfW6udTcc2eZvXk0r6a_UCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2Mzos1Cisg%253D%253D&md5=2d949c16f3e6beb6911d4b2b7cc739e7</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DSakamoto%26aufirst%3DT.%26aulast%3DHinton%26aufirst%3DD.%2BR.%26aulast%3DSpee%26aufirst%3DC.%26aulast%3DOgura%26aufirst%3DY.%26aulast%3DTabata%26aufirst%3DY.%26aulast%3DIkada%26aufirst%3DY.%26aulast%3DRyan%26aufirst%3DS.%2BJ.%26atitle%3DA%2520new%2520model%2520of%2520subretinal%2520neovascularization%2520in%2520the%2520rabbit%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D1995%26volume%3D36%26spage%3D2110%26epage%3D2119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lima e Silva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatara, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khu, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauer, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Trans-scleral delivery of polyamine analogs for ocular neovascularization</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1260</span><span class="NLM_x">–</span> <span class="NLM_lpage">1267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50a&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1016%2Fj.exer.2006.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50a&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=16950258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50a&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFGnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2006&pages=1260-1267&author=R.+Lima+e+Silvaauthor=S.+Kachiauthor=H.+Akiyamaauthor=J.+Shenauthor=M.+C.+Hataraauthor=S.+Aslamauthor=Y.+Y.+Gongauthor=N.+H.+Khuauthor=T.+W.+Lauerauthor=S.+F.+Hackettauthor=L.+J.+Martonauthor=P.+A.+Campochiaro&title=Trans-scleral+delivery+of+polyamine+analogs+for+ocular+neovascularization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50aR"><div class="casContent"><span class="casTitleNuber">50a</span><div class="casTitle"><span class="NLM_cas:atitle">Transscleral delivery of polyamine analogs for ocular neovascularization</span></div><div class="casAuthors">Lima e Silva, Raquel; Kachi, Shu; Akiyama, Hideo; Shen, Ji Kui; Hatara, Maria Christina; Aslam, Sadia; Gong, Yuan Yuan; Khu, Naw Htee; Lauer, Thomas W.; Hackett, Sean F.; Marton, Laurence J.; Campochiaro, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1260-1267</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Periocular injections of the polyamine analog CGC-11144 three times a week causes regression of choroidal neovascularization.  This regimen was selected to maximize chances of success for proof of concept, but is not ideal for clin. application.  In this study we explored other regimens for periocular delivery of CGC-11144, and 2 other polyamine analogs, CGC-11047 and CGC-11093.  A single periocular injection of 200 μg of CGC-11144, 2 mg of CGC-11047, or 1.5 mg of CGC-11093 caused significant suppression and regression of laser-induced choroidal neovascularization.  An injection of 2 mg of CGC-11047 or 1.5 mg of CGC-11093 one or two weeks before, but not 3 wk before, rupture of Bruch's membrane also caused significant suppression.  Periocular injection of polyamine analogs also caused strong inhibition of retinal or subretinal neovascularization in mice with oxygen-induced ischemic retinopathy or Rhodopsin promoter/VEGF transgenic mice, resp.  These data suggest that periocular injection of one of 3 different polyamine analogs inhibits retinal or choroidal neovascularization and a single injection provides inhibitory activity for at least 2 to 3 wk, which could provide the basis for a feasible treatment regimen for clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0OdSe4SZZZ7Vg90H21EOLACvtfcHk0lhqLQB0waR56w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFGnsbo%253D&md5=ab37c7a51f7bbe06f5a7bbfb3b85a3cc</span></div><a href="/servlet/linkout?suffix=cit50a&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2006.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2006.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DLima%2Be%2BSilva%26aufirst%3DR.%26aulast%3DKachi%26aufirst%3DS.%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DHatara%26aufirst%3DM.%2BC.%26aulast%3DAslam%26aufirst%3DS.%26aulast%3DGong%26aufirst%3DY.%2BY.%26aulast%3DKhu%26aufirst%3DN.%2BH.%26aulast%3DLauer%26aufirst%3DT.%2BW.%26aulast%3DHackett%26aufirst%3DS.%2BF.%26aulast%3DMarton%26aufirst%3DL.%2BJ.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DTrans-scleral%2520delivery%2520of%2520polyamine%2520analogs%2520for%2520ocular%2520neovascularization%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2006%26volume%3D83%26spage%3D1260%26epage%3D1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit50b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Umeda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vossmeyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stragies, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1820</span><span class="NLM_x">–</span> <span class="NLM_lpage">1828</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=1820-1828&author=N.+Umedaauthor=S.+Kachiauthor=H.+Akiyamaauthor=G.+Zahnauthor=D.+Vossmeyerauthor=R.+Stragiesauthor=P.+A.+Campochiaro&title=Suppression+and+regression+of+choroidal+neovascularization+by+systemic+administration+of+an+alpha5beta1+integrin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUmeda%26aufirst%3DN.%26aulast%3DKachi%26aufirst%3DS.%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DZahn%26aufirst%3DG.%26aulast%3DVossmeyer%26aufirst%3DD.%26aulast%3DStragies%26aufirst%3DR.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DSuppression%2520and%2520regression%2520of%2520choroidal%2520neovascularization%2520by%2520systemic%2520administration%2520of%2520an%2520alpha5beta1%2520integrin%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D69%26spage%3D1820%26epage%3D1828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit50c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Nambu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularization</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3650</span><span class="NLM_x">–</span> <span class="NLM_lpage">3655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50c&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1167%2Fiovs.02-0985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50c&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=12882819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50c&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADC%252BD3szltV2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=3650-3655&author=H.+Nambuauthor=R.+Nambuauthor=M.+Meliaauthor=P.+A.+Campochiaro&title=Combretastatin+A-4+phosphate+suppresses+development+and+induces+regression+of+choroidal+neovascularization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50cR"><div class="casContent"><span class="casTitleNuber">50c</span><div class="casTitle"><span class="NLM_cas:atitle">Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularization</span></div><div class="casAuthors">Nambu Hiroyuki; Nambu Rie; Melia Michele; Campochiaro Peter A</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology & visual science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3650-5</span>
        ISSN:<span class="NLM_cas:issn">0146-0404</span>.
    </div><div class="casAbstract">PURPOSE:  Combretastatin A-4 (CA-4) is a naturally occurring agent that binds tubulin and causes necrosis and shrinkage of tumors by damaging their blood vessels.  In this study the effect of a CA-4 prodrug, combretastatin A-4-phosphate (CA-4-P), was tested in two models of ocular neovascularization.  METHODS:  The effect of CA-4-P was quantitatively assessed in transgenic mice with overexpression of vascular endothelial growth factor in the retina (rho/VEGF mice) and mice with choroidal neovascularization (CNV) due to laser-induced rupture of Bruch's membrane.  RESULTS:  In rho/VEGF mice, daily intraperitoneal injections of 4.0 mg/kg CA-4-P starting at postnatal day (P)7, the time of onset of transgene expression, resulted in a significant reduction in the number of neovascular lesions and total area of neovascularization per retina at P21, compared with vehicle-injected mice.  In mice with laser-induced rupture of Bruch's membrane, daily intraperitoneal injections of 75 or 100 mg/kg CA-4-P resulted in a significant reduction in the area of CNV at rupture sites compared with vehicle-injected mice.  In mice with established CNV, daily intraperitoneal injections of 100 mg/kg CA-4-P for 1 week resulted in a significant reduction in CNV area at rupture sites compared with the baseline area before treatment or the area of CNV in vehicle-treated mice.  CONCLUSIONS:  These data indicate that CA-4-P suppresses the development of VEGF-induced neovascularization in the retina and both blocks development and promotes regression of CNV.  Therefore, CA-4-P shows potential for both prevention and treatment of ocular neovascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQH74-mFuwyNaNc3HjJRoFAfW6udTcc2eZS6zfbE6NW37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szltV2rtg%253D%253D&md5=36be9072a6e9c8307039d7412a26330f</span></div><a href="/servlet/linkout?suffix=cit50c&amp;dbid=16384&amp;doi=10.1167%2Fiovs.02-0985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.02-0985%26sid%3Dliteratum%253Aachs%26aulast%3DNambu%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DR.%26aulast%3DMelia%26aufirst%3DM.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DCombretastatin%2520A-4%2520phosphate%2520suppresses%2520development%2520and%2520induces%2520regression%2520of%2520choroidal%2520neovascularization%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2003%26volume%3D44%26spage%3D3650%26epage%3D3655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit50d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saishin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melia, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bingaman, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Topical nepafenac inhibits ocular neovascularization</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50d&amp;dbid=16&amp;doi=10.1021%2Fjm7011276&amp;key=10.1167%2Fiovs.02-0346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50d&amp;dbid=8&amp;doi=10.1021%2Fjm7011276&amp;key=12506103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50d&amp;dbid=32&amp;doi=10.1021%2Fjm7011276&amp;key=1%3ACAS%3A280%3ADC%252BD38jktFOmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=409-415&author=K.+Takahashiauthor=Y.+Saishinauthor=Y.+Saishinauthor=K.+Moriauthor=A.+Andoauthor=S.+Yamamotoauthor=Y.+Oshimaauthor=H.+Nambuauthor=M.+B.+Meliaauthor=D.+P.+Bingamanauthor=P.+A.+Campochiaro&title=Topical+nepafenac+inhibits+ocular+neovascularization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50dR"><div class="casContent"><span class="casTitleNuber">50d</span><div class="casTitle"><span class="NLM_cas:atitle">Topical nepafenac inhibits ocular neovascularization</span></div><div class="casAuthors">Takahashi Kyoichi; Saishin Yoshitsugu; Saishin Yumiko; Mori Keisuke; Ando Akira; Yamamoto Satoru; Oshima Yuji; Nambu Hiroyuki; Melia Michele B; Bingaman David P; Campochiaro Peter A</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology & visual science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">409-15</span>
        ISSN:<span class="NLM_cas:issn">0146-0404</span>.
    </div><div class="casAbstract">PURPOSE:  Topical nepafenac readily penetrates the cornea and is metabolized to amfenac, a potent cyclooxygenase (COX)-1 and COX-2 inhibitor.  In this study, we tested the effect of topical nepafenac in three murine models of ocular neovascularization (NV).  METHODS:  A masked trial was performed to compare the topical effects of vehicle with one of several concentrations of nepafenac (0.01%, 0.03%, 0.1%, or 0.5%), 0.1% diclofenac, or 0.5% ketorolac tromethamine in mice with oxygen-induced ischemic retinopathy, mice with choroidal NV (CNV) due to laser-induced rupture of Bruch's membrane, or transgenic mice with increased expression of vascular endothelial growth factor (VEGF) in photoreceptors (rho/VEGF transgenic mice).  RESULTS:  Mice treated with 0.1% or 0.5% nepafenac had significantly less CNV and significant less ischemia-induced retinal NV than did vehicle-treated mice.  Nepafenac also blunted the increase in VEGF mRNA in the retina induced by ischemia.  In rho/VEGF transgenic mice, nepafenac failed to inhibit neovascularization.  In additional studies, compared with vehicle-treated mice, mice treated with 0.1% or 0.03% nepafenac had significantly less CNV, whereas eyes treated with 0.1% diclofenac showed no significant difference.  Mice treated with 0.5% ketorolac tromethamine for 14 days had high mortality, but when evaluated after 7 days of treatment showed no difference from mice treated with vehicle for 7 days.  CONCLUSIONS:  Topical nepafenac inhibits CNV and ischemia-induced retinal neovascularization by decreasing production of VEGF.  The absence of effect in rho/VEGF transgenic mice is consistent with this mechanism.  Topical nepafenac may provide an effective new treatment for ocular neovascularization.  The excellent corneal penetration of nepafenac certainly plays an important role in this effect.  It is possible that other antiangiogenic agents are also amenable to topical application after formulations are identified that maximize their corneal penetration.  Because of the many advantages of the topical route of delivery, this is a possible topic for exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBZdWOugH4ZD0SWnHPWbmmfW6udTcc2eZS6zfbE6NW37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jktFOmtQ%253D%253D&md5=ef3bd727f479e3d1b785578c93676a30</span></div><a href="/servlet/linkout?suffix=cit50d&amp;dbid=16384&amp;doi=10.1167%2Fiovs.02-0346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.02-0346%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DSaishin%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DS.%26aulast%3DOshima%26aufirst%3DY.%26aulast%3DNambu%26aufirst%3DH.%26aulast%3DMelia%26aufirst%3DM.%2BB.%26aulast%3DBingaman%26aufirst%3DD.%2BP.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DTopical%2520nepafenac%2520inhibits%2520ocular%2520neovascularization%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2003%26volume%3D44%26spage%3D409%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><div class="note"><p class="first last">Private communication from Professor Martin Friedlander. Manuscript is in preparation.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Private+communication+from+Professor+Martin+Friedlander.+Manuscript+is+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Calalb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polte, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, S.</span><span> </span><span class="NLM_article-title">Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=1996&pages=662-668&author=M.+Calalbauthor=X.+Zhangauthor=T.+Polteauthor=S.+Hanks&title=Focal+adhesion+kinase+tyrosine-861+is+a+major+site+of+phosphorylation+by+Src"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalalb%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPolte%26aufirst%3DT.%26aulast%3DHanks%26aufirst%3DS.%26atitle%3DFocal%2520adhesion%2520kinase%2520tyrosine-861%2520is%2520a%2520major%2520site%2520of%2520phosphorylation%2520by%2520Src%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1996%26volume%3D228%26spage%3D662%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Lim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahk, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, E.</span><span> </span><span class="NLM_article-title">Phosphorylation of focal adhesion kinase at tyrosine 861 is crucial for ras transformation of fibroblasts</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">29060</span><span class="NLM_x">–</span> <span class="NLM_lpage">29065</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=29060-29065&author=Y.+Limauthor=I.+Hanauthor=J.+Jeonauthor=H.+Parkauthor=Y.+Bahkauthor=E.+Oh&title=Phosphorylation+of+focal+adhesion+kinase+at+tyrosine+861+is+crucial+for+ras+transformation+of+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DI.%26aulast%3DJeon%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DBahk%26aufirst%3DY.%26aulast%3DOh%26aufirst%3DE.%26atitle%3DPhosphorylation%2520of%2520focal%2520adhesion%2520kinase%2520at%2520tyrosine%2520861%2520is%2520crucial%2520for%2520ras%2520transformation%2520of%2520fibroblasts%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D29060%26epage%3D29065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Eliceiri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartzberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D.</span><span> </span><span class="NLM_article-title">Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=915-924&author=B.+Eliceiriauthor=R.+Paulauthor=P.+Schwartzbergauthor=J.+D.+Hoodauthor=J.+Lengauthor=D.+Cheresh&title=Selective+requirement+for+Src+kinases+during+VEGF-induced+angiogenesis+and+vascular+permeability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEliceiri%26aufirst%3DB.%26aulast%3DPaul%26aufirst%3DR.%26aulast%3DSchwartzberg%26aufirst%3DP.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DLeng%26aufirst%3DJ.%26aulast%3DCheresh%26aufirst%3DD.%26atitle%3DSelective%2520requirement%2520for%2520Src%2520kinases%2520during%2520VEGF-induced%2520angiogenesis%2520and%2520vascular%2520permeability%26jtitle%3DMol.%2520Cell%26date%3D1999%26volume%3D4%26spage%3D915%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Abu-Ghazaleh, R.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabir, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zachary, I.</span><span> </span><span class="NLM_article-title">Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2001&pages=255-264&author=R.%3B+Abu-Ghazalehauthor=J.+Kabirauthor=H.%3B+Jiaauthor=M.+Loboauthor=I.+Zachary&title=Src+mediates+stimulation+by+vascular+endothelial+growth+factor+of+the+phosphorylation+of+focal+adhesion+kinase+at+tyrosine+861%2C+and+migration+and+anti-apoptosis+in+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbu-Ghazaleh%26aufirst%3DR.%253B%26aulast%3DKabir%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DH.%253B%26aulast%3DLobo%26aufirst%3DM.%26aulast%3DZachary%26aufirst%3DI.%26atitle%3DSrc%2520mediates%2520stimulation%2520by%2520vascular%2520endothelial%2520growth%2520factor%2520of%2520the%2520phosphorylation%2520of%2520focal%2520adhesion%2520kinase%2520at%2520tyrosine%2520861%252C%2520and%2520migration%2520and%2520anti-apoptosis%2520in%2520endothelial%2520cells%26jtitle%3DBiochem.%2520J.%26date%3D2001%26volume%3D360%26spage%3D255%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Eliceiri, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puente, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupack, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span> </span><span class="NLM_article-title">Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2002&pages=149-160&author=B.+P.+Eliceiriauthor=X.+S.+Puenteauthor=J.+D.+Hoodauthor=D.+G.+Stupackauthor=D.+D.+Schlaepferauthor=X.+Z.+Huangauthor=D.+Sheppardauthor=D.+A.+Cheresh&title=Src-mediated+coupling+of+focal+adhesion+kinase+to+integrin+alpha%28v%29beta5+in+vascular+endothelial+growth+factor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEliceiri%26aufirst%3DB.%2BP.%26aulast%3DPuente%26aufirst%3DX.%2BS.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DStupack%26aufirst%3DD.%2BG.%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26aulast%3DHuang%26aufirst%3DX.%2BZ.%26aulast%3DSheppard%26aufirst%3DD.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26atitle%3DSrc-mediated%2520coupling%2520of%2520focal%2520adhesion%2520kinase%2520to%2520integrin%2520alpha%2528v%2529beta5%2520in%2520vascular%2520endothelial%2520growth%2520factor%2520signaling%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2002%26volume%3D157%26spage%3D149%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><a href="http://www.clinicaltrials.gov/ct/show/NCT00509548?order=1" class="extLink">http://www.clinicaltrials.gov/ct/show/NCT00509548?order=1</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.clinicaltrials.gov%2Fct%2Fshow%2FNCT00509548%3Forder%3D1."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Doukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umeda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellamary, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racanelli-Layton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noronha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campochiaro, P. A.</span><span> </span><span class="NLM_article-title">Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema.</span> <span class="citation_source-journal">J. Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span> <span class="NLM_fpage"></span><div class="note"><p class="first last">accepted for publication</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2008&author=J.+Doukasauthor=S.+Maheshauthor=N.+Umedaauthor=S.+Kachiauthor=H.+Akiyamaauthor=K.+Yokoiauthor=J.+Caoauthor=Z.+Chenauthor=L.+Dellamaryauthor=B.+Tamauthor=A.+Racanelli-Laytonauthor=J.+Hoodauthor=M.+Martinauthor=G.+Noronhaauthor=R.+Sollauthor=P.+A.+Campochiaro&title=Topical+administration+of+a+multi-targeted+kinase+inhibitor+suppresses+choroidal+neovascularization+and+retinal+edema."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoukas%26aufirst%3DJ.%26aulast%3DMahesh%26aufirst%3DS.%26aulast%3DUmeda%26aufirst%3DN.%26aulast%3DKachi%26aufirst%3DS.%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DYokoi%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDellamary%26aufirst%3DL.%26aulast%3DTam%26aufirst%3DB.%26aulast%3DRacanelli-Layton%26aufirst%3DA.%26aulast%3DHood%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DNoronha%26aufirst%3DG.%26aulast%3DSoll%26aufirst%3DR.%26aulast%3DCampochiaro%26aufirst%3DP.%2BA.%26atitle%3DTopical%2520administration%2520of%2520a%2520multi-targeted%2520kinase%2520inhibitor%2520suppresses%2520choroidal%2520neovascularization%2520and%2520retinal%2520edema.%26jtitle%3DJ.%2520Cell%2520Physiol.%26date%3D2008%26volume%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Verbeke, G.; Molenberghs, G.</span>.  <span class="citation_source-book">Linear Mixed Models for Longitudinal Data</span>; <span class="NLM_publisher-name">Springer-Verlag Inc.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=93-120&author=G.+Verbeke&author=G.+Molenberghs&title=Linear+Mixed+Models+for+Longitudinal+Data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVerbeke%26aufirst%3DG.%26btitle%3DLinear%2520Mixed%2520Models%2520for%2520Longitudinal%2520Data%26pub%3DSpringer-Verlag%2520Inc%26date%3D2000%26spage%3D93%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2src" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2src','PDB','2src'); return false;">PDB: 2src</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1fmk" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1fmk','PDB','1fmk'); return false;">PDB: 1fmk</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1y57" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1y57','PDB','1y57'); return false;">PDB: 1y57</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ptk" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ptk','PDB','2ptk'); return false;">PDB: 2ptk</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ywn" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ywn','PDB','1ywn'); return false;">PDB: 1ywn</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1vr2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1vr2','PDB','1vr2'); return false;">PDB: 1vr2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1y6a" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1y6a','PDB','1y6a'); return false;">PDB: 1y6a</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1y6b" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1y6b','PDB','1y6b'); return false;">PDB: 1y6b</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yom" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yom','PDB','1yom'); return false;">PDB: 1yom</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yol" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yol','PDB','1yol'); return false;">PDB: 1yol</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yoj" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1yoj','PDB','1yoj'); return false;">PDB: 1yoj</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i58"><a href="/doi/suppl/10.1021/jm7011276">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_78848"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis results and details of the effects of <b>5</b> on target kinases and topically applied <b>5</b> and <b>12</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm7011276/suppl_file/jm7011276-file002.pdf">jm7011276-file002.pdf (516.37 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm7011276&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm7011276%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-6%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm7011276" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                669KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b23d6954231a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
